SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF
THE SECURITIES EXCHANGE ACT OF 1934
þ
Filed by the Registrant
o Filed by a Party other than the Registrant
Check the appropriate box:
o Preliminary Proxy Statement
þ Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Materials Pursuant to Sec 240.14a-11(c)
NOVELIS
INC.
(Name of Registrant as Specified in Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement)
PAYMENT OF
FILING FEE
(Check the appropriate box):
|
|
|
o |
|
Fee computed on table below per Exchange Act Rule 14a-6(i)(1) and 0-11. |
|
1) |
|
Title of each class of securities to which transactions applies: |
|
|
2) |
|
Aggregate number of securities to which transactions applies: |
|
|
3) |
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11. |
|
|
4) |
|
Proposed maximum aggregate value of Transaction: |
|
|
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act
Rule 0- 11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing. |
|
1) |
|
Amount previously paid: |
|
|
2) |
|
Form, Schedule or Registration Statement No.: |
|
|
3) |
|
Filing Party: |
|
|
4) |
|
Date Filed: |
NOVELIS INC.
NOTICE OF ANNUAL MEETING OF
SHAREHOLDERS
NOTICE IS HEREBY GIVEN that the 2006 annual meeting of
shareholders of Novelis Inc. (the Meeting) will be
held at The Westin Buckhead Atlanta, 3391 Peachtree Road,
Atlanta, GA 30326, on October 26, 2006, at 10:00 a.m.,
(EDT) for:
1. receiving the consolidated and combined financial
statements for the year ended December 31, 2005, together
with the independent registered public accounting firms
report thereon;
2. electing directors;
3. appointing the independent registered public accounting
firm and authorizing directors to fix the independent registered
public accounting firms remuneration;
4. approving the Novelis Inc. 2006 Incentive Plan; and
5. transacting such other business as may properly be
brought before the Meeting or any adjournment or postponement
thereof.
The directors have fixed September 19, 2006, as the record
date for the determination of the holders of common shares of
Novelis Inc. entitled to receive notice of the Meeting. Only the
holders of record of our common shares at the close of business
on September 19, 2006 are entitled to notice of and to vote
at the Meeting and any adjournment or postponement of the
Meeting. We anticipate that the information circular and the
accompanying proxy card will first be mailed to holders of our
common shares on or about September 22, 2006.
Your attention is directed to the information circular provided
with this notice.
Your vote is important. Whether or not you plan to attend the
Meeting in person, please submit your proxy as soon as possible.
You can vote by telephone, on the Internet or by mail with the
enclosed proxy card. Voting by any of these three methods will
ensure that you are represented at the Meeting even if you are
not there in person. Please review the instructions on the proxy
card regarding each of these voting options. Shareholders who
have previously voted, but attend the Meeting, may change their
vote at the Meeting.
BY ORDER OF THE BOARD OF DIRECTORS
Nichole Robinson
Corporate Secretary
September 22, 2006
Atlanta, Georgia
NOVELIS INC.
INFORMATION CIRCULAR
WHATS INSIDE
|
|
|
|
|
|
|
|
1
|
|
|
|
|
6
|
|
|
|
|
6
|
|
|
|
|
6
|
|
|
|
|
11
|
|
|
|
|
12
|
|
|
|
|
17
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
22
|
|
|
|
|
24
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
26
|
|
|
|
|
27
|
|
|
|
|
28
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
30
|
|
|
|
|
31
|
|
|
|
|
37
|
|
|
|
|
38
|
|
|
|
|
39
|
|
|
|
|
39
|
|
|
|
|
39
|
|
|
|
|
39
|
|
|
|
|
A-1
|
|
|
|
|
B-1
|
|
|
|
|
C-1
|
|
|
|
|
D-1
|
|
|
|
|
E-1
|
|
|
|
|
F-1
|
|
3399 Peachtree Road NE
Suite 1500
Atlanta, Georgia 30326
This information circular (this Circular) is
provided in connection with the solicitation of proxies by the
board of directors and management of Novelis Inc.
(Novelis) for use at the first annual meeting of
shareholders of Novelis or at any adjournment or postponement
thereof (the Meeting). In this Circular
you and your refer to the shareholders
of Novelis, and Novelis, the Company,
we, us or our refer to
Novelis. The Meeting will be held at The Westin Buckhead
Atlanta, 3391 Peachtree Road, Atlanta, GA 30326, on
October 26, 2006, at 10:00 a.m. (EDT) for the purposes
set forth in the foregoing Notice of Annual Meeting of
Shareholders. We anticipate that this Circular and the
accompanying proxy card will first be mailed to holders of our
common shares (the Shares) on or about
September 22, 2006. Except where otherwise indicated, the
information contained herein is provided as of August 31,
2006, and all dollar amounts are in U.S. dollars.
QUESTIONS &
ANSWERS ON VOTING AND PROXIES
|
|
|
Q: |
|
WHY AM I RECEIVING THIS CIRCULAR?
|
|
A: |
|
You are receiving this Circular and accompanying proxy card from
Novelis because you are a record holder of our Shares on
September 19, 2006 (the Record Date). This
Circular is furnished in connection with the solicitation of
shareholder proxies by the board of directors and management of
Novelis for use at the Meeting. This Circular describes issues
on which we would like you, as a shareholder, to vote. It also
gives you information on these issues so that you can make an
informed decision. |
|
Q:
|
|
HOW WILL MY PROXY BE SOLICITED?
|
|
A: |
|
The solicitation of proxies will be made primarily by mail, but
may also be made by electronic means, by telephone or in person.
The cost of soliciting proxies will be borne by Novelis.
Georgeson Inc. has been retained by Novelis in Canada and the
United States to assist in the solicitation of proxies from
shareholders. For these services, Georgeson Inc. is expected to
receive, from Novelis, fees of approximately $7,500 plus
reimbursement of reasonable expenses. In addition, employees of
Novelis may solicit proxies without compensation. CIBC Mellon
Trust Company (CIBC Mellon), our registrar and
transfer agent, is responsible for the tabulation of proxies. |
|
Q:
|
|
WHAT AM I VOTING ON?
|
|
A: |
|
Shareholders will be voting on the: |
|
|
|
election of our directors;
|
|
|
|
appointment of PricewaterhouseCoopers LLP as the
independent registered public accounting firm for the fiscal
year ending December 31, 2006, and to authorize the
directors to fix the independent registered public accounting
firms remuneration; |
|
|
|
approval of the Novelis Inc. 2006 Incentive Plan
(the Incentive Plan); and |
|
|
|
such other business as may properly be brought
before the Meeting or any adjournment or postponement thereof. |
|
|
|
Q:
|
|
HOW DO I VOTE?
|
|
A: |
|
If you are a registered shareholder (that is, if your Shares are
registered in your name with our transfer agent), you can vote
your Shares by telephone at 1-866-271-1207 or on the Internet
at http://www.eproxy.com/novelis.
More information regarding telephone and Internet voting is
provided on the proxy card. Voting or transmitting voting
authority by electronic means is generally recognized as a valid
exercise of those rights in Canada. |
|
|
|
Registered shareholders may also vote by mail. Simply complete,
sign and date the enclosed proxy card. Use either the enclosed
return envelope or the address provided in the instructions on
the proxy card to return the proxy card. |
|
|
|
If you are a non-registered shareholder (that is, if your Shares
are held in the name of an intermediary, such as a bank, broker,
trust company or other nominee), your broker or other nominee
will provide you with separate instructions on how to vote your
Shares. Many brokers or other nominees make telephone or
Internet voting available, but the specific processes available
will depend on your brokers or other nominees
specific arrangements. |
|
|
|
If you are a participant in the Novelis Savings and Retirement
Plan or the Novelis Hourly Savings Plan, you must provide the
trustee of the Novelis Savings and Retirement Plan or the
Novelis Hourly Savings Plan with your voting instructions in
advance of the Meeting according to the instructions provided by
the trustee. You cannot vote the Shares you hold through the
Novelis Savings and Retirement Plan or the Novelis Hourly
Savings Plan in person at the Meeting; the trustee is the only
person who can vote your Shares. The trustee will vote your
Shares as you have instructed. If the trustee does not receive
your voting instructions by the specified time, subject to
applicable laws, your Shares will be voted in the same
proportion as the Shares for which the trustee has received
voting instructions. |
|
Q:
|
|
HOW MAY I VOTE?
|
|
A: |
|
In respect of the election of directors, you may: |
|
|
|
Vote FOR the election of the nominees for
director; or |
|
|
|
WITHHOLD your vote for the nominees for
director. |
|
|
|
In respect of the appointment of the independent registered
public accounting firm and to authorize the directors to fix the
independent registered accounting firms remuneration, you
may: |
|
|
|
Vote FOR the appointment of
PricewaterhouseCoopers LLP as our independent registered public
accounting firm for the fiscal year ending December 31,
2006, and authorize the directors to fix the independent
registered public accounting firms remuneration; or |
|
|
|
WITHHOLD your vote for the appointment of
PricewaterhouseCoopers LLP as our independent registered public
accounting firm. |
|
|
|
In respect of approval of the Incentive Plan, you may: |
|
|
|
Vote FOR the approval of the Incentive Plan; |
|
|
|
Vote AGAINST the approval of the Incentive
Plan; or |
|
|
|
ABSTAIN from voting on the approval of the
Incentive Plan. |
|
Q:
|
|
WHAT HAPPENS WHEN I SIGN AND RETURN THE PROXY?
|
|
A: |
|
Signing the enclosed proxy card gives authority to the named
proxyholders on the proxy card, or to another person you have
appointed, to vote your Shares at the Meeting in accordance with
the voting instructions you provide. |
2
|
|
|
Q: |
|
CAN I APPOINT SOMEONE OTHER THAN THE NAMED PROXYHOLDERS TO
VOTE MY SHARES?
|
|
A: |
|
Yes. Write the name of the person you wish to appoint, who need
not be a shareholder, in the blank space provided on the proxy
card. It is important to ensure that the person you appoint
attends the Meeting and is aware that he or she has been
appointed to vote your Shares. Proxyholders should, upon their
arrival at the Meeting, present themselves to a representative
of CIBC Mellon. Please note that if you choose to vote your
Shares on the Internet or by telephone, only the persons
selected by Novelis and named on the proxy card may be appointed. |
|
Q: |
|
HOW WILL MY SHARES BE VOTED IF I RETURN MY PROXY?
|
|
A: |
|
The persons named in the proxy card will vote or withhold from
voting your Shares in accordance with your instructions. In the
absence of such instructions, however, your Shares will be voted: |
|
|
|
FOR the election of the director nominees; |
|
|
|
FOR the appointment of the independent
registered public accounting firm for the fiscal year ending
December 31, 2006, and to authorize the directors to fix
the independent registered public accounting firms
remuneration; |
|
|
|
FOR approval of the Incentive Plan; and |
|
|
|
Subject to applicable laws, in the discretion of the
proxyholders as to any other matters that may properly be
brought before the Meeting. |
|
Q: |
|
IF I CHANGE MY MIND, CAN I TAKE BACK MY PROXY ONCE I HAVE
GIVEN IT?
|
|
A: |
|
Yes. You may revoke your proxy at any time before it is
exercised at the Meeting. You may do so by executing and
returning a proxy card dated later than the previous one you
have submitted or by properly submitting a later proxy via
telephone or the Internet. You also may revoke your proxy by
casting your vote by ballot at the Meeting. The participation in
person by a shareholder in a vote by ballot at the Meeting will
automatically revoke any proxy that has been previously given by
the shareholder. |
|
Q:
|
|
HOW WILL MY SHARES BE VOTED IF I DO NOT SIGN AND RETURN
THE PROXY? |
|
A: |
|
If you are a registered shareholder and you do not sign and
return your proxy card, your Shares will not be voted at the
Meeting nor will they be used for purposes of establishing a
quorum. If you are a non-registered shareholder and you do not
follow the instructions provided by your broker or other nominee
to vote your Shares, your United States broker or other nominee
may, under certain circumstances, vote your Shares. On certain
routine matters, such as the election of directors
in an uncontested election and the appointment of the
independent registered public accounting firm, your United
States broker or other nominee has authority under New York
Stock Exchange rules to vote your Shares if you do not provide
voting instructions. On non-routine matters, such as
approval of the Incentive Plan, if your United States broker or
other nominee has not received voting instructions from you, the
broker or other nominee does not have authority to vote your
Shares. If your broker or other nominee has not received voting
instructions on a non-routine matter, these Shares will be
considered broker non-votes to the extent that the
broker or other nominee submits a proxy. Broker non-votes will
be counted for purposes of establishing a quorum to conduct
business at the Meeting but not for determining the number of
Shares voted FOR or AGAINST approval of the
Incentive Plan proposal. Broker non-votes will not be counted as
voted in determining whether the New York Stock
Exchange requirement that the Incentive Plan proposal be voted
on by more than 50% of the Shares entitled to vote is satisfied. |
|
|
|
Therefore, if you are a non-registered shareholder and you do
not return your proxy, your Shares may be voted by your United
States broker or other nominee with respect to the election of
director nominees and the appointment of the independent
registered public accounting firm in the absence of your
instructions but will not be voted with respect to the approval
of the Incentive Plan. |
|
|
|
We encourage you to provide instructions to your broker or other
nominee by returning your proxy. This action ensures that your
Shares will be voted at the Meeting. |
3
|
|
|
Q: |
|
WHAT IF I ABSTAIN FROM VOTING?
|
|
A: |
|
Abstentions with respect to a proposal are counted for purposes
of establishing a quorum to conduct business at the Meeting but
not for determining the number of Shares voted FOR or
AGAINST a proposal. If a quorum is present, abstentions
have no effect on the outcome of a vote on the election of
directors or the appointment of the independent registered
public accounting firm. Abstentions will not be counted as
Shares voted in determining whether the New York
Stock Exchange requirement that the Incentive Plan proposal be
voted on by more than 50% of the Shares entitled to vote is
satisfied. |
|
Q:
|
|
WHAT IF I PLAN TO ATTEND THE MEETING AND VOTE IN PERSON?
|
|
A: |
|
If you plan to attend the Meeting and wish to vote your Shares
in person at the Meeting, it is not necessary for you to
complete or return the proxy card. Your vote will be taken and
counted at the Meeting. However, we urge you to vote by proxy
even if you plan to attend the Meeting to help us determine that
enough votes will be present to establish a quorum. |
|
|
|
Please register with the transfer agent, CIBC Mellon, upon
arrival at the Meeting. Your participation in person in a vote
by ballot at the Meeting will automatically revoke any proxy
that you have previously given. Non-registered shareholders
wishing to attend the Meeting should obtain admission material
from their broker or other nominee and have their broker or
other nominee appoint them as proxyholder, or bring evidence of
ownership as of the record date, such as a bank or brokerage
account statement, to the Meeting. In all cases you must bring
photo identification to the Meeting for admission and if you do
not provide an admission ticket, a registration process will be
required. |
|
Q:
|
|
WHAT IF AMENDMENTS ARE MADE TO THE MATTERS TO BE CONSIDERED
AT THE MEETING OR IF OTHER MATTERS ARE BROUGHT BEFORE THE
MEETING?
|
|
A: |
|
The persons named in the proxy card will have discretionary
authority, subject to applicable laws, with respect to
amendments or variations to matters identified in the Notice of
Annual Meeting of Shareholders and to other matters which may
properly come before the Meeting. As of the date of this
Circular, the management of Novelis knows of no such amendment,
variation or other matter expected to come before the Meeting.
If any other matters properly come before the Meeting, the
persons named in the proxy card will vote on them in accordance
with their best judgment. |
|
Q: |
|
HOW WILL THE PROPOSALS BE DECIDED AT THE MEETING?
|
|
A: |
|
A majority of the votes cast in favor, by proxy or in person,
will constitute approval for (i) the election of the
director nominees, (ii) the appointment of our independent
registered public accounting firm and (iii) the Incentive
Plan. In addition, under New York Stock Exchange rules, the
proposal to approve the Incentive Plan must be voted on by more
than 50% of the Shares entitled to vote on the proposal. |
|
Q:
|
|
WHAT CONSTITUTES A QUORUM FOR THE MEETING?
|
|
A: |
|
A quorum consists of the presence, in person or by proxy, of the
holders of 25% or more of the Shares entitled to vote at the
Meeting. A quorum is necessary to conduct business at the
Meeting. You are part of the quorum if you have voted by proxy.
Abstentions and broker non-votes are counted for purposes of
establishing a quorum. |
|
Q:
|
|
WHO IS ENTITLED TO VOTE?
|
|
A: |
|
On the Record Date, 74,005,649 Shares were outstanding.
Shareholders of record as of the close of business on the Record
Date are entitled to receive notice of the Meeting and either
they or their duly appointed proxyholders will be entitled to
attend the Meeting and vote. |
|
|
|
Each holder of Shares is entitled to one vote at the Meeting for
each Share registered in the holders name at the close of
business on the Record Date. |
4
|
|
|
Q:
|
|
WHAT IS THE FINAL DATE TO SUBMIT A SHAREHOLDER
PROPOSAL FOR THE 2007 ANNUAL MEETING?
|
|
A: |
|
The final date for submitting shareholder proposals to Novelis
for inclusion in the information circular for the 2007 Annual
Meeting of Shareholders is December 15, 2006. If you have a
proposal that you would like us to consider at the 2007 Annual
Meeting of Shareholders, and you do not want the Companys
proxyholders to be allowed to use their discretionary voting
authority to vote against this shareholder proposal when and if
raised, you must submit your proposal to us no later than
March 1, 2007. Proposals should be sent to our principal
executive offices located at 3399 Peachtree Road NE,
Suite 1500, Atlanta, GA 30326, Attention: Corporate
Secretary. |
|
Q: |
|
WHAT DOCUMENTS ARE AVAILABLE TO SHAREHOLDERS?
|
|
A: |
|
You will receive our Annual Report on
Form 10-K
for the year ended December 31, 2005, which includes our
consolidated and combined financial statements and
managements discussion and analysis of financial condition
and results of operations for the year ended December 31,
2005 and this Circular. |
|
|
|
Copies of our Annual Report on
Form 10-K
for the year ended December 31, 2005 and consolidated and
combined financial statements for the year ended
December 31, 2005 filed with the Canadian and
U.S. securities regulators can be found on the
Companys website at www.novelis.com or may be
obtained, without charge, on request from: Novelis Inc., 3399
Peachtree Road NE, Suite 1500, Atlanta, GA 30326,
Attention: Corporate Secretary. Requests for information can
also be sent from the Companys website:
www.novelis.com. |
|
Q: |
|
WHERE DO I FIND THE VOTING RESULTS OF THE MEETING?
|
|
A: |
|
We will announce the preliminary voting results at the Meeting
and will publish the final results in our quarterly report on
Form 10-Q
for the third quarter of 2006, which will be filed with the
U.S. Securities and Exchange Commission (the
SEC), and will be available by contacting: Novelis
Inc., 3399 Peachtree Road NE, Suite 1500, Atlanta, GA
30326, Attention: Corporate Secretary. Our quarterly report on
Form 10-Q
for the third quarter of 2006 will also be available on our
website at www.novelis.com, on the Canadian Securities
Administrators SEDAR system at www.sedar.com, and on the
SECs EDGAR system at www.sec.gov. |
|
Q: |
|
HOW CAN I CONTACT THE TRANSFER AGENT?
|
|
A: |
|
You can contact the transfer agent at: |
|
|
|
CIBC Mellon Trust Company
P.O. Box 7010
Adelaide Street Postal Station
Toronto, Ontario, Canada M5C 2W9
Telephone:
(416) 643-5500
1-800-387-0825
(toll free throughout Canada and the U.S.)
Telecopier:
(416) 643-5501
|
|
Q:
|
|
WHO ARE THE PRINCIPAL SHAREHOLDERS OF THE COMPANY?
|
|
A: |
|
To the knowledge of the directors and executive officers of the
Company, as of September 8, 2006, no person or company
beneficially owns or exercises control or direction over more
than 5% of the outstanding Shares of the Company other than FMR
Corp, which reported to the SEC that it owned or exercised
control or direction over 15.4% of the Shares on
February 14, 2006; McLean Budden Ltd., which reported to
the SEC that it owned or exercised control or direction over
9.8% of the Shares on August 11, 2006; and Kensico Capital
Management Corporation, which reported to the SEC that it owned
or exercised control or direction over 6.27% of the Shares on
September 8, 2006. |
5
BUSINESS
TO BE TRANSACTED AT THE MEETING
(See Notice of Annual Meeting of Shareholders)
|
|
1.
|
Presentation
of Financial Statements
|
Our consolidated and combined financial statements for the year
ended December 31, 2005 and the Auditors Report for
2005 will be submitted to you at the Meeting, but no vote with
respect thereto is required or proposed to be taken. The
consolidated and combined financial statements are included in
our Annual Report on
Form 10-K
for the year ended December 31, 2005 that is being mailed
to you with the Notice of Annual Meeting of Shareholders and
this Circular.
Thirteen directors are to be elected to serve until the close of
the next annual meeting of the Company or until their successors
shall be elected. Mr. J.E. Newall, O.C., who has served on
our board of directors since January 2005, retired from the
board of directors in July 2006 and will not be standing for
re-election. Brian W. Sturgell also served on our board of
directors from January 2005 through August 29, 2006. Edward
A. Blechschmidt, Jacques Bougie, O.C., Charles G. Cavell,
Clarence J. Chandran, C. Roberto Cordaro, Helmut Eschwey,
David J. FitzPatrick, Suzanne Labarge, William T. Monahan,
Rudolf Rupprecht, Kevin M. Twomey, John D. Watson and Edward V.
Yang have, upon the recommendation of the Nominating and
Corporate Governance Committee, been nominated to stand for
election at the Meeting. Our board of directors recommends the
election of all these nominees.
Unless authority is withheld, the persons designated in the
accompanying proxy card intend to vote FOR the election of
these nominees. The persons nominated are, in the opinion of
our board of directors, well qualified to act as directors of
the Company for the ensuing year. Our board of directors does
not contemplate that any of these nominees will be unable to
serve as a director, but should that occur for any reason before
the Meeting, the persons designated in the accompanying proxy
card reserve the right to vote for another nominee at their
discretion unless the shareholder who has given such proxy has
directed that their Shares be withheld from voting on the
election of directors.
To better align the interests of our board of directors with
those of our shareholders, with the exception of our Chairman
and Interim Chief Executive Officer, William T. Monahan, all of
the nominees for election to the board of directors are
independent. In determining whether a director is
independent, the board of directors applies the
standards developed by the Canadian Securities Administrators
and the New York Stock Exchange and the additional standards
adopted by the board of directors. These standards are set out
in the Guidelines on the Independence of the Board of Directors
of Novelis Inc. (Guidelines on Independence)
attached to this Circular as Schedule C and are also
available on our website at www.novelis.com.
6
The following table sets out certain biographical information,
including a brief description of principal occupation and
business experience during at least the past five years,
directorships of public companies (other than Novelis) presently
held, and certain other information regarding the nominees for
election as directors. This information has been furnished to us
by the respective nominees.
|
|
|
Name, Age,(1) Residence, and Business Experience
|
|
Independence, Committee Membership, Other Directorships
|
|
|
|
|
William T. Monahan, 59
West Chester, Pennsylvania, USA
Mr. Monahan is Chairman of our board of directors and Interim Chief Executive Officer. Mr. Monahan has served on the board of directors since January 6, 2005, and became Interim Chief Executive Officer on August 29, 2006. Mr. Monahan is the retired chairman and chief executive officer of Imation Corporation (imaging and data storage), where he served in that capacity from its spin-off from 3M Co. (industrial, medical, consumer and office products) in 1996 to May 2004. Prior to that, he held numerous executive positions at 3M, including Group Vice President, Senior Vice President of 3M Italy and Vice President of the data storage division.
|
|
Mr. Monahan is: Not Independent
Director of:
Pentair, Inc. (water industry)
Hutchinson Technology Inc. (computer industry)
Mosaic, Inc. (chemicals)
|
|
|
|
|
Edward A. Blechschmidt, 54
Villanova, Pennsylvania, USA
Mr. Blechschmidt has served on the board of directors since June 30, 2006. Mr. Blechschmidt was Chairman, Chief Executive Officer and President of Gentiva Health Services, Inc., (pharmaceutical and home health care services) from March 2000 to June 2002. From March 1999 to March 2000, Mr. Blechschmidt served as Chief Executive Officer and a director of Olsten Corporation (staffing services), the conglomerate from which Gentiva Health Services was spun off and taken public. He served as President of Olsten Corporation from October 1998 to March 1999. He also served as President and Chief Executive Officer of Siemens Nixdorf Americas and Siemens Pyramid Technologies (information technology) from July 1996 to October 1998. Prior to Siemens, he spent more than 20 years with Unisys Corporation (information technology), including serving as its Chief Financial Officer.
|
|
Mr. Blechschmidt is:
Independent
Member of:
Audit Committee
Customer Relations Committee
Director of:
HealthSouth Corp. (healthcare)
Lionbridge Technologies, Inc. (software)
Option Care, Inc. (healthcare)
Columbia Laboratories, Inc. (pharmaceuticals)
|
|
|
|
|
Jacques Bougie, O.C., 59
Verdun, Quebec, Canada
Mr. Bougie has served on the board of directors since January 6, 2005. Mr. Bougie was President and Chief Executive Officer of Alcan Inc. from 1993 to 2001, at which time he retired. Mr. Bougie is also Chairman of the International Advisory Council of CGI Group Inc. (information technology).
|
|
Mr. Bougie is:
Independent
Member of:
Nominating and Corporate Governance Committee
Human Resources Committee
Director of:
NOVA Chemicals Corporation (chemical and
plastics manufacturing)
Abitibi Consolidated Inc. (paper)
|
7
|
|
|
Name, Age,(1) Residence, and Business Experience
|
|
Independence, Committee Membership, Other Directorships
|
|
Charles G. Cavell, 64
Westmount, Quebec, Canada
Mr. Cavell has served on the board of directors since January 6, 2005. Mr. Cavell is a retired former President and Chief Executive Officer of Quebecor World Inc., one of the worlds largest commercial printers, with plants throughout Europe, South America and North America. He served in such capacity from 1989 to his retirement in 2003. He currently serves on the board of several private companies and charitable institutions and he is Vice Chairman of the Board of Governors of Concordia University.
|
|
Mr. Cavell is:
Independent
Member of:
Human Resources Committee
Nominating and Corporate Governance Committee
|
|
|
|
|
Clarence J. Chandran, 57
Miami Beach Florida, USA
Mr. Chandran has served on the board of directors since January 6, 2005. Mr. Chandran has served on the board of directors since January 6, 2005. Mr. Chandran is Chairman of Chandran Family Foundation Inc. (health care research and education) and, since 2001, Chairman of Conros Corporation (private mass market consumer products company including LePages USA and PineMountain). He retired as President, Business Process Services, of CGI Group Inc. (information technology) in 2004 and retired as Chief Operating Officer of Nortel Networks Corporation (communications) in 2001. Mr. Chandran is a member of the Duke University Board of Visitors and the Strategic Plan Executive Committee of the Pratt School of Engineering at Duke.
|
|
Mr. Chandran is:
Independent
Member of:
Human Resources Committee, Chair
Customer Relations Committee
|
|
|
|
|
C. Roberto Cordaro, 56
Boston, Massachusetts, USA
Mr. Cordaro has served on the board of directors since January 6, 2005. Mr. Cordaro has been President and Chief Executive Officer of Nuvera Fuel Cells, Inc. (fuel cell power systems manufacturing) since 2002. He was Chief Executive Officer of Motor Coach Industries International (coach manufacturing) from 2000 to 2001 and was Executive Vice President and Group President Automotive of Cummins Inc. (engine manufacturing) from 1996 to 1999.
|
|
Mr. Cordaro is:
Independent
Member of:
Human Resources Committee
Customer Relations Committee, Chair
Director of:
Nuvera Fuel Cells, Inc.
|
8
|
|
|
Name, Age,(1) Residence, and Business Experience
|
|
Independence, Committee Membership, Other Directorships
|
|
Helmut Eschwey, 57
Homburg, Germany
Mr. Eschwey has served on the board of directors since January 6, 2005. Mr. Eschwey has been Chairman of the Board of Management of Heraeus Holding GmbH (precious metals) in Germany since 2003. From 1994 to 2003, Dr. Eschwey was the head of the plastics technology business at SMS AG (engineering). Before he joined SMS AG, he held management positions at Freudenberg Group of Companies (industrial products), Pirelli & C. S.p.A. (tires) and the Henkel Group (chemicals).
|
|
Mr. Eschwey is:
Independent
Member of:
Nominating and Corporate Governance Committee
Human Resources Committee
Director of:
Heraeus Holding GmbH
|
|
|
|
|
David J. FitzPatrick, 52
Farmington, Connecticut, USA
Mr. FitzPatrick has served on the board of directors since March 24, 2005. Mr. FitzPatrick was the senior advisor to the chief executive officer of Tyco International Ltd. (Tyco) (fire, security, electronics, healthcare and other industrial products) from March 2005 until December 2005, at which time he retired. Previously, he was Executive Vice President and Chief Financial Officer of Tyco, a post he held from September 2002 until March 2005. He was Senior Vice President and Chief Financial Officer of United Technologies Corporation (aerospace and building) from June 1998 until September 2002.
|
|
Mr. FitzPatrick is:
Independent
Member of:
Audit Committee
Nominating and Corporate Governance Committee
|
|
|
|
|
Suzanne Labarge, 59
Toronto, Ontario, Canada
Ms. Labarge has served on the board of directors since January 6, 2005. Ms. Labarge retired in 2004 from her position as Vice Chairman and Chief Risk Officer of the Royal Bank of Canada, which she held since 1999. She was Executive Vice President, Corporate Treasury, of the Royal Bank of Canada from 1995 to 1998. She is a member of the Board of Governors of McMaster University.
|
|
Ms. Labarge is:
Independent
Member of:
Audit Committee, Chair
Customer Relations Committee
|
|
|
|
|
Rudolf Rupprecht, 66
Augsburg, Germany
Mr. Rupprecht has served on the board of directors since January 6, 2005. Mr. Rupprecht was the chairman of the executive board of MAN AG (mechanical engineering and trucks), in Germany from 1996 until the end of 2004, at which time he retired. Prior to that, Dr. Rupprecht was chairman of various supervisory boards within that company which he joined in 1966.
|
|
Mr. Rupprecht is:
Independent
Member of:
Customer Relations Committee
Director of:
Salzgitter AG (steel mill)
MAN AG
KME AG (copper manufacturer)
Bayerische Staatsforsten (forestry and related
products)
SMS GmbH (steel mill equipment)
|
9
|
|
|
Name, Age,(1) Residence, and Business Experience
|
|
Independence, Committee Membership, Other Directorships
|
|
Kevin M. Twomey, 59
Ponte Vedra Beach, Florida, USA
Mr. Twomey has served on the board of directors since May 25, 2006. He recently retired as President and Chief Operating Officer of The St. Joe Company (real estate), having joined the company in 1999. He currently serves as a consultant to The St. Joe Company. Mr. Twomey formerly served as Vice Chairman and Chief Financial Officer or H.F. Ahmanson & Company and its principal subsidiary, Home Savings of America (financial services). Prior to joining Ahmanson in 1993, Mr. Twomey was Chief Financial Officer at First Gibraltar Bank, a company held by MacAndrews and Forbes Holdings of New York. Mr. Twomey also held management positions with MCorp and Bank of America. Mr. Twomey is a trustee of the University of North Florida and serves on the board of trustees of the United Way of Northeast Florida, the Navy Supply Corps Foundation and the Schultz Center for Teaching and Leadership Executive Board.
|
|
Mr. Twomey is:
Independent
Member of:
Audit Committee
Nominating and Corporate Governance Committee
Director of:
PartnerRe Ltd. (reinsurance)
Intergraph Corporation (computer software)
|
|
|
|
|
John D. Watson, 61
Calgary, Alberta, Canada
Mr. Watson is an Executive Advisor of EnCana Corporation (oil and gas) after retiring in February 2006 as Executive Vice President and Chief Financial Officer of EnCana Corporation, a position he had held since 2002. Prior to that, he was Vice President, Finance, and Chief Financial Officer of an EnCana Corporation predecessor, Alberta Energy Company Ltd, from 1987 to 2002. Mr. Watson serves as the chair of the Calgary Police Commission, and is a member of the Audit Committee for the Province of Alberta.
|
|
Mr. Watson is:
Independent
Director of:
UTS Energy Corporation (energy)
Nortel Networks Corporation (communications)
|
|
|
|
|
Edward V. Yang, 61
Hong Kong, China
Mr. Yang has served on the board of directors since January 6, 2005. Mr. Yang has been chairman of Cross Shore Acquisition Corporation (service outsourcing) since April 2006. From 2001 to 2006 he has been a senior advisor at ING Barings Private Equity Partners Asia (financial services). He was formerly Vice Chairman and Chief Executive Officer of the Netstar Group (network management services) from 2002 to 2006. Prior to this role, Mr. Yang was also a corporate senior vice president and the president of Asia Pacific at Electronic Data Systems Corporation (information technology outsourcing) from 1992 to 2000.
|
|
Mr. Yang is:
Independent
Member of:
Human Resources Committee
Customer Relations Committee
Director of:
Cross Shore Acquisition Corporation
|
|
|
|
(1) |
|
The age of the directors is provided as of August 31, 2006. |
10
A record of attendance by directors at meetings of the board of
directors and its committees, as well as the number of board and
board committee meetings held during the year ended
December 31, 2005, are set out in Schedule A to this
Circular.
Except with respect to the cease trade orders imposed upon
Novelis, its directors and certain of its officers by Canadian
securities regulators in connection with the Companys
delayed filings of its
Form 10-Q
for the quarter ended September 30, 2005, its Annual Report
on
Form 10-K
for the year ended December 31, 2005 and its quarterly
reports on
Form 10-Q
for the first two quarters of 2006 (which orders affected each
of the nominees for election to the board of directors other
than Messrs. Twomey, Blechschmidt and Watson), to the
knowledge of the Company and based upon information provided to
it by the nominees for election to the board of directors, no
such nominee is or has been, in the last 10 years, a
director or executive officer of any company that, while such
person was acting in that capacity: (a) was the subject of
a cease trade or similar order or an order that denied the
relevant company access to any exemption under securities
legislation, for a period of more than 30 consecutive days;
(b) was subject to an event that resulted, after that
person ceased to be a director or executive officer, in the
company being the subject of a cease trade or similar order or
an order that denied the relevant company access to any
exemption under securities legislation, for a period of more
than 30 consecutive days; or (c) within a year of that
person ceasing to act in that capacity, became bankrupt, made a
proposal under any legislation relating to bankruptcy or
insolvency or was subject to or instituted any proceedings,
arrangement or compromise with creditors or had a receiver,
receiver manager or trustee appointed to hold its assets.
|
|
3.
|
Appointment
of the Independent Registered Public Accounting Firm
|
In 2005, fees for audit, audit-related, tax and all other
services provided to the Company by PricewaterhouseCoopers LLP
were as follows:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2005
|
|
|
Audit Fees
|
|
$
|
6,757,191
|
|
Audit-Related Fees
|
|
$
|
0
|
|
Tax Fees
|
|
$
|
0
|
|
All Other Fees
|
|
$
|
0
|
|
|
|
|
|
|
Total
|
|
$
|
6,757,191
|
|
|
|
|
|
|
Audit
Fees
PricewaterhouseCoopers LLP has served as our independent
registered public accounting firm since our spin-off from Alcan
on January 6, 2005. In 2005, fees for audit services
provided to the Company by PricewaterhouseCoopers LLP totalled
$6,757,191.
PricewaterhouseCoopers LLP did not perform any other services
for the Company during 2005.
Pre-Approval
of Audit and Permissible Non-Audit Services
Effective May 9, 2005, the Audit Committee established a
policy requiring its pre-approval of all audit and permissible
non-audit services provided by our independent registered public
accounting firm. The policy gives detailed guidance to
management as to the specific services that are eligible for
general pre-approval and provides specific cost limits for
certain services on an annual basis. Pursuant to the policy and
the Audit Committee charter, the Audit Committee has granted to
its chair the authority to address any requests for pre-approval
of individual services. None of the services provided by our
independent registered public accounting firm for 2005 that were
approved by the Audit Committee made use of the de minimus
exception to pre-approval set forth in applicable rules of the
SEC.
11
Board
of Directors Recommendation
In accordance with the Canada Business Corporations Act, our
shareholders appoint the Companys independent registered
public accounting firm. In carrying out its responsibilities,
the Audit Committee has recommended to our board of directors
and it, in turn, recommends to the shareholders that
PricewaterhouseCoopers LLP be appointed at the Meeting as
independent registered public accounting firm for the fiscal
year ending December 31, 2006. Unless contrary instructions
are indicated on the proxy card, the persons designated in the
accompanying proxy card intend to vote FOR the
appointment of PricewaterhouseCoopers LLP as our independent
registered public accounting firm for the fiscal year ending
December 31, 2006 and to authorize the board of directors
to fix the independent registered public accounting firms
remuneration.
A representative of PricewaterhouseCoopers LLP will be present
at the Meeting and will be available to make a statement if they
desire to do so and to respond to appropriate questions.
|
|
4.
|
Approval
of the Incentive Plan
|
The Incentive Plan was approved by our board of directors,
subject to the approval of the shareholders of the Company. The
Incentive Plan will replace, on a prospective basis, the Novelis
Conversion Plan of 2005 (the Conversion Plan) and
the Novelis Inc. Stock Price Appreciation Unit Plan (the
SPAU Plan) and no future awards will be granted
under such plans if the Incentive Plan is approved by the
Companys shareholders. This summary is qualified in its
entirety by reference to the full text of the Incentive Plan, a
copy of which is attached as Schedule F to this Circular.
As of August 31, 2006, the closing price of our Shares on
the New York Stock Exchange was $20.85, per share, and on the
Toronto Stock Exchange was C$23.08 per share.
Purpose
The purpose of the Incentive Plan is to promote the interests of
the Company and its shareholders by aligning, motivating,
attracting and retaining key employees and non-employee
directors of the Company and its subsidiaries through the
issuance of equity-based awards and short-term incentive
compensation.
Types
of Awards
The Incentive Plan authorizes the award of stock options, stock
appreciation rights (SARs), restricted shares,
restricted share units, performance shares and other stock-based
incentives. The Incentive Plan also authorizes payment of
short-term incentives, payable in cash or Shares, following
satisfaction of pre-established performance objectives.
Administration
of the Incentive Plan
The Incentive Plan will be administered by the Human Resources
Committee of the board of directors (the Human Resources
Committee), except that the full board of directors will
be responsible for the administration of awards to the
Companys non-employee directors.
Shares Subject
to the Incentive Plan
The number of Shares of the Company authorized to be issued
under the Incentive Plan is 7,000,000 Shares. Any Shares
that are subject to an award other than stock options or SARs
will be counted against this limit as 1.75 Shares for every
one Share subject to the award. If any Shares related to an
award are forfeited, terminated, expire unexercised, tendered in
connection with an exercise of an award, withheld from issuance
to pay applicable tax withholding, settled in cash in lieu of
Shares, or settled in any similar manner so that a portion of
the Shares are not issued to the participant, then such Shares
will be automatically available for future awards and will not
count against the maximum share limit above.
12
Eligibility
for Awards
The Human Resources Committee has the discretion to determine
the employees and non-employee directors eligible to receive
awards under the Incentive Plan and the type, size and
conditions of such awards. As of August 31, 2006,
approximately 3,000 of our employees are eligible to participate
in short-term awards, and approximately 150 employees and 12
non-employee directors are eligible to participate in long-term
awards under the Incentive Plan. The awards that will be granted
to eligible employees under the Incentive Plan will be at the
discretion of the Human Resources Committee and, therefore, are
not determinable at this time. The full board of directors will
determine the type, size and conditions of any awards to the
Companys non-employee directors. No employee participant
may receive during any one calendar year awards representing
more than 750,000 Shares or $20,000,000. The maximum number
of Shares that may be granted to a non-employee director during
any one calendar year shall not exceed 7,500 Shares. The
maximum aggregate number of incentive stock options (discussed
below) that may be granted under the Incentive Plan for all
years is 3,000,000 Shares.
Stock
Options
The Incentive Plan authorizes the grant of stock options. Stock
options may be either nonqualified stock options or incentive
stock options (ISOs). ISOs are options granted to
employees that are designed to meet the requirements of
Section 422 of the United States Internal Revenue Code of
1986, as amended (the Code). Any option that does
not satisfy Section 422 of the Code will be treated as a
nonqualified stock option. The exercise price per share under
any stock option may not be less than 100% of the fair market
value per share on the date of grant, and no option may be
re-priced, including the cancellation of an existing option and
substituting a new option with a lower exercise price, without
the approval of the Companys shareholders. Options will
become vested and exercisable in accordance with the terms set
forth in the participants award agreement, provided that
in no event may an option be exercisable later than the seventh
anniversary of its date of grant.
Stock
Appreciation Rights
The Incentive Plan authorizes the grant of SARs. SARs represent
the right to receive an amount equal to the appreciation in the
Companys Shares over a specified period of time. SARs may
be settled in cash, Shares or a combination of both as set forth
in the participants award agreement. The exercise price
per share under any SAR may not be less than 100% of the fair
market value per share on the date of grant, and no SAR may be
re-priced, including the cancellation of an existing SAR and
substituting a new SAR with a lower exercise price, without the
approval of the Companys shareholders. SARs will become
vested and exercisable in accordance with the terms set forth in
the participants award agreement, provided that in no
event may a SAR be exercisable later than the seventh
anniversary of its date of grant.
Restricted
Shares and Restricted Share Units
The Incentive Plan authorizes the grant of restricted shares and
restricted share units that are tied to the expiration of a
specified period of time, the achievement of performance goals,
and/or the
occurrence of one or more other events. Restricted share units
are similar to restricted shares except that no Shares are
actually awarded to the participant at the time of award.
Accordingly, the holder of restricted share units does not have
dividend, voting or other ownership rights during the period
that such restricted share units are outstanding although a
restricted share unit award may include dividend equivalent
rights payable on a current, deferred or contingent basis.
Restricted share units may be paid in cash, Shares or a
combination of both at the time of vesting as set forth in the
participants award agreement.
Performance
Awards
The Incentive Plan authorizes the grant of performance shares
and units. Performance awards represent a conditional right to
receive cash, Shares, or a combination of cash and Shares, upon
the achievement of specified performance goals during one or
more performance periods. Performance objectives may be
described in terms of Company-wide objectives or objectives that
are related to the performance of an
13
individual participant or Company subsidiary, division,
department or function within the Company in which the
participant is employed. Performance objectives may be measured
on an absolute or relative basis. Relative performance may be
measured by a group of peer companies or by a financial market
index.
Short-Term
Incentives
Short-term incentives may be paid in cash or Shares. Short-term
incentive compensation generally will only be paid upon
satisfaction of pre-established performance objectives, provided
that adjustments and exceptions may be made under special
circumstances.
Other
Awards
The Human Resources Committee has the discretion to grant any
other type of award that is based on or related to Shares or
factors that may influence the value of such Shares, or to grant
Shares as a bonus or payment in lieu of other obligations of the
Company to a participant.
Compliance
with Section 162(m) of the United States Internal Revenue
Code
Section 162(m) of the Code contains special rules regarding
the federal income tax deductibility of compensation paid to the
Companys Chief Executive Officer and to each of the other
four most highly compensated executive officers. The general
rule is that annual compensation paid to any of these covered
employees will be deductible for any tax year only to the extent
that such compensation does not exceed $1 million. The
Company may preserve the deductibility of certain compensation
in excess of $1 million, however, if the Company complies
with conditions imposed by Section 162(m) of the Code,
including the establishment of specified performance goals which
must be achieved prior to payment.
The performance measures upon which awards intended to comply
with Section 162(m) of the Code may include the following:
return on equity, regional income, diluted earnings per share,
net earnings, total earnings, earnings growth, return on
capital, working capital turnover, return on assets, earnings
before interest and taxes, sales, sales growth, gross margin
return on investment, increase in the fair market value of the
Shares, share price (including but not limited to, growth
measures and total shareholder return), operating profit, cash
flow (including, but not limited to, operating cash flow and
free cash flow), cash flow return on investment (which equals
net cash flow divided by total capital), inventory turns,
financial return ratios, total return to shareholders, market
share, earnings measures/ratios, economic value added, balance
sheet measurements such as receivable turnover, internal rate of
return, increase in net present value or expense targets,
productivity and satisfaction of health, safety and environment
compliance targets.
Taxation
The following discussion is intended to provide an overview of
the U.S. federal income tax laws that are generally applicable
to awards granted under the Incentive Plan as of the date of
this Circular. Persons or entities in differing circumstances
may have different tax consequences, and the tax laws may change
in the future. This discussion is not to be construed as tax
advice.
Stock Options: The granting of a nonqualified
option to an individual is not ordinarily a taxable event. Upon
exercise of the option, the optionee will recognize ordinary
taxable income equal to the excess of the then fair market value
of the Shares over the exercise price paid for such Shares. The
Company will be entitled to a tax deduction equal to the
ordinary income recognized by the optionee. Upon disposition of
the acquired Shares, the difference between the sale price and
the optionees basis in the Shares will be treated as a
capital gain or loss and generally will be characterized as
long-term capital gain or loss if the Shares have been held for
more than one year at the time of disposition.
In the case of an ISO, neither the granting of the option nor
its exercise is ordinarily a taxable event to the optionee.
Instead, the optionee recognizes taxable income upon the
disposition of the acquired Shares. The tax treatment to the
optionee and the Company will depend primarily upon whether the
optionee has met certain holding period requirements at the time
he or she disposes of the Shares. If an optionee exercises an
14
ISO and does not dispose of the Shares received within two years
after the date such option was granted or within one year after
the transfer of the Shares to him or her, any gain realized upon
the disposition will be characterized as long-term capital gain.
If the optionee disposes of the ISO Shares either within two
years after the date the option is granted or within one year
after the exercise of the option and transfer of Shares to him
or her, such disposition will be treated as a disqualifying
disposition and an amount equal to the lesser of (i) the
fair market value of the Shares on the date of exercise minus
the exercise price, or (ii) the amount realized on the
disposition minus the exercise price, will be taxed as ordinary
income to the optionee. The excess, if any, of the amount
realized upon disposition over the fair market value at the time
of the exercise of the option will be treated as capital gain.
Except in the case of disqualifying dispositions, there will be
no federal income tax deductions allowed to the Company upon the
grant, exercise, or termination of an ISO.
SARs: The recipient of a SAR will not
recognize any taxable income at the time the SAR is granted.
Instead, the appreciation inherent in the SAR will be taxable as
ordinary income at the time the SAR is exercised. If the
participant receives the SAR appreciation in Shares rather than
cash, the participant will recognize ordinary income equal to
the excess of the fair market value of the Shares on the day it
is received over any amounts paid by the participant for the
Shares. There will be no federal income tax deduction allowed to
the Company upon the grant or expiration of a SAR. However, upon
the exercise of the SAR, the Company will be entitled to a
deduction for federal income tax purposes equal to the amount of
ordinary income that the participant is required to recognize as
a result of the exercise.
Share Awards: The recipient of a share award
will recognize ordinary income at the time the property is
received equal to the excess, if any, of the fair market value
of the Shares received over the amount paid by the participant
in exchange for the Shares. If, however, the Shares are subject
to a substantial risk of forfeiture at the time of grant (e.g.,
if the participant is required to work for a period of time
before the Shares becomes freely transferable), the participant
generally will not recognize income until the restrictions on
such Shares lapse, at which time the recipient will recognize
ordinary income equal to the excess, if any, of the fair market
value of the Shares on the date they become vested over any
amount paid by the recipient in exchange for the Shares. Upon
the disposition of any Shares received as a share award under
the Incentive Plan, the difference between the sale price and
the recipients basis in the Shares will be treated as a
capital gain or loss and generally will be characterized as
long-term capital gain or loss if the Shares have been held for
more than one year at the time of their disposition.
The Company will be entitled to a deduction for federal income
tax purposes equal to the amount of ordinary income that the
recipient is required to recognize, provided that the deduction
is not otherwise disallowed under the Code.
Awards Settled in Cash: The recipient of any
award settled in cash will recognize ordinary income at the time
the payment is received. The Company will be entitled to a
corresponding deduction for federal income tax purposes in an
amount equal to the ordinary income recognized by such recipient.
Change
in Control
Unless otherwise specified by the Human Resources Committee, a
pro rata portion of a participants performance-based
awards and short-term incentive (both at 100% target level) will
be payable to such participant within ten days following a
change in control of the Company. In addition, a
participants outstanding options and SARs will become
immediately vested and exercisable and all outstanding
restricted shares and restricted share units will become fully
vested and non-forfeitable.
Restrictions
on Transferability of Awards
No award granted under the Incentive Plan may be sold,
transferred, pledged, assigned, or otherwise alienated or
hypothecated, other than by will or by the applicable laws of
descent and distribution, except as otherwise permitted under
the Incentive Plan and the terms of the award agreement.
New
Plan Benefits
The awards that will be granted to eligible participants under
the Incentive Plan will be at the discretion of the Human
Resources Committee and, therefore, are not determinable at this
time.
15
Amendment
and Termination of the Incentive Plan
Subject to shareholder approval as required by applicable laws,
regulations and rules to which the Company is subject, the
Companys board of directors may amend or terminate the
Incentive Plan at any time and for any reason, provided that no
amendment may, subject to certain exceptions set forth in the
Incentive Plan, increase the number of Shares available for
award or adversely affect any outstanding awards.
Board
of Directors Recommendation
The board of directors recommends that the Incentive Plan be
approved by the shareholders of the Company. Unless contrary
instructions are indicated on the proxy card, the persons
designated in the accompanying proxy card intend to vote FOR
approval of the Incentive Plan.
Securities
Authorized for Issuance Under Equity Compensation
Plans
The following table provides information as of December 31,
2005 regarding the Shares issuable upon the exercise of options
under the Conversion Plan, as well as the number of Shares
remaining available for issuance under the Conversion Plan. If
the Incentive Plan is approved by our shareholders at the
Meeting, then no new options will be granted under the
Conversion Plan on or after the proposed effective date of the
Incentive Plan. The table also shows the number of deferred
share units granted pursuant to the Novelis Inc. Deferred Share
Unit Plan for Non-Executive Directors.
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Remaining Available for
|
|
|
|
Number of
|
|
|
Weighted-
|
|
|
Future Issuance Under
|
|
|
|
Securities to be
|
|
|
Average
|
|
|
Equity Compensation
|
|
|
|
Issued Upon
|
|
|
Exercise Price of
|
|
|
Plans (Excluding
|
|
|
|
Exercise of
|
|
|
Outstanding
|
|
|
Securities Reflected in
|
|
Plan Category
|
|
Options/DDSUs
|
|
|
Options
|
|
|
First Column)
|
|
|
Equity compensation plans approved
by security holders(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Novelis Conversion Plan of
2005(2)
|
|
|
2,704,790
|
|
|
$
|
21.60
|
|
|
|
2,291,937
|
(4)
|
Novelis Inc. Deferred Share
Unit Plan for Non-Executive
Directors(3)
|
|
|
57,051
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Equity compensation plans not
approved by security holders
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
|
(1) |
|
Such plans were approved by Alcan, as our sole shareholder,
prior to the spin-off date. |
|
(2) |
|
On January 5, 2005, our board of directors adopted the
Conversion Plan to allow for all Alcan stock options held by
employees of Alcan who became employees of Novelis following our
spin-off from Alcan to be replaced with options to purchase our
Shares and for new options to be granted. There were no new
options granted in 2005 under the Conversion Plan. In the case
of a change in control of the Company, vesting of stock options
will accelerate. |
|
(3) |
|
On January 5, 2005, our board of directors adopted the
Deferred Share Unit Plan for Non-Executive Directors. Fifty
percent of our non-executive directors compensation is
required to be paid in the form of directors deferred
share units (DDSUs), and 50% in the form of either
cash, additional DDSUs or a combination of the two at the
election of each non-executive director. DDSUs are the economic
equivalent of Shares. The DDSUs are redeemable only upon
termination of the directorship and may be redeemed in cash,
Shares or a combination of both, at the election of the
non-executive director. The amount to be paid by us upon
redemption will be calculated by multiplying the accumulated
balance of DDSUs by the average per share closing price of our
Shares on the Toronto and New York Stock Exchanges on the last
five trading days prior to the redemption date. As of
December 31, 2005, approximately 41,862 DDSUs had been
granted with an additional 15,189 units granted on
January 1, 2006, all for services rendered in 2005. |
16
|
|
|
(4) |
|
Under the Conversion Plan, we may issue new options in aggregate
not exceeding 3% of the Shares outstanding immediately after our
spin-off from Alcan on January 6, 2005, provided that the
total number of new options and conversion options (options
granted to replace options in the share capital of Alcan held by
our employees at the time of the spin-off) do not exceed 10% of
the Shares outstanding immediately after the spin-off. |
BOARD OF
DIRECTORS AND CORPORATE GOVERNANCE MATTERS
We are committed to the highest levels of corporate governance
practices, which we believe are essential to our success and to
the enhancement of shareholder value. Our Shares are listed on
the Toronto Stock Exchange and New York Stock Exchange and we
make required filings with the Canadian and U.S. securities
regulators. We make these filings available on our website at
www.novelis.com as soon as reasonably practicable after
they are electronically filed. We are subject to a variety of
corporate governance and disclosure requirements. Our corporate
governance practices meet the Toronto Stock Exchange Corporate
Governance Guidelines (the TSX Guidelines), the New
York Stock Exchange rules and other applicable regulatory
requirements to ensure transparency and effective governance of
the Company. Schedule B attached to this Circular describes
our current corporate governance practices under the TSX
Guidelines.
Our board of directors regularly reviews corporate governance
practices in light of developing requirements in this field. As
new provisions come into effect, our board of directors will
reassess our corporate governance practices and implement
changes as and when appropriate. The following is an overview of
our corporate governance practices.
Novelis
Board of Directors
Our board of directors has the responsibility for stewardship of
Novelis, including the responsibility to ensure that we are
managed in the interest of our shareholders as a whole, while
taking into account the interests of other stakeholders. Our
board of directors supervises the management of our business and
affairs and discharges its duties and obligations in accordance
with the provisions of: (1) the Canada Business
Corporations Act (CBCA); (2) our articles of
incorporation and bylaws; (3) the charters of our board of
directors and its committees; and (4) other applicable
legislation and Company policies.
Our corporate governance practices require that, in addition to
its statutory duties, the following matters be subject to our
board of directors approval: (1) capital expenditure
budgets and significant investments and divestments;
(2) our strategic and value-maximizing plans; (3) the
number of directors within the limits provided in our articles
of incorporation; and (4) any matter which may have the
potential for substantial impact on our business. Our board of
directors reviews the composition and size of our board of
directors once a year. All new directors will receive a board of
directors manual containing a record of historical public
information about Novelis, as well as the charters of our board
of directors and its committees, and other relevant corporate
and business information. Senior management makes regular
presentations to our board of directors on the main areas of our
business. Directors are invited to tour our various facilities.
Corporate
Governance Guidelines
Our board of directors has adopted a charter that establishes
various corporate governance guidelines relating to, among other
things, the composition and organization of the board of
directors, the duties and responsibilities of the board of
directors and the resources and authority of the board of
directors (the Board of Directors Charter). Under
the Board of Directors Charter, which is available on our
website at www.novelis.com and is available in print from
our Corporate Secretary upon request, every meeting of the board
of directors is to be followed by an executive session at which
no executive directors or other members of management are
present. These executive sessions are designed to ensure free
and open discussion and communication among the non-management
directors. The chairman of the board of directors leads these
meetings. Mr. Monahan currently serves as chairman.
Shareholders and other interested parties may communicate with
the board of directors, a committee or an individual director by
writing to Novelis Inc., 3399 Peachtree Rd. NE, Suite 1500,
Atlanta, GA 30326, Attention: Corporate Secretary
Board
17
Communication. All such communications will be compiled by the
Corporate Secretary and submitted to the appropriate director or
board committee. The Corporate Secretary will reply or take
other actions in accordance with instructions from the
applicable board contact.
Independence
of Our Board of Directors
To assist in determining the independence of its members, our
board of directors has established Guidelines on the
Independence of the Directors of Novelis Inc. (Guidelines
on Independence). The definition of an Independent
Director under the Guidelines on Independence, which is
available on our website at www.novelis.com and is
available in print from our Corporate Secretary upon request,
encompasses both the definition of an unrelated
director within the meaning of the TSX Guidelines and of an
independent director within the meaning of the rules
of the New York Stock Exchange. Such a director: (1) must
not have any relationship with us or any of our employees which
is likely to be perceived to interfere with the exercise of his
or her judgment in a manner that is independent from management;
and (2) must not have an interest or relationship which
could reasonably be perceived to materially interfere with his
or her ability to act in the best interests of Novelis (an
Independent Director). Under the Guidelines on Independence, the
following relationships generally will be considered not to be
material relationships that would impair a directors
independence: (1) if a director is an officer, partner or
significant shareholder in an entity that does business with us
and the annual sales or purchases, for goods or services, to or
from us are less than two percent of the consolidated gross
annual revenues of that entity; (2) if a director is a
limited partner, a non-managing member or occupies a similar
position in an entity that does business with us, or has a
shareholding in such entity which is not significant, and who,
in each case, has no active role in sales to or in providing
services to us and derives no direct material personal benefit
from the same; and (3) if a director serves as an officer,
director or trustee of a charitable organization and our
charitable contributions to the organization are less than two
percent of that organizations total consolidated gross
annual revenues. For purposes of the Guidelines on Independence,
a significant shareholding means direct or indirect
beneficial ownership of five percent or more of the outstanding
equity or voting rights of the relevant entity. Our board of
directors has determined that all members of the board of
directors, with the exception of our Chairman and Interim Chief
Executive Officer, William T. Monahan, are Independent Directors.
The Guidelines on Independence establish standards for members
of our Audit, Human Resources and Nominating and Corporate
Governance Committees. These standards comply with the audit
committee member independence qualifications under the
U.S. Sarbanes-Oxley Act of 2002 (SOX). To
satisfy the SOX audit committee qualifications, a director must
not, directly or indirectly, accept any consulting, advisory or
other compensatory fee from us (except in his or her capacity as
director) and may not be an affiliated person of Novelis or any
subsidiary other than in his or her capacity as a member of our
board of directors or any committee of our board of directors.
Committees
of Our Board of Directors
Our board of directors has established four standing committees:
the Audit Committee, the Nominating and Corporate Governance
Committee, the Human Resources Committee and the Customer
Relations Committee. Each committee is governed by its own
charter which is available on our website at
www.novelis.com and is available in print from our
Corporate Secretary upon request. All four standing committees
are required to be composed entirely of Independent Directors.
According to their authority as set out in their charters, our
board and each of its committees may engage outside advisors at
the expense of Novelis.
Audit
Committee and Financial Experts
Our board of directors has a separately-designated standing
Audit Committee established in accordance with
Section 3(a)(58)(A) of the Securities Exchange Act of 1934,
as amended, (the Exchange Act), the requirements of
the CBCA and the New York Stock Exchange and Toronto Stock
Exchange rules. Our board of directors has determined that
Edward A. Blechschmidt, David J. FitzPatrick, Suzanne Labarge
and Kevin M. Twomey are Audit Committee financial experts as
defined by the rules of the SEC and that each member
18
of our Audit Committee is an Independent Director within the
meaning of the applicable New York Stock Exchange and Toronto
Stock Exchange listing standards. Our Audit Committee Charter is
attached as Schedule E to this Circular, is available on
our website at www.novelis.com and is available in print
upon request from our Corporate Secretary.
Our Audit Committees main objective is to assist our board
of directors in fulfilling its oversight responsibilities for
the integrity of our financial statements, our compliance with
legal and regulatory requirements, the qualifications and
independence of our independent registered public accounting
firm and the performance of both our internal audit function and
our independent registered public accounting firm. Under the
Audit Committee charter, the Audit Committee is responsible for,
among other matters:
|
|
|
|
|
evaluating and compensating our independent registered public
accounting firm;
|
|
|
|
making recommendations to the board and shareholders relating to
the appointment, retention and termination of our independent
registered public accounting firm;
|
|
|
|
discussing with our independent registered public accounting
firm their independence from management;
|
|
|
|
reviewing with our independent registered public accounting firm
the scope and results of their audit;
|
|
|
|
pre-approving all audit and permissible non-audit services to be
performed by our independent registered public accounting firm;
|
|
|
|
overseeing the financial reporting process and discussing with
management and our independent registered public accounting firm
the interim and annual financial statements that we file with
the SEC; and
|
|
|
|
reviewing and monitoring our accounting principles, accounting
policies and disclosure, internal control over financial
reporting and disclosure controls and procedures.
|
Our Audit Committee will also assist us in ensuring that our
process for monitoring compliance with, and dealing with
violations of, our Code of Conduct, which is described below, is
established and updated. In particular, our Audit Committee has
established procedures in relation to complaints or concerns
that we may receive involving accounting, internal accounting
controls or audit matters, including the anonymous handling
thereof. Such procedures are available at www.novelis.com
under our Code of Conduct.
Nominating
and Corporate Governance Committee
Our Nominating and Corporate Governance Committee has the broad
responsibility of regularly reviewing our corporate governance
practices in general. Our Nominating and Corporate Governance
Committee is composed entirely of Independent Directors.
In addition to its responsibilities for the design,
implementation, review, and evaluation of our corporate
governance policies and practices, our Nominating and Corporate
Governance Committee oversees the composition and size of our
board of directors. The committee reviews candidates for
nomination as directors and recommends candidates for election
to our board of directors. The committee also considers nominees
submitted by shareholders to our Corporate Secretary. You may
submit director nominations in writing to Novelis Inc., 3399
Peachtree Road, NE Suite 1500, Atlanta, Georgia, 30326,
Attention: Corporate Secretary.
In identifying and evaluating candidates for nomination to our
board of directors, our Nominating and Corporate Governance
Committee considers several factors, including judgment,
independence, skill, diversity, experience with businesses and
other organizations of comparable size, and the requirement
that, as a federal Canadian corporation, at least 25% of our
directors must be resident Canadians. The qualifications and
backgrounds of prospective candidates are reviewed in the
context of the current composition of the board of directors to
ensure it maintains the proper balance of knowledge, experience
and diversity to effectively manage our business for the
long-term interests of our shareholders. Our Nominating and
Corporate Governance Committee is allowed to employ search firms
for identifying and evaluating director nominees.
Our Nominating and Corporate Governance Committee assesses and
ensures on an annual basis the effectiveness of our board of
directors as a whole, of each committee of our board of
directors and the
19
contribution of individual directors. Each director will
complete a survey of board effectiveness on an annual basis
which we anticipate will cover the subjects under the categories
of board composition, responsibility, meetings and committees.
As part of this survey, each of our directors will be asked to
complete a self-evaluation and an evaluation of the board of
directors as a whole and its committees. Our Nominating and
Corporate Governance Committee also assesses our boards
relationship with management.
Human
Resources Committee
Our Human Resources Committee has the broad responsibility to
review human resources policy and employee relations matters and
makes recommendations with respect to such matters to our board
of directors or our chief executive officer, as appropriate. Our
Human Resources Committee is composed entirely of Independent
Directors. Its specific roles and responsibilities are set out
in its charter. Our Human Resources Committee will periodically
review the effectiveness of our overall management organization
structure and succession planning for senior management, review
recommendations for the appointment of executive officers, and
consider and make recommendations to our board of directors
based on trends and developments in the area of human resource
management.
Our Human Resources Committee will establish our general
compensation philosophy and oversee the development and
implementation of compensation policies and programs. It also
will review and approve the level of
and/or
changes in the compensation of individual executive officers,
except that in the case of the chief executive officer and chief
operating officer, it will make recommendations regarding
compensation and objectives to the board of directors, in each
case taking into consideration individual performance and
competitive compensation practices.
Our Human Resources Committee has the responsibility of
reviewing our policies, management practices and performance in
environment, health and safety matters and making
recommendations to our board of directors on such matters in
light of current and changing requirements. Our Human Resources
Committee will also review, assess and provide advice to our
board of directors on policy, legal, regulatory and consumer
trends and developments related to the environment, as they
impact us, our employees, businesses, processes and products.
Customer
Relations Committee
In an advisory capacity, our Customer Relations Committee
reviews information furnished by management, provides advice and
counsel, and serves as a conduit for communications with our
board of directors for the purposes of deepening our
boards understanding of: (1) key end-use markets
served by us; (2) our existing and prospective customers in
such markets; (3) the nature of our relationships with such
customers (and efforts to further develop such relationships);
(4) the needs of, and trends facing, our customers and key
end-use markets; (5) the fact base regarding flat rolled
products markets and competitive environments that, in the
foreseeable future, may be served by us; and (6) our
efforts to identify and implement best practices in the areas of
marketing and sales.
Code of
Ethics and Code of Conduct
Novelis has adopted a Code of Ethics for Senior Financial
Officers (Code of Ethics) that applies to our senior
financial officers including our chief executive officer, chief
financial officer and controller. We have also adopted a Code of
Conduct that governs all our employees as well as our directors.
As an annex to the Code of Conduct and supplemental thereto, we
have adopted additional standards specifically tailored to our
business operations around the globe. Copies of the Code of
Ethics and Code of Conduct are available on our website at
www.novelis.com. We will promptly disclose any future
amendments to these codes on our website as well as any waivers
from these codes for executive officers and directors. Copies of
these codes are also available in print upon request by our
shareholders from our Corporate Secretary.
We have also established whistleblower procedures so
that an employee can anonymously report concerns that he or she
may have regarding compliance with corporate policies, the Code
of Conduct, the Code of Ethics, applicable laws or auditing,
internal accounting controls and accounting matters. These
procedures are part of the Code of Conduct.
20
REPORT OF
THE AUDIT COMMITTEE
The following report does not constitute soliciting material
and should not be deemed filed or incorporated by reference by
any general statement incorporating by reference this Circular
into any other filing under Canadian securities laws, under the
United States Securities Act of 1933, as amended, or under the
Exchange Act except to the extent that we specifically
incorporate this information by reference.
In accordance with its charter attached as Schedule E of
this Circular, our Audit Committee has oversight responsibility
for Novelis financial reporting process and internal
control functions. Management has the primary responsibility for
the financial reporting process and the system of internal
controls. PricewaterhouseCoopers LLP, the Companys
independent registered public accounting firm, has the
responsibility to express an opinion on the consolidated and
combined financial statements based on their audit in accordance
with generally accepted auditing standards.
At each regular meeting, the Audit Committee meets separately
with senior management, our Chief Internal Auditor and our
independent registered public accounting firm to discuss any
matters that the Audit Committee or any of these parties believe
should be discussed privately.
The Audit Committee has reviewed and discussed with the
Companys management and PricewaterhouseCoopers LLP the
consolidated and combined financial statements of the Company
for the year ended December 31, 2005. The Audit Committee
has also discussed with PricewaterhouseCoopers LLP the matters
required to be discussed pursuant to Statement on Auditing
Standards No. 61, as amended.
The Audit Committee has received and reviewed the written
disclosures and the letter from PricewaterhouseCoopers LLP
required by Independence Standards Board Standard No. 1
(Independence Discussions with Audit Committees), and has
discussed with PricewaterhouseCoopers LLP its independence from
the Company.
Based on the review and discussions referred to above, the Audit
Committee recommended to the board of directors that the
consolidated and combined financial statements be included in
the Companys Annual Report on
Form 10-K
for year ended December 31, 2005 for filing with the SEC.
Approval
of this Report
The Audit Committee, whose members are set forth below, has
approved the issue of this report and its inclusion in this
Circular.
|
|
|
|
|
Suzanne Labarge, Chair
|
|
|
|
Edward A. Blechschmidt
|
|
|
|
David J. FitzPatrick
|
|
|
|
Kevin M. Twomey
|
HUMAN
RESOURCES COMMITTEE REPORT ON EXECUTIVE COMPENSATION
The following report does not constitute soliciting material
and should not be deemed filed or incorporated by reference by
any general statement incorporating by reference this Circular
into any other filing under Canadian securities laws, under the
United States Securities Act of 1933, as amended, or under the
Exchange Act except to the extent that we specifically
incorporate this information by reference.
General
Our Human Resources Committee is responsible for administering
the compensation program for our executive officers. Our
executive compensation program is based upon a
pay-for-performance
philosophy. Under our program, an executives compensation
is based on three components, namely, base salary, short-term
(annual) incentives and long-term incentives. Our Human
Resources Committee is assisted by independent consultants.
21
The total direct compensation policy is aligned with prevalent
U.S. competitive median compensation practices.
U.S. compensation data is obtained from two primary
sources: (1) comparison to executive compensation within a
peer group of companies; and (2) published survey
information that includes large multinational companies
representative of the general market.
Both the short-term and long-term incentive plans are aligned
with the Companys governing objective to maximize
shareholder value over time. The details of Noveliss
compensation programs are outlined below.
Compensation
of the Executive Officers
Total direct compensation levels reflect both the responsibility
of each position (internal equity) and competitive market levels
(external competitiveness). The total direct compensation policy
is targeted at the median of the competitive market level as
indicated by peer group comparison and by survey information.
Base
Salary
The target base salary is the median of a salary range for an
executive officer and reflects the competitive level of similar
positions in a compensation peer group and as reported in the
survey information. Actual base salaries for executive officers
reflect the individuals performance and contribution to
the Company. Base salaries of executive officers are therefore
reviewed annually and any proposed changes are approved by our
Human Resources Committee before implementation. The board of
directors must approve base salaries for the most senior of the
executive officers including those listed in the Summary
Compensation Table. We have established a compensation peer
group, and we utilize published survey information from
established human resources consulting firms.
Short-Term
(Annual) Incentives
We provide annual incentive benefits, which are administered by
our Human Resources Committee. Short-term incentive awards are
determined by three components, each based on a different aspect
of our performance. For each position, a target award is set
(expressed as percent of base salary midpoint)
reflecting both the responsibilities of the position and the
competitive compensation levels. For 2005, the short-term
incentive awards were determined by performance measured against
the following three components:
1. 50% of the incentive opportunity of an executive is
based on our overall cash flow generation as measured against
working capital turns improvement;
2. 40% of the incentive opportunity is based on our
profitability as measured against economic value added
targets; and
3. 10% of the incentive opportunity is based on the
achievement of environment, health and safety objectives as
measured against pre-established continuous improvement targets.
The overall award paid is the sum of the weighted results of
each component, modified for individual performance and
contribution to the Company. Currently, short-term incentive
awards are paid in cash. For 2006, the three measurement
criteria described above remain unchanged except that 40% of the
incentive opportunity is measured against regional income
targets instead of economic value added targets. If the 2006
Incentive Plan is approved by our shareholders at the 2006
annual meeting of shareholders, short-term incentive awards may
be paid in cash, Shares or a combination of both. The award paid
may range from zero when the results achieved are less than the
minimum target thresholds set by our Human Resources Committee,
up to 200% of the target award when the results achieved are at
or exceed the maximum target level which was set by our Human
Resources Committee. For 2005, executive officers earned
short-term incentive awards that were generally above the target
amounts reflecting performance on the three performance
components that was above the pre-established targets.
22
Long-Term
Incentives
The purpose of our long-term incentives is to attract and retain
employees and to encourage them to contribute to our growth and
long-term success. Long-term incentives are tied to the
successful share price performance of the Company thereby
aligning the interests of our executives with those of our
shareholders.
Stock
Options
On January 5, 2005, our board of directors adopted the
Novelis Conversion Plan of 2005 (the Conversion
Plan) to allow for all Alcan stock options held by
employees of Alcan who became our employees following our
spin-off from Alcan to be replaced with options to purchase our
Shares. While new options may be granted under the Conversion
Plan, there were no new options granted in 2005 under the plan.
As of December 31, 2005 our employees held stock options
covering 2,704,790 of our Shares at a weighted average exercise
price per share of $21.60. No future awards will be granted
under the Conversion Plan if the 2006 Incentive Plan is approved
by our shareholders at the 2006 annual meeting of shareholders.
All converted options that were vested on the spin-off date
continued to be vested. Unvested options vest in four equal
annual installments beginning on January 6, 2006, the first
anniversary of the spin-off date. In the case of a change in
control of Novelis, all options will become immediately
exercisable.
Stock
Price Appreciation Units
Our board of directors approved the Stock Price Appreciation
Unit Plan, effective as of January 5, 2005. Prior to the
spin-off date, a small number of Alcan employees held Alcan
stock price appreciation units (SPAUs) entitling
them to receive cash in an amount equal to the excess of the
market value of an Alcan common share on the SPAU exercise date
over the market value of an Alcan common share on the SPAU grant
date. As of the spin-off date, we replaced all of the Alcan
SPAUs held by employees of Alcan who became our employees,
including our executive officers, with Novelis SPAUs. There were
no new SPAUs granted in 2005 under the plan. No future awards
will be granted under the Stock Price Appreciation Unit Plan if
the 2006 Incentive Plan is approved by our shareholders at the
2006 annual meeting of shareholders. As of December 31,
2005, our employees held 418,777 SPAUs at a weighted average
price of $22.04. All converted SPAUs that were vested on the
spin-off date continued to be vested. Unvested SPAUs vest in
four equal annual installments beginning on January 6,
2006, the first anniversary of the spin-off date. In the case of
a change in control of Novelis, all SPAUs will become
immediately exercisable.
Novelis
Founders Performance Awards
On March 24, 2005, our board of directors adopted the
Novelis Founders Performance Award Plan (the Founders
Plan) to allow for an additional compensation opportunity
tied to Novelis share price improvement targets for certain of
our executives approved by the Human Resources Committee,
including those listed in the Summary Compensation Table.
Participants earn performance share units (PSUs) if
Novelis share price improvement targets are achieved within
prescribed time periods. The Founders Plan identifies three
relevant performance periods. The first performance period runs
from March 24, 2005 to March 23, 2008, the second
performance period runs from March 24, 2006 to
March 23, 2008 and the third performance period runs
from March 24, 2007 to March 23, 2008. The share price
improvement targets for these three tranches are $23.57, $25.31
and $27.28, respectively. Participants are eligible to receive
an aggregate of 399,050 PSUs under the Founders Plan, but only
if the share price improvement targets are achieved. An equal
amount of PSUs may be earned during each performance period if
the applicable share price improvement target is achieved during
such period. As described below in footnote 1 under the
caption Long-Term Incentive Plan Table
Founders Plan, in March 2006 Mr. Sturgell and our
board of directors agreed to alter the allocation of
Mr. Sturgells PSUs for each of the three tranches.
If earned, a particular tranche will be paid in cash on a
particular payment date, which is defined as the
later of six months from the date the specific share price
improvement target is achieved or twelve months after the start
of the applicable performance period. The value of a PSU equals
the average of the daily closing price of our common stock as
reported on the New York Stock Exchange for the last five
trading days prior to
23
the payment date. For example, the share price improvement
target for the performance period running from March 24,
2005 to March 23, 2008 has already been achieved and
180,350 PSUs were earned on June 20, 2005. Subsequent to
June 30, 2005, 48,500 PSUs were forfeited, leaving 131,850
PSUs still active. The value of each of these PSUs was
calculated in the manner described above using a valuation date
of March 24, 2006 (which is the date that is twelve months
after the start of the applicable performance period). In April
2006, these PSUs were settled in cash in the amount of
$2,655,459.
On March 14, 2006, the board of directors amended the
Founders Plan in order to clarify when PSUs will be earned under
the second and third tranches of the Founders Plan for periods
beginning in 2006 and 2007, respectively. The amended Founders
Plan now provides that the second and third tranches of PSUs
will be earned if, during the period of each tranche, the share
price reaches (or exceeds) the target price and is maintained or
exceeded for 15 consecutive trading days during an open trading
period for directors and executive officers. An open trading
period is any period, other than a trading blackout period, in
which directors and executives are free to purchase or sell
Shares. Previously, the Founders Plan did not specify that the
15-day
vesting period must occur during an open trading period.
Incentive
Plan
The Incentive Plan was approved by our board of directors,
subject to the approval of the shareholders of the Company. The
Incentive Plan will replace, on a prospective basis, the
Conversion Plan and the SPAU Plan and no future awards will be
granted under such plans if the Incentive Plan is approved by
the Companys shareholders. Short-term (annual) incentive
compensation will also be paid pursuant to the Incentive Plan.
This summary is qualified in its entirety by reference to the
full text of the Incentive Plan, a copy of which is attached as
Schedule F to this Circular.
The purpose of the Incentive Plan is to promote the interests of
the Company and its shareholders by motivating, attracting and
retaining key employees and non-employee directors of the
Company and its subsidiaries through the issuance of
equity-based awards and short-term incentive compensation.
The Incentive Plan authorizes the award of stock options, SARs,
restricted shares, restricted share units, performance shares
and other stock-based incentives. The Incentive Plan also
authorizes payment of short-term incentives, payable in cash or
Shares, following satisfaction of pre-established performance
objectives.
The Incentive Plan will be administered by the Human Resources
Committee, except that the full board of directors will be
responsible for the administration of awards to the
Companys non-employee directors.
Compensation
of the Chief Executive Officer
The CEOs annual compensation is administered by the board
of directors, based on recommendations from the Human Resources
Committee according to the policies described above.
Mr. Sturgell became CEO on January 6, 2005 and entered
into an employment agreement with the Company. The board of
directors set Mr. Sturgells compensation on a
competitive level with other U.S. chief executive officers
of global companies of similar size, and also provided Mr.
Sturgell with a comparable level of compensation to that
received from his previous employer.
On August 29, 2006, the Board of Directors terminated
Mr. Sturgell as CEO and appointed Chairman William T.
Monahan to also serve as Interim CEO until a successor for
Mr. Sturgell is identified. At this time, Mr. Sturgell
and the Company are still negotiating the terms of his
separation agreement that are not otherwise addressed by the
provisions of his existing agreements with the Company. Once the
agreement is finalized and executed, the details of the
separation agreement will be filed with the SEC via
Item 1.01 of
Form 8-K.
Decisions pertaining to the CEOs compensation are based on
our boards evaluation of the CEOs performance
against pre-determined financial and strategic objectives. These
objectives are set and approved annually at the beginning of the
year. Mr. Sturgells goals and objectives for 2005
included performance against pre-established targets for cash
flow, economic value added, environment, health and safety.
Goals and objectives also included increasing financial
awareness of the investment community, succession planning and
customer relations. The Human Resources Committee recommended to
the board of directors that the CEOs
24
total direct compensation (base salary, target short-term
incentives and target long-term incentives) be set at the median
of the U.S. market. The overall performance against the
goals and objectives is reflected in establishing the actual
compensation of the CEO.
In 2005, Mr. Sturgells base salary (representing
approximately 17% of his target total direct compensation) was
$985,000. It was not increased for 2006. Mr. Sturgell also
received short-term incentive award for 2005 equal to $820,147.
This amount is approximately 50% less than the amount he would
have received ($1,681,130) based on the original short-term
incentive targets established by the Company and the
Companys 2005 financial performance. The board of
directors reduced Mr. Sturgells 2005 short-term
incentive pay because of the delay in the Companys
financial reporting and overall share price performance.
Mr. Sturgell received no options in 2005. Mr. Sturgell
received a grant in the aggregate of 140,550 PSUs on
March 24, 2005, subject to the achievement of share price
improvement targets, under the Founders Plan. On March 14,
2006, Mr. Sturgell agreed with the board of directors that,
in light of our 2005 and 2006 financial reporting delay and
restatement, Mr. Sturgell would forfeit 46,850 PSUs
attributable to the first tranche of the award. The board of
directors also approved an increase in the size of the award
opportunity for Mr. Sturgell for the second and third
tranches under the Founders Plan in an amount equal to 23,425
PSUs for each tranche, increasing the total award size to 70,275
PSUs for each PSU tranche. The PSUs for the second and third
tranches would not have vested and become payable unless the
share price improvement targets specified in the Plan ($25.31
and $27.28 respectively) were achieved. As a result of
Mr. Sturgells termination as CEO on August 29,
2006, all of his PSUs attributable to the second and third
tranches were forfeited.
Mr. Sturgells employment agreement provides for
competitive retirement benefits. In addition, Mr. Sturgell
and the Company entered into a change in control agreement dated
December 5, 2005, which provides for payment and other
benefits upon the termination of employment for any reason other
than cause, as defined in the agreement. Pursuant to the change
in control agreement, Mr. Sturgell will be entitled to an amount
equal to 36 months of his base salary and target short-term
incentive award (payable in 36 equal monthly instalments), plus
the amount payable under provisions of the TSR Plan. Mr.
Sturgell will also be entitled to continuation of certain
employee benefits and additional service credits of three years
under the Companys pension plans.
Section 162(m)
Limitation
The Human Resources Committee believes that the compensation
program serves its intended objectives. Section 162(m) of
the United States Internal Revenue Code of 1986, as amended,
provides a number of exceptions to the $1 million deduction
limitation on compensation paid to executives, and it is the
intent of the Human Resources Committee to qualify for these
exceptions to the extent feasible and in the best interests of
the Company, including the exceptions with respect to
performance-based compensation.
While it is the Human Resources Committees intention to
maximize the deductibility of compensation payable to the
Companys Named Executive Officers, deductibility will be
only one among a number of factors used by the Human Resources
Committee in ascertaining appropriate levels or methods of
compensation. The Company intends to maintain the flexibility to
compensate Named Executive Officers based upon an overall
determination of what it believes to be in the best interests of
the Company and its shareholders.
Approval
of this Report on Executive Compensation
The Human Resources Committee, whose members are set forth
below, has approved the issue of this report and its inclusion
in this Circular.
|
|
|
|
|
Clarence J. Chandran, Chair
|
|
|
|
Jacques Bougie, O.C.
|
25
|
|
|
|
|
Charles G. Cavell
|
|
|
|
C. Roberto Cordaro
|
|
|
|
Helmut Eschwey
|
|
|
|
Edward V. Yang
|
Human
Resources Committee Interlocks and Insider
Participation
In fiscal 2005, only Independent Directors served on our Human
Resources Committee. Clarence J. Chandran was the chair of our
Human Resources Committee. The other committee members during
all or part of the year were Charles G. Cavell, C. Roberto
Cordaro, Helmut Eschwey, Suzanne Labarge, William T. Monahan and
J.E. Newall. No member of our Human Resources Committee had any
relationship with us requiring disclosure under Item 404 of
SEC
Regulation S-K.
No executive officer of Novelis served on any board of directors
or compensation committee of any other company for which any of
our directors served as an executive officer at any time during
fiscal 2005.
26
PERFORMANCE
GRAPH
The shares price performance graph does not constitute
soliciting material and should not be deemed filed or
incorporated by reference by any general statement incorporating
by reference this Circular into any other filing under Canadian
securities laws, under the United States Securities Act of 1933,
as amended, or under the Exchange Act except to the extent that
we specifically incorporate this information by reference.
The following graph and tables provide the cumulative total
shareholder return on $100 invested in Shares from
January 6, 2005 through December 31, 2005 as compared
to the cumulative total return of the Standard &
Poors/Toronto Stock Exchange Composite Index and the
Standard & Poors Industrial Composite Index over
the same period of time, assuming reinvestment of all dividends.
CUMULATIVE
TOTAL RETURN
Based upon an initial investment of Can. $100
on January 6, 2005 with dividends reinvested
Comparison of Cumulative Total Return
Canadian Dollar Data: amounts in the following
table are expressed in Canadian dollars and reflect the data in
the above graph.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 6,
|
|
|
December 31,
|
|
|
|
2005
|
|
|
2005
|
Novelis Inc.
|
|
|
C$
|
100.00
|
|
|
|
C$
|
82.72
|
|
S&P/TSX Composite Index
|
|
|
C$
|
100.00
|
|
|
|
C$
|
126.49
|
|
S&P Industrial Composite Index
|
|
|
C$
|
100.00
|
|
|
|
C$
|
99.95
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Dollar Data: for purposes of
comparison, amounts in the following table show cumulative total
shareholder returns in U.S. dollars with differences from
the Canadian dollar data attributable to the relative
differences in the values of the two currencies over the period
presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 6,
|
|
|
December 31,
|
|
|
|
2005
|
|
|
2005
|
Novelis Inc.
|
|
|
$
|
100.00
|
|
|
|
$
|
86.79
|
|
S&P/TSX Composite Index
|
|
|
$
|
100.00
|
|
|
|
$
|
134.55
|
|
S&P Industrial Composite Index
|
|
|
$
|
100.00
|
|
|
|
$
|
106.31
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholder returns over the period shown in the graph and
tables should not be considered indicative of future shareholder
returns.
27
NOVELIS
SHARE OWNERSHIP
Share
Ownership of Certain Beneficial Owners
Based on filings with the SEC, the following shareholders are
known by us to own more than 5% of our Shares as of
September 8, 2006:
|
|
|
|
|
|
|
|
|
|
|
Shares Beneficially
|
|
|
|
|
Name and Address of Beneficial Owner
|
|
Owned
|
|
|
Percentage of Class*
|
|
|
FMR Corp.(i)
|
|
|
11,405,602
|
|
|
|
15.4
|
%
|
82 Devonshire Street
Boston, MA 02109
|
|
|
|
|
|
|
|
|
McLean Budden Ltd.(ii)
|
|
|
7,270,318
|
|
|
|
9.8
|
%
|
145 King Street West
Suite 2525
Toronto, ON M5H 1J8
|
|
|
|
|
|
|
|
|
Kensico Capital Management
Corporation(iii)
|
|
|
4,633,700
|
|
|
|
6.27
|
%
|
55 Railroad Avenue,
2nd Floor
Greenwich, Connecticut 06830
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
As of September 8, 2006, we had 74,005,649 Shares
outstanding. |
|
(i) |
|
The following information is based on the Schedule 13G,
filed on February 14, 2006 with the SEC by FMR Corp.
Fidelity Management & Research Company
(Fidelity), 82 Devonshire Street, Boston,
Massachusetts 02109, a wholly-owned subsidiary of FMR Corp., and
an investment adviser registered under the Investment Advisers
Act of 1940, is the beneficial owner of 10,830,102 Shares
as a result of acting as investment adviser to various
investment companies. The ownership of one investment company,
FA Mid Cap Stock Fund, 82 Devonshire Street, Boston,
Massachusetts 02109, amounted to 6,553,560 Shares. Edward
C. Johnson 3d, FMR Corp., through its control of Fidelity, and
the funds each has sole power to dispose of the
10,830,102 Shares owned by the Funds. Neither FMR Corp.,
nor Edward C. Johnson 3d, Chairman of FMR Corp., has the sole
power to vote or direct the voting of the Shares owned directly
by the Fidelity Funds, which power resides with the Funds
Boards of Trustees. Fidelity carries out the voting of the
Shares under written guidelines established by the Funds
Boards of Trustees. Fidelity Management Trust Company, 82
Devonshire Street, Boston, Massachusetts 02109, a wholly-owned
subsidiary of FMR Corp., is the beneficial owner of
129,800 Shares as a result of its serving as investment
manager of the institutional account(s). Edward C. Johnson 3d
and FMR Corp., through its control of Fidelity Management Trust
Company, each has sole dispositive power over
129,800 Shares and sole power to vote or to direct the
voting of 129,800 Shares owned by the institutional
account(s). Members of the Edward C. Johnson 3d family are the
predominant owners of Class B shares of common stock of FMR
Corp., representing approximately 49% of the voting power of FMR
Corp. The Johnson family group and all other Class B
shareholders have entered into a shareholders voting
agreement under which all Class B shares will be voted in
accordance with the majority vote of Class B shares.
Accordingly, through their ownership of voting common stock and
the execution of the shareholders voting agreement,
members of the Johnson family may be deemed, under the United
States Investment Company Act of 1940, to form a controlling
group with respect to FMR Corp. Fidelity International
(FIL), Pembroke Hall, 42 Crowlane, Hamilton,
Bermuda, and various foreign-based subsidiaries provide
investment advisory and management services to a number of
non-U.S. investment
companies and certain institutional investors. FIL is the
beneficial owner of 445,700 Shares and has the sole power
to vote and dispose of such Shares. FMR Corp. and FIL are of the
view that they are not acting as a group for
purposes of Section 13(d) under the Exchange Act and that
they are not otherwise required to attribute to each other the
beneficial ownership of securities
beneficially owned by the other corporation within
the meaning of
Rule 13d-3
under the Exchange Act. The Schedule 13G states that FMR
Corp. is making the filing on a voluntary basis as if all the
Shares are beneficially owned by FMR Corp. and FIL on a joint
basis. |
|
(ii) |
|
The following information is based on the Form 13F filed on
August 11, 2006 with the SEC by McLean Budden Ltd.
(McLean Budden). The Form 13F indicates that
McLean Budden is the beneficial owner |
28
|
|
|
|
|
of 7,270,318 Shares. McLean Budden has sole voting power
and sole dispositive power over 7,270,318 Shares. |
|
(iii) |
|
The following information is based on the Form 13D filed on
September 8, 2006 with the SEC by Kensico Capital
Management Corporation (Kensico). The Form 13D
indicates that Kensico is the beneficial owner of
4,633,700 Shares. Kensico has sole voting power and sole
dispositive power over 4,633,700 Shares. |
Share
Ownership of Directors and Executive Officers
The following table sets forth, as of August 10, 2006,
beneficial ownership of Shares by each director and each
executive officer named in the Summary Compensation Table on
page 31, and all directors, nominees and executive officers
as a group.
Beneficial ownership is determined in accordance with the rules
of the SEC and generally includes voting or investment power
with respect to securities. Shares and options, warrants and
convertible securities that are currently exercisable or
convertible within 60 days of August 10, 2006, into
our Shares are deemed to be outstanding and to be beneficially
owned by the person holding the options, warrants or convertible
securities for the purpose of computing the percentage ownership
of the person, but are not treated as outstanding for the
purpose of computing the percentage ownership of any other
person.
The address for the following individuals is: c/o Novelis Inc.,
3399 Peachtree Road NE; Suite 1500; Atlanta, GA 30326.
|
|
|
|
|
|
|
|
|
|
|
Shares Beneficially
|
|
|
Percentage
|
|
Name of Beneficial Owner
|
|
Owned
|
|
|
of Class**
|
|
|
Brian W. Sturgell, Former Director
and Chief Executive Officer(i)
|
|
|
222,621
|
|
|
|
*
|
|
William T. Monahan, Chairman of
the Board and Interim Chief Executive Officer (ii)
|
|
|
8,622
|
|
|
|
*
|
|
Edward Blechschmidt, Director(iii)
|
|
|
136
|
|
|
|
*
|
|
Jacques Bougie, O.C., Director(iv)
|
|
|
10,459
|
|
|
|
*
|
|
Charles G. Cavell, Director(v)
|
|
|
5,404
|
|
|
|
*
|
|
Clarence J. Chandran, Director(vi)
|
|
|
11,259
|
|
|
|
*
|
|
C. Roberto Cordaro, Director(vii)
|
|
|
5,230
|
|
|
|
*
|
|
Helmut Eschwey, Director(viii)
|
|
|
5,230
|
|
|
|
*
|
|
David J. FitzPatrick, Director(ix)
|
|
|
9,798
|
|
|
|
*
|
|
Suzanne Labarge, Director(x)
|
|
|
9,101
|
|
|
|
*
|
|
Rudolf Rupprecht, Director(xi)
|
|
|
5,404
|
|
|
|
*
|
|
Kevin M. Twomey, Director(xii)
|
|
|
361
|
|
|
|
*
|
|
Edward V. Yang, Director(xiii)
|
|
|
5,404
|
|
|
|
*
|
|
Martha Finn Brooks, Chief
Operating Officer(xiv)
|
|
|
189,489
|
|
|
|
*
|
|
Chris Bark-Jones, Former Senior
Vice President and President Europe(xv)
|
|
|
1,177
|
|
|
|
*
|
|
Kevin Greenawalt, Senior Vice
President and President North America(xvi)
|
|
|
12,166
|
|
|
|
*
|
|
Pierre Arseneault, Former Vice
President, Strategic Planning and Information Technology(xvii)
|
|
|
22,256
|
|
|
|
*
|
|
Directors and executive officers
as a group (28 persons)(xviii)
|
|
|
566,000
|
|
|
|
*
|
|
|
|
|
* |
|
Indicates less than 1% of the Shares. |
|
** |
|
As of August 10, 2006, we had 74,005,649 Shares
outstanding. |
|
(i) |
|
Includes 14,957 Shares held in the Savings and Retirement
Plan and options to purchase approximately 188,367 Shares
that are exercisable within 60 days. Mr. Sturgell was
terminated as Chief Executive |
29
|
|
|
|
|
Offer on August 29, 2006. William T. Monahan, Chairman of
Noveliss Board of Directors, is currently serving as
Interim Chief Executive Officer until Mr. Sturgells
successor has been selected and is in place. |
|
(ii) |
|
Includes 5,622 DDSUs. See Directors
Compensation. |
|
(iii) |
|
Includes 136 DDSUs. See Directors Compensation. |
|
(iv) |
|
Includes 10,459 DDSUs. See Directors
Compensation. |
|
(v) |
|
Includes 5,404 DDSUs. See Directors
Compensation. |
|
(vi) |
|
Includes 10,459 DDSUs. See Directors
Compensation. |
|
(vii) |
|
Includes 5,230 DDSUs. See Directors
Compensation. |
|
(viii) |
|
Includes 5,230 DDSUs. See Directors
Compensation. |
|
(ix) |
|
Includes 4,798 DDSUs. See Directors
Compensation. |
|
(x) |
|
Includes 6,101 DDSUs. See Directors
Compensation. |
|
(xi) |
|
Includes 5,404 DDSUs. See Directors
Compensation. |
|
(xii) |
|
Includes 361 DDSUs. See Directors Compensation. |
|
(xiii) |
|
Includes 5,404 DDSUs. See Directors
Compensation. |
|
(xiv) |
|
Includes options to purchase 164,489 Shares that are
exercisable within 60 days. |
|
(xv) |
|
Includes options to purchase 1,157 Shares that are
exercisable within 60 days. |
|
(xvi) |
|
Includes options to purchase 12,137 Shares that are
exercisable within 60 days. |
|
(xvii) |
|
Includes options to purchase 22,256 Shares that are
exercisable within 60 days. |
|
(xviii) |
|
Our directors and executive officers as a group hold 566,000 of
our Shares. Our directors and executive officers as a group hold
options to purchase 426,829 of our Shares that are currently
exercisable or are exercisable within 60 days. Our
directors as a group hold 64,608 DDSUs. |
Section 16(a)
Beneficial Ownership Reporting Compliance
The rules of the SEC require that we disclose late filings of
reports of share ownership by Novelis directors and executive
officers. Because we were a foreign private issuer
for U.S. securities law purposes throughout the 2005 fiscal
year, our directors and officers were exempt from the filing
requirements of Section 16(a) of the Exchange Act.
Accordingly, we have nothing to report in respect of
Section 16(a) compliance in 2005. We determined that under
the rules and regulations promulgated by the SEC, as of
February 27, 2006, a majority of our outstanding Shares are
now directly or indirectly held by U.S. residents and,
accordingly, we ceased to qualify as a foreign private issuer.
We will henceforth assume the status of a domestic issuer for
purposes of the Exchange Act. Therefore, our directors and
officers are now required to file reports under
Section 16(a) of the Exchange Act.
30
EXECUTIVE
OFFICERS COMPENSATION
Summary
Compensation Table
The following table sets out the compensation for our chief
executive officer and the four other most highly compensated
executive officers (collectively, the Named Executive
Officers) for the years ended December 31, 2005,
December 31, 2004 and December 31, 2003.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Compensation Awards
|
|
|
|
|
|
|
|
|
|
Annual Compensation
|
|
|
|
|
|
Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
Bonus
|
|
|
|
|
|
|
|
|
Under
|
|
|
|
|
|
|
|
|
|
|
|
|
(Executive
|
|
|
|
|
|
|
|
|
Options
|
|
|
All
|
|
|
|
|
|
|
|
|
|
Performance
|
|
|
Other Annual
|
|
|
Restricted
|
|
|
Granted/
|
|
|
Other
|
|
|
|
|
|
|
Salary
|
|
|
Award)
|
|
|
Compensation(1)
|
|
|
Share Units
|
|
|
SPAUs(2)
|
|
|
Compensation(3)
|
|
Name and Principal Position
|
|
Year
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Brian W. Sturgell
|
|
|
2005
|
|
|
|
985,000
|
|
|
|
820,147
|
|
|
|
426,371
|
(4)
|
|
|
3,876,090
|
(5)
|
|
|
|
|
|
|
223,157
|
(7)
|
(Former President and
|
|
|
2004
|
|
|
|
781,200
|
|
|
|
932,257
|
|
|
|
280,686
|
(4)
|
|
|
|
|
|
|
438,751
|
|
|
|
41,301
|
|
Chief Executive Officer)
|
|
|
2003
|
|
|
|
600,000
|
|
|
|
561,845
|
|
|
|
254,115
|
(4)
|
|
|
347,212
|
(6)
|
|
|
138,114
|
|
|
|
29,679
|
|
Martha Finn Brooks
|
|
|
2005
|
|
|
|
655,000
|
|
|
|
716,252
|
|
|
|
298,669
|
(8)
|
|
|
1,828,600
|
(5)
|
|
|
|
|
|
|
1,889,844
|
(9)
|
(Chief Operating Officer)
|
|
|
2004
|
|
|
|
514,400
|
|
|
|
631,538
|
|
|
|
50,723
|
(8)
|
|
|
|
|
|
|
155,974
|
|
|
|
14,666
|
|
|
|
|
2003
|
|
|
|
440,000
|
|
|
|
445,608
|
|
|
|
32,661
|
|
|
|
|
|
|
|
71,438
|
|
|
|
16,440
|
|
Christopher Bark-Jones
|
|
|
2005
|
|
|
|
440,611
|
|
|
|
472,667
|
|
|
|
20,289
|
|
|
|
1,440,034
|
(5)
|
|
|
|
|
|
|
|
|
(Former President
|
|
|
2004
|
|
|
|
440,600
|
|
|
|
395,210
|
|
|
|
43,892
|
|
|
|
|
|
|
|
127,398
|
|
|
|
|
|
European Operations)(12)
|
|
|
2003
|
|
|
|
375,000
|
|
|
|
465,972
|
|
|
|
9,659
|
|
|
|
|
|
|
|
54,769
|
|
|
|
8,348
|
|
Kevin Greenawalt
|
|
|
2005
|
|
|
|
310,000
|
|
|
|
323,190
|
|
|
|
18,450
|
|
|
|
439,044
|
(5)
|
|
|
|
|
|
|
11,933
|
|
(President North
|
|
|
2004
|
|
|
|
255,400
|
|
|
|
192,850
|
|
|
|
582,751
|
(10)
|
|
|
|
|
|
|
29,766
|
|
|
|
15,655
|
|
American Operations)
|
|
|
2003
|
|
|
|
230,800
|
|
|
|
175,440
|
|
|
|
381,849
|
(10)
|
|
|
|
|
|
|
16,669
|
|
|
|
16,922
|
|
Pierre Arseneault
|
|
|
2005
|
|
|
|
300,000
|
|
|
|
247,720
|
|
|
|
113,207
|
(11)
|
|
|
568,108
|
(5)
|
|
|
|
|
|
|
5,208
|
|
(Former Vice President
|
|
|
2004
|
|
|
|
300,000
|
|
|
|
257,731
|
|
|
|
37,285
|
|
|
|
|
|
|
|
47,030
|
|
|
|
12,214
|
|
Strategic Planning and
|
|
|
2003
|
|
|
|
272,000
|
|
|
|
186,045
|
|
|
|
23,145
|
|
|
|
|
|
|
|
19,646
|
|
|
|
10,880
|
|
Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology)(13)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In addition to tax equalization payments and perquisites listed
separately below, amounts included in this column for one or
more Named Executive Officers include the following perquisites
that are either in the aggregate valued at the lesser of $50,000
or 10% of the Named Executive Officers total salary and
bonus or represent less than 25% of the perquisites reported for
a given year: amounts relating to professional financial advice,
club memberships, automobile allowance, education expenses,
relocation allowances, housing expenses (including interest on
housing-related loans transferred to third party financial
institutions) and cash payments to be used for perquisites at
the Named Executive Officers discretion. |
|
(2) |
|
See Long-Term Incentives Stock
Options above for a description of the Conversion Plan and
Long-Term Incentives Stock Price
Appreciation Units above for a description of the Stock
Price Appreciation Unit Plan. On January 6, 2005, Alcan
stock options held by employees of Alcan who became our
employees following our spin-off from Alcan were replaced with
options to purchase our Shares. The number of options shown for
periods prior to 2005 have been recast from the number of Alcan
options granted into the as-converted number of Novelis options.
On January 6, 2005, all Alcan SPAUs held by our
employees were replaced with Novelis SPAUs. The number of SPAUs
for periods prior to 2005 have been recalculated from the number
of Alcan SPAUs granted into the as-converted number of Novelis
SPAUs. |
|
(3) |
|
In addition to the other amounts stated separately below,
All Other Compensation for each of our Named
Executive Officers for 2005 includes: |
|
|
|
savings plan contributions; and
|
|
|
|
amounts paid by us for term life insurance.
|
31
|
|
|
|
|
The following table shows the amount of these benefits received
by each Named Executive Officer for 2005: |
|
|
|
|
|
|
|
|
|
Name
|
|
Savings Plan Contributions ($)
|
|
|
Life Insurance ($)
|
|
|
Brian W. Sturgell
|
|
|
57,614
|
|
|
|
16,452
|
|
Martha Finn Brooks
|
|
|
22,509
|
|
|
|
2,644
|
|
Christopher Bark-Jones
|
|
|
0
|
|
|
|
0
|
|
Kevin Greenawalt
|
|
|
10,617
|
|
|
|
1,316
|
|
Pierre Arseneault
|
|
|
3,686
|
|
|
|
1,522
|
|
|
|
|
(4) |
|
Amounts include $393,941 (in 2005), $254,756 (in 2004) and
$219,155 (in 2003) for tax equalization payments (i.e.,
amounts paid such that net income after taxes was not less than
it would have been in the United States). |
|
(5) |
|
The Named Executive Officers were participants in the Alcan
Total Shareholder Returns Performance Plan (TSR
Plan) prior to the spin-off. On January 6, 2005, our
employees who were Alcan employees immediately prior to the
spin-off and who were eligible to participate in the Alcan TSR
Plan ceased to actively participate in and accrue benefits under
the TSR Plan. The accrued award amounts for each participant in
the TSR Plan were converted into Novelis restricted share units.
The then current three-year performance periods, namely
2002 2005 and 2003 2006, were truncated
as of the date of the spin-off. At the end of each performance
period, each holder of restricted share units will receive the
net proceeds based on our common share price at that time,
including declared dividends. The number of restricted share
units granted to our Named Executive Officers and the dollar
value of such restricted share units as of January 6, 2005
was as follows: |
|
|
|
|
|
|
|
|
|
Name
|
|
Restricted Share Units (#)
|
|
|
Value of Restricted Share Units ($)
|
|
|
Brian W. Sturgell
|
|
|
166,213
|
|
|
|
3,876,090
|
|
Martha Finn Brooks
|
|
|
78,413
|
|
|
|
1,828,600
|
|
Christopher Bark-Jones
|
|
|
61,751
|
|
|
|
1,440,034
|
|
Kevin Greenawalt
|
|
|
18,827
|
|
|
|
439,044
|
|
Pierre Arseneault
|
|
|
24,361
|
|
|
|
568,108
|
|
|
|
|
(6) |
|
Represents the value, at the time of the grant, of restricted
share units granted prior to our spin-off from Alcan. These
restricted share units vested in full and were paid in January
2005. |
|
(7) |
|
Includes $149,092 that we were obligated to pay under an Alcan
employee compensation plan as part of our spin-off from Alcan.
No future payments will be required under the plan. |
|
(8) |
|
Amounts for 2005 include reimbursement of relocation expenses of
$266,245. Amounts for 2004 include $18,211 for tax equalization. |
|
(9) |
|
Includes $1,864,691 for the cash payout of deferred share units
received prior to the spin-off that were converted to Novelis
deferred share units as part of the spin-off. The deferred units
vested and were paid in August 2005. |
|
(10) |
|
Amounts include $369,293 (in 2004) and $154,815 (in
2003) for tax equalization payments. |
|
(11) |
|
Amounts for 2005 include reimbursement of relocation expenses of
$84,031. |
|
(12) |
|
Chris Bark-Jones stepped down as Senior Vice President and
President European Operations on May 1, 2006. |
|
(13) |
|
Pierre Arseneault retired from Novelis on June 1, 2006. |
32
Fiscal
Year-End Option/ SPAU Table
The following table summarizes, for each of the Named Executive
Officers, the total number of Shares underlying unexercised
options held on December 31, 2005 and the aggregate value
of unexercised
in-the-money
options on December 31, 2005, which is the difference
between the exercise price of the options and the market value
of the Shares on December 31, 2005, which was
$20.89 per share. The aggregate values indicated with
respect to unexercised
in-the-money
options at fiscal year-end have not been, and may never be,
realized. These options have not been, and may never be
exercised and actual gains, if any, on exercise will depend on
the value of the Shares on the date of exercise. There can be no
assurance that these values will be realized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of Unexercised
|
|
|
|
Shares Underlying Unexercised
|
|
|
In-the-Money
|
|
|
|
Options and SPAUs
|
|
|
Options and SPAUs
|
|
|
|
on December 31, 2005(1)
|
|
|
on December 31, 2005(1)
|
|
Name
|
|
(#)
|
|
|
$
|
|
|
Brian W. Sturgell
|
|
Options (E):
|
|
|
|
|
|
|
E:
|
|
|
|
|
|
(Former President and Chief
Executive
|
|
Options (U):
|
|
|
753,477
|
|
|
|
U:
|
|
|
|
508,995
|
|
Officer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Martha Finn Brooks
|
|
Options (E):
|
|
|
89,960
|
|
|
|
E:
|
|
|
|
|
|
(Chief Operating Officer)
|
|
Options (U):
|
|
|
298,121
|
|
|
|
U:
|
|
|
|
129,679
|
|
Christopher Bark-Jones
|
|
Options (E):
|
|
|
|
|
|
|
E:
|
|
|
|
|
|
(Former President
European
|
|
Options (U):
|
|
|
4,630
|
|
|
|
U:
|
|
|
|
9,029
|
|
Operations)
|
|
SPAUs (E):
|
|
|
|
|
|
|
E:
|
|
|
|
|
|
|
|
SPAUs (U):
|
|
|
213,850
|
|
|
|
U:
|
|
|
|
123,926
|
|
Kevin Greenawalt
|
|
Options (E):
|
|
|
|
|
|
|
E:
|
|
|
|
|
|
(President North
American
|
|
Options (U):
|
|
|
48,550
|
|
|
|
U:
|
|
|
|
35,438
|
|
Operations)
|
|
SPAUs (E):
|
|
|
|
|
|
|
E:
|
|
|
|
|
|
|
|
SPAUs (U):
|
|
|
22,952
|
|
|
|
U:
|
|
|
|
31,666
|
|
Pierre Arseneault
|
|
Options (E):
|
|
|
|
|
|
|
E:
|
|
|
|
|
|
(Former Vice President Strategic
|
|
Options (U):
|
|
|
89,032
|
|
|
|
U:
|
|
|
|
68,598
|
|
Planning and Information
Technology)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
E: Exercisable U: Unexercisable |
33
Long-Term
Incentive Plan Table Founders Plan
On March 24, 2005, our board of directors adopted the
Founders Plan to allow for an additional compensation
opportunity tied to Novelis share price improvement targets for
certain of our executives approved by the Human Resources
Committee. Participants earn PSUs if Novelis share price
improvement targets are achieved within three performance
periods: March 24, 2005 to March 23, 2008;
March 24, 2006 to March 23, 2008; and March 24,
2007 to March 23, 2008. The table below sets forth PSU
tranches representing the number of PSUs that participants are
eligible to receive for the three performance periods under the
Founders Plan if share improvement targets are achieved. The
share price improvement targets for these three tranches are
$23.57, $25.31 and $27.28, respectively.
|
|
|
|
|
|
|
|
|
Name
|
|
Units Granted
|
|
|
Performance Period
|
|
|
Brian W. Sturgell(1)
|
|
|
0
|
|
|
|
March 24, 2005 to March 23, 2008
|
|
(Former President and Chief
|
|
|
70,275
|
|
|
|
March 24, 2006 to March 23, 2008
|
|
Executive Officer)
|
|
|
70,275
|
|
|
|
March 24, 2007 to March 23, 2008
|
|
Martha Finn Brooks
|
|
|
23,750
|
(2)
|
|
|
March 24, 2005 to March 23, 2008
|
|
(Chief Operating Officer)
|
|
|
23,750
|
|
|
|
March 24, 2006 to March 23, 2008
|
|
|
|
|
23,750
|
|
|
|
March 24, 2007 to March 23, 2008
|
|
Christopher Bark-Jones
|
|
|
7,200
|
(2)
|
|
|
March 24, 2005 to March 23, 2008
|
|
(Former
President European
|
|
|
7,200
|
|
|
|
March 24, 2006 to March 23, 2008
|
|
Operations)
|
|
|
7,200
|
|
|
|
March 24, 2007 to March 23, 2008
|
|
Kevin Greenawalt
|
|
|
7,200
|
(2)
|
|
|
March 24, 2005 to March 23, 2008
|
|
(President North
American
|
|
|
7,200
|
|
|
|
March 24, 2006 to March 23, 2008
|
|
Operations)
|
|
|
7,200
|
|
|
|
March 24, 2007 to March 23, 2008
|
|
Pierre Arseneault
|
|
|
6,000
|
(2)
|
|
|
March 24, 2005 to March 23, 2008
|
|
(Former Vice President Strategic
|
|
|
6,000
|
|
|
|
March 24, 2006 to March 23, 2008
|
|
Planning and Information
|
|
|
6,000
|
|
|
|
March 24, 2007 to March 23, 2008
|
|
Technology)
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
On March 14, 2006, Mr. Sturgell agreed with the board
of directors decision that, in light of our 2005 and 2006
financial reporting delay and restatement, Mr. Sturgell
would forfeit 46,850 PSUs attributable to the first tranche of
the award. The board of directors also approved an increase in
the size of the award opportunity for Mr. Sturgell for the
second and third tranches under the Founders Plan to provide an
additional incentive for reaching the share price improvement
targets for those tranches. The award size for each tranche was
increased by 23,425 PSUs to a potential of 70,275 PSUs. The PSUs
for the second and third tranches would not have been earned
unless the share price improvement targets specified in the
Founders Plan ($25.31 and $27.28, respectively) were achieved.
As a result of Mr. Sturgells termination as CEO on
August 29, 2006, all of his PSUs attributable to the second
and third tranches of the Founders Plan were forfeited. |
|
(2) |
|
The share price improvement targets for the first tranche were
satisfied in June 2005. As a result, Ms. Brooks and
Messrs. Bark-Jones, Greenawalt and Arseneault received the
full amount of their performance unit tranche for the
performance period from March 24, 2005 to March 23,
2008. Ms. Brooks and Messrs. Bark-Jones, Greenawalt
and Arseneault received cash payments for the payout of these
awards in April 2006 in the amounts of $478,325, $145,008,
$145,008 and $120,840, respectively, which will be reported as
2006 compensation. |
34
Retirement
Benefits
Novelis
Pension Plan for Officers
Our Human Resources Committee determines participants in the
Pension Plan for Officers (PPO). This plan is a
supplemental executive retirement plan that provides an
additional pension benefit based on combined service up to
20 years as an officer of Novelis or of Alcan and eligible
earnings which consist of the excess of the average annual
salary and target short-term incentive award during the 60
consecutive months when they were the greatest over eligible
earnings in the U.S. Plan or the U.K. Plan, as applicable.
Both the U.S. Plan and U.K. Plan are described below. Each
provides for a maximum pension benefit on eligible earnings that
is established with reference to the position of the officer
prior to being designated a PPO participant. The following table
shows the percentage of eligible earnings in the PPO, payable
upon normal retirement after age 60, according to combined
years of service as an officer of Novelis or of Alcan.
|
|
|
|
|
|
|
Years as Officer
|
5
|
|
10
|
|
15
|
|
20
|
|
15%
|
|
30%
|
|
40%
|
|
50%
|
The normal form of payment of pensions is a lifetime annuity.
Pensions are not subject to any deduction for social security or
other offset amounts.
Prior to their termination, Brian W. Sturgell and Christopher
Bark-Jones were the only participants in the PPO.
Mr. Sturgell has 9 years and 10 months of
combined service and Mr. Bark-Jones has 14 years and
10 months of combined service under the PPO. Eligible
earnings under the PPO for 2005 for Mr. Sturgell were
$983,556 and were $282,414 for Mr. Bark-Jones.
U.S. Plan
During 2005, those of our employees previously participating in
the Alcancorp Pension Plan and the Alcan Supplemental Executive
Retirement Plan (collectively referred to as the
U.S. Plan) received up to one year of
additional service under each plan to the extent that such
employees continued to be employed by us during the year. We
paid to Alcan the normal cost (in the case of the Alcancorp
Pension Plan) and the current service cost (in the case of the
Alcan Supplemental Executive Retirement Plan) with respect to
those employees. The U.S. Plan provides for pensions
calculated based upon combined service with us or Alcan of up to
35 years. Eligible earnings consist of the average annual
salary and the short-term incentive award up to its target
during the 3 consecutive calendar years when they were the
greatest, subject to a cap for those participating in the PPO.
Effective January 1, 2006, Novelis adopted the Novelis
Pension Plan which provides benefits identical to the benefits
provided under the Alcancorp Pension Plan. Executive officers
who were participants in the Alcancorp Pension Plan will
participate in the Novelis Plan. Executive officers who were not
participants in the Alcancorp Pension Plan will not participate
in the Novelis Plan. Executive officers who were hired on
January 1, 2005 or later will participate in the Novelis
Savings and Retirement Plan.
The following table shows estimated retirement benefits,
expressed as a percentage of eligible earnings, payable upon
normal retirement at age 65 according to years of combined
service.
|
|
|
|
|
|
|
|
|
|
|
Years of Service
|
10
|
|
15
|
|
20
|
|
25
|
|
30
|
|
35
|
|
17%
|
|
25%
|
|
34%
|
|
42%
|
|
51%
|
|
59%
|
The normal form of payment of pensions is a lifetime annuity
with either a guaranteed minimum of 60 monthly payments or
a 50% lifetime pension to the surviving spouse.
At age 65, the estimated credited years of combined service
for Martha Finn Brooks, Kevin Greenawalt and Pierre Arseneault
would be approximately 22 years, 39 years and
40 years, respectively. Mr. Sturgell has 17 years
and 5 months of combined service under the U.S. Plan.
Eligible earnings under the plan for 2005 for
35
Mr. Sturgell, Ms. Brooks, Mr. Greenawalt and
Mr. Arseneault were $938,340, $1,029,800, $443,000 and
$460,380, respectively.
Individual
Pension Undertakings
In addition to participation in the U.S. Plan described
above, Martha Finn Brooks will receive from us a supplemental
pension equal to the excess, if any, of the pension she would
have received from her employer prior to joining Alcan had she
been covered by her prior employers pension plan until her
separation or retirement from Novelis, over the sum of her
pension from the U.S. Plan and the pension rights actually
accrued with her previous employer.
U.K.
Plan.
The U.K. Plan, which was transferred to us from Alcan in
connection with the spin-off, provides for pensions calculated
on service of up to 40 years and eligible earnings, which
consist of the average annual salary and the short-term
incentive award up to its target during the last 12 months
before retirement, subject to a cap for those participating in
the PPO.
The following table shows estimated retirement benefits,
expressed as a percentage of eligible earnings, payable upon
normal retirement at age 65 according to combined years of
service.
|
|
|
|
|
|
|
|
|
|
|
Years of Service
|
10
|
|
15
|
|
20
|
|
25
|
|
30
|
|
35
|
|
17%
|
|
26%
|
|
35%
|
|
43%
|
|
52%
|
|
60%
|
The normal form of payment of pensions is a lifetime annuity
with a guaranteed minimum of 60 monthly payments and a 60%
lifetime pension to the surviving spouse.
Prior to his termination, Christopher Bark-Jones was the only
executive officer entitled to participate in the U.K. Plan.
Mr. Bark-Jones has approximately 29 credited years of
combined service under the U.K. Plan and his eligible earnings
in 2005 were $480,386.
Value
of the Retirement Benefits
A measure of the value of the U.S. Plan, U.K. Plan and of
the Pension Plan for Officers that can be deemed to be part of
the total 2005 compensation of the five aforementioned Named
Executive Officers is the service cost of the plans. The service
cost is the estimated present value of benefits attributable by
the pension benefit formula to services rendered by the plan
members during a given period. The valuation of benefits is
based on actuarial assumptions in relation to future events that
will vary by plan to take into account the general
characteristics of its membership.
Another measure of the value of pension plans or pension
benefits is the projected benefit obligation (PBO).
The PBO is the actuarial present value of the part of the total
pension payable at retirement that is attributable to service
rendered up to the date of valuation.
The following table indicates the total projected annual pension
of each Named Executive Officer from the plans described above,
based on years of credited combined service up to the normal
retirement age of 65 and eligible earnings to the end of 2005.
The table also indicates 2005 service cost and the PBO as of
December 31, 2005 in relation to each Named Executive
Officer.
The service cost and the PBO amounts are only estimates using
prevailing interest rates of the discounted value of contractual
entitlements. The value of these estimated entitlements may
change over time because they are based on long-term
assumptions, such as the expected distribution of retirement
ages, future compensation increases and life expectancy, that
may not represent actual developments. Furthermore, the methods
used to determine these amounts will not be the same as those
used by other companies and therefore will not be directly
comparable. The actuarial assumptions applied are the same as
those used to determine the service cost and the benefit
obligation as described in Note 15 to our combined and
consolidated financial
36
statements for the year ended December 31, 2005. There is
no contractual undertaking by the Company to pay benefits of
equivalent amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected Benefit
|
|
|
|
Projected Annual
|
|
|
2005 Service
|
|
|
Obligation as of
|
|
|
|
Pension Payable at Age 65
|
|
|
Cost
|
|
|
December 31, 2005
|
|
Name
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Brian W. Sturgell
|
|
|
850,068
|
|
|
|
425,124
|
|
|
|
5,261,224
|
|
Martha Finn Brooks
|
|
|
306,821
|
|
|
|
109,686
|
|
|
|
396,400
|
|
Christopher Bark-Jones
|
|
|
396,084
|
|
|
|
194,751
|
|
|
|
4,739,233
|
|
Kevin Greenawalt
|
|
|
235,673
|
|
|
|
52,933
|
|
|
|
1,271,600
|
|
Pierre Arseneault
|
|
|
270,369
|
|
|
|
65,899
|
|
|
|
1,422,000
|
|
EMPLOYMENT
AGREEMENTS AND CHANGE IN CONTROL AGREEMENTS
In connection with our spin-off from Alcan, we entered into
employment agreements with Brian W. Sturgell, our former Chief
Executive Officer, Martha Finn Brooks, our Chief Operating
Officer, Chris Bark-Jones, our former President of our European
operations, Kevin Greenawalt, President of our North American
operations and Pierre Arseneault, our former Vice President of
Strategic Planning and Information Technology, and other
executive officers, setting out the terms and conditions of
their employment. In 2005, under their respective employment
agreements, Brian W. Sturgell was entitled to a base salary of
$985,000, Martha Finn Brooks was entitled to a base salary of
$655,000, Chris Bark-Jones was entitled to a base salary of
$440,611, Kevin Greenawalt was entitled to a base salary of
$310,000 and Pierre Arseneault was entitled to a base salary of
$300,000. Each of these officers was also eligible for
participation in programs providing short-term incentives,
long-term incentives and other types of compensation that
reflect the competitive level of similar positions in the
compensation peer groups or as included in published survey
information.
Certain of our executive officers have also entered into change
in control agreements that provide for severance payments by us
upon the termination of the executive officers employment
without cause or by the executive officer for good reason.
Except in the case of Brian W. Sturgell, upon the occurrence of
such an event, the executive would be entitled to an amount
equal to 24 months of his or her base salary and target
short-term incentive award. These change in control agreements
will expire on the earliest to occur of the second anniversary
of the spin-off (January 6, 2007), the date of the
executives death or retirement, or the date following the
termination of the executives employment for any other
reason.
Mr. Sturgell is entitled to an amount equal to
36 months of his base salary and target short-term
incentive award (payable in 36 equal monthly instalments), plus
the amount payable under provisions of the TSR Plan upon
termination of his employment without cause. In addition,
Mr. Sturgells change in control agreement provides
that severance payments under such agreement will be excluded
from the calculation of earnings for purposes of calculating
pension benefits; however, the duration of such payments will be
included for purposes of calculating years of service under the
Companys pension plans.
On July 1, 2002, Alcancorp entered into a Deferred Share
Agreement with Martha Finn Brooks pursuant to which Alcancorp
agreed to grant to Ms. Brooks 33,500 shares of Alcan
common shares on August 1, 2005, the date of her third
anniversary of employment, as compensation for the loss by
Ms. Brooks of accrued benefits and unvested restricted
shares at her former employer. In connection with our spin-off
from Alcan, on January 6, 2005, we assumed Alcancorps
obligations under the Deferred Share Agreement and the
33,500 shares of Alcan common stock to be granted were
converted into 66,477 Shares. On July 27, 2005, the
Deferred Share Agreement was amended to provide that we will, in
lieu of granting Ms. Brooks 66,477 Shares, pay
Ms. Brooks cash in an amount equal to the value of such
Shares based on the closing price of such Shares on the New York
Stock Exchange on August 1, 2005, subject to applicable
withholding taxes. Ms. Brooks received a payment in the
gross amount of $1,864,691.
37
DIRECTORS
COMPENSATION
Each of our non-executive directors is entitled to receive
compensation equal to $150,000 per year, payable in
quarterly installments, except that the directors who are
members of our Audit Committee are entitled to $155,000. The
chair of our board of directors is to receive compensation equal
to $250,000 per year, and the chair of our Audit Committee is
entitled to receive $175,000 per year. We have adopted a
Deferred Share Unit Plan for Non-Executive Directors, pursuant
to which 50% of our directors compensation is required to
be paid in the form of DDSUs, and 50% in the form of either
cash, additional DDSUs, or a combination of the two at the
election of each non-executive director, unless otherwise
determined by our Human Resources Committee. An employee of
Novelis who is a director is not entitled to receive fees for
serving on our board of directors.
Because at least half of our non-executive directors
compensation will be paid in DDSUs, our non-executive directors
are not required to own a specific amount of our Shares. DDSUs
are the economic equivalent of our Shares. A director cannot
redeem the accumulated DDSUs until he or she ceases to be a
member of our board of directors.
Our board of directors believes that compensation in the form of
DDSUs together with the requirement that our non-executive
directors retain all DDSUs until they cease to be a director
helps to align the interests of our non-executive directors with
those of our shareholders.
The number of DDSUs to be credited to the account of a
non-executive director each quarter will be determined by
dividing the quarterly amount payable in DDSUs, by the average
closing prices of a common share on the Toronto and New York
stock exchanges on the last five trading days of each quarter.
Additional DDSUs will be credited to each non-executive director
corresponding to dividends declared on our Shares. The DDSUs are
redeemable only upon termination of the directorship and may be
redeemed in cash, our Shares or a combination thereof, at the
election of the director. The amount to be paid by us upon
redemption will be calculated by multiplying the accumulated
balance of DDSUs by the average closing prices of a common share
on the Toronto and New York stock exchanges on the last five
trading days prior to the redemption date. For services rendered
by directors in 2005, 57,051 DDSUs were granted.
Our non-executive directors are entitled to reimbursement for
transportation, lodging and other expenses incurred in attending
meetings of our board of directors and meetings of committees of
our board of directors. Our non-executive directors who are not
Canadian residents are entitled to reimbursement for tax advice
related to compensation.
The following table sets out the individual election of each
non-executive director in relation to their compensation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portion of Fees Paid
|
|
|
Portion of Fees
|
|
|
Amount of Fees
|
|
Name
|
|
in the Form of DDSUs
|
|
|
Paid in Cash
|
|
|
Paid in Cash (US$)
|
|
|
Edward A. Blechschmidt
|
|
|
100%
|
|
|
|
0%
|
|
|
|
|
|
Jacques Bougie, O.C
|
|
|
100%
|
|
|
|
0%
|
|
|
|
|
|
Charles G. Cavell
|
|
|
50%
|
|
|
|
50%
|
|
|
|
77,500
|
|
Clarence J. Chandran
|
|
|
100%
|
|
|
|
0%
|
|
|
|
|
|
C. Roberto Cordaro
|
|
|
50%
|
|
|
|
50%
|
|
|
|
75,000
|
|
Helmut Eschwey
|
|
|
50%
|
|
|
|
50%
|
|
|
|
75,000
|
|
David J. FitzPatrick
|
|
|
50%
|
|
|
|
50%
|
|
|
|
64,583
|
|
Suzanne Labarge
|
|
|
50%
|
|
|
|
50%
|
|
|
|
87,500
|
|
William T. Monahan
|
|
|
50%
|
|
|
|
50%
|
|
|
|
75,000
|
|
J.E. Newall
|
|
|
100%
|
|
|
|
0%
|
|
|
|
|
|
Rudolf Rupprecht
|
|
|
50%
|
|
|
|
50%
|
|
|
|
77,500
|
|
Kevin M. Twomey
|
|
|
50%
|
|
|
|
50%
|
|
|
|
|
|
Edward Yang
|
|
|
50%
|
|
|
|
50%
|
|
|
|
77,500
|
|
38
CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Alcancorp established a real estate loan program to assist
relocating employees in the United States. Under the program, an
employee was permitted to obtain an interest-free loan from
Alcancorp, the proceeds of which were to be used only to
purchase a new principal residence. The loan is secured by a
mortgage on the new principal residence. On July 1, 2003,
Jo-Ann Longworth, our former Vice President and Controller,
received a loan from Alcancorp in the amount of $75,000 under
this program. As of January 20, 2005, the loan was
transferred to a third-party bank. The largest amount
outstanding under the loan in 2005 was $73,125. There was no
interest paid to us for the loan prior to it being transferred
to the third party bank.
DIRECTORS
AND OFFICERS LIABILITY INSURANCE
Novelis carries insurance covering liability, including defense
costs, of directors and officers of Novelis and its
subsidiaries, incurred as a result of their acting as such,
except in the case of failure to act honestly and in good faith.
The policy provides coverage against certain risks in situations
where Novelis may be prohibited by law from indemnifying the
directors or officers. The policy also reimburses Novelis for
certain indemnity payments made by Novelis to such directors or
officers, subject to a $2.5 million deductible in respect
of each insured loss.
The premium paid by Novelis for coverage in 2005 was
$1.62 million and the limit of insurance is
$125 million per occurrence and in the aggregate per year.
ADDITIONAL
INFORMATION
NOVELIS WILL MAIL WITHOUT CHARGE, UPON WRITTEN REQUEST, A
COPY OF ITS ANNUAL REPORT ON
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2005, INCLUDING THE
CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS AND FINANCIAL
STATEMENT SCHEDULES. REQUESTS SHOULD BE SENT TO: NOVELIS INC.,
3399 PEACHTREE ROAD NE, SUITE 1500, ATLANTA, GA 30326,
ATTENTION: CORPORATE SECRETARY.
Additional information relating to Novelis may be found on our
website at www.novelis.com, on SEDAR at
www.sedar.com or on EDGAR at www.sec.gov.
APPROVAL
OF THE BOARD OF DIRECTORS
The board of directors has approved the contents of this
Circular and the sending to shareholders.
Nichole Robinson
Corporate Secretary
39
SCHEDULE A
(For the
12-month
period ended December 31, 2005)
|
|
|
|
|
|
|
|
|
|
|
Number of Meetings Attended
|
|
Director
|
|
Board
|
|
|
Committees
|
|
|
Jacques Bougie, O.C.
|
|
|
7 of 8
|
|
|
|
8 of 9
|
|
Charles G. Cavell
|
|
|
8 of 8
|
|
|
|
22 of 24
|
|
Clarence J. Chandran
|
|
|
7 of 8
|
|
|
|
13 of 14
|
|
C. Roberto Cordaro
|
|
|
8 of 8
|
|
|
|
12 of 14
|
|
Helmut Eschwey
|
|
|
8 of 8
|
|
|
|
17 of 17
|
|
David J. FitzPatrick
|
|
|
6 of 6
|
*
|
|
|
11 of 12
|
|
Suzanne Labarge
|
|
|
6 of 8
|
|
|
|
20 of 21
|
|
William T. Monahan
|
|
|
7 of 8
|
|
|
|
16 of 17
|
|
J.E. Newall, O.C.
|
|
|
8 of 8
|
|
|
|
25 of 25
|
|
Rudolf Rupprecht
|
|
|
7 of 8
|
|
|
|
17 of 21
|
|
Brian W. Sturgell
|
|
|
8 of 8
|
|
|
|
**
|
|
Edward V. Yang
|
|
|
8 of 8
|
|
|
|
18 of 21
|
|
|
|
|
* |
|
Not appointed to the board of directors until March 24,
2005. |
|
** |
|
Mr. Sturgell attended 25 of 25 committee meetings, although
he is not an appointed member of any board committee.
Mr. Sturgell did not attend any meeting of the Nominating
Sub-Committee.
|
|
|
|
|
|
|
|
Number of
|
|
Board and Board Committee Meetings
|
|
Meetings Held
|
|
|
Board
|
|
|
8
|
|
Audit Committee
|
|
|
11
|
|
Nominating and Corporate
Governance Committee
|
|
|
3
|
|
Human Resources Committee
|
|
|
7
|
|
Customer Relations Committee
|
|
|
4
|
|
Nominating
Sub-Committee
|
|
|
2
|
|
During 2005, all directors attended at least 75% of the meetings
of the board of directors and the committees on which they
served.
A-1
SCHEDULE B
STATEMENT
OF CORPORATE GOVERNANCE PRACTICES
In January 2004, the Canadian Securities Administrators (the
CSAs) adopted Multilateral Instrument
52-110 Audit Committees. Certain amendments to such
instrument were subsequently adopted and are effective since
June 30, 2005 (such instrument, as amended, the Audit
Committee Rules). The Audit Committee Rules include
requirements regarding audit committee composition and
responsibilities, as well as reporting obligations with respect
to audit related matters. The Company complies with these rules
and appropriate disclosure is made, where applicable, in the
following table.
The CSAs also adopted, effective on June 30, 2005, National
Instrument 58-101 Disclosure of Corporate Governance
Practices (the Disclosure Instrument) and National
Policy 58-201 Effective Corporate Governance (the
Governance Policy). The Governance Policy provides
guidance on governance practices to Canadian issuers, while the
Disclosure Instrument requires issuers to make the prescribed
disclosure regarding their governance practices. The disclosure
made hereunder refers to the items of the Disclosure Instrument
as well as to the Governance Policy, where appropriate. We
believe that our corporate governance practices meet and exceed
the requirements of the Disclosure Instrument and the Governance
Policy, as reflected in the disclosure made hereunder.
Please also refer to our Charter of the Board of Directors and
Corporate Governance Guidelines (the Board of Directors
Charter) and our Code of Business Conduct and Ethics
available on the Companys website at
www.novelis.com. The other charters, codes and guidelines
referred to in the table below are also available on our
website. All of these documents are available in print to any
shareholder who requests copies by contacting our Corporate
Secretary. The Company is dedicated to amending its corporate
governance practices on an ongoing basis in order to respond to
the evolution of best practices that are appropriate for the
Company.
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
1. Board of
Directors
|
|
|
(a) Disclose the
identity of directors who are independent.
|
|
Of the 13 current directors, our
board (the board) has determined that 12 are
independent, and 1 (our Chairman and Interim
Chief Executive Officer, Mr. Monahan) is not
independent.
|
(b) Disclose the
identity of directors who are not independent, and describe the
basis for that determination.
|
|
Please see above.
|
(c) Disclose whether
or not a majority of directors are independent. If a majority of
directors are not independent, describe what the board does to
facilitate its exercise of independent judgement in carrying out
its responsibilities.
|
|
Please see above. See also our
Guidelines on the Independence of the Board of Directors
available on the Companys website at
www.novelis.com.
|
(d) If a director is
presently a director of any other issuer that is a reporting
issuer (or the equivalent) in a jurisdiction or a foreign
jurisdiction, identify both the director and the other issuer.
|
|
Please see director biographies in
this Circular.
|
(e) Disclose whether
or not the independent directors hold regularly scheduled
meetings at which non- independent directors and members of
management are not in attendance. If the independent directors
hold such meetings, disclose the number of meetings held since
the beginning of the issuers most recently completed
financial year. If the independent directors do not hold such
meetings, describe
|
|
Every meeting of our board is
followed by an
in-
camera session at which members of management are not
present, to ensure free and open discussion and communication
among the non-executive directors. Please see Board
of Directors and Corporate Governance Matters in this
Circular.
|
B-1
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
what the board does to facilitate
open and candid discussion among its independent directors.
|
|
|
(f) Disclose whether
or not the chair of the board is an independent director. If the
board has a chair or lead director who is an independent
director, disclose the identity of the independent chair or lead
director, and describe his or her role and responsibilities. If
the board has neither a chair that is independent nor a lead
director that is independent, describe what the board does to
provide leadership for its independent directors.
|
|
Our Board of Directors Charter
states that in the event that the Chairman is a director who is
an executive of the Company, the board must also appoint a lead
director from among the non-executive directors to chair the
board at all meetings where management is absent and to assume
other appropriate functions. Mr. Newall, is the
independent board chair. The Chairmans responsibilities
include the following: (i) presiding at meetings of
shareholders and the board; (ii) providing leadership to
enhance board effectiveness and focus; (iii) acting as
liaison between the board and management; (iv) assisting
in representing the Company to external groups; and (v)
ensuring good corporate governance.
|
(g) Disclose the
procedure for shareholders to communicate with the presiding
director or non-management directors as a group.
|
|
You may contact our board, a
committee of our board, or an individual director by writing to
our Corporate Secretary Board Communication at our
head office. All communications will be compiled by the
Corporate Secretary and submitted to the appropriate board
member. The Corporate Secretary will reply or take other
instructions from the applicable board contact. Please see
Board of Directors and Corporate Governance
Matters in this Circular.
|
(h) Disclose the
attendance record of each director for all board meetings held
during the issuers most recently completed financial year.
|
|
Please see Schedule A to this
Circular.
|
2. Board
Mandate
Disclose the text of the boards written mandate. If the
board does not have a written mandate, describe how the board
delineates its role and responsibilities.
|
|
On February 23, 2006, the
board approved a revised charter which is included as Schedule D
to this Circular and which states that the prime stewardship
responsibility of the board is to ensure the viability of the
Company and to ensure that it is managed in the interest of
shareholders as a whole, while taking into account the interests
of other stakeholders.
|
3. Position
Descriptions
|
|
|
(a) Disclose whether
or not the board has developed written position descriptions for
the chair and the chair of each board committee. If the board
has not developed written position descriptions for the chair
and/or the
chair of each board committee, briefly describe how the board
delineates the role and responsibilities of each such position.
|
|
Our Board of Directors Charter
includes position descriptions for the board chair. Our Audit
Committee Charter includes a position description for the Audit
Committee chair. Our other committee charters do not have
specific descriptions for the committee chairs.
|
(b) Disclose whether
or not the board and CEO have developed a written position
description for the CEO. If the board and CEO have not developed
such a position description, briefly describe how the board
delineates the role and responsibilities of the CEO.
|
|
We do not have a CEO job position
description. The CEOs role is tied to the achievement of
annual objectives and responsibilities outlined in various
policies.
|
B-2
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
4. Orientation and
Continuing Education
|
|
|
(a) Briefly describe
what measures the board takes to orient new directors
regarding
(i) the role of the board, its committees and its
directors, and
(ii) the nature and operation of the issuers
business.
|
|
Our Corporate Secretary maintains
material on Company policies and director responsibilities and
liabilities, which is updated as necessary, and provides this
material to directors. Detailed current information on the
Company and its business, operations and finances are sent on a
monthly basis to the directors. Particularly important items and
information requiring urgent attention is conveyed immediately.
In addition, new directors spend time with members of senior
management, including those involved in our business operations,
so that they become rapidly familiar with the Company, its
issues, business and operations. On site plant tours and
meetings are also made available. Care is taken to ensure that
new directors understand the roles and responsibilities of the
board of directors and its committees, as well at the commitment
level that we expect from our directors. The Company also
encourages directors to attend seminars and other educational
programs and to report back to the board on the quality of such
programs.
|
(b) Briefly describe
what measures, if any, the board takes to provide continuing
education for its directors. If the board does not provide
continuing education, describe how the board ensures that its
directors maintain the skill and knowledge necessary to meet
their obligations as directors.
|
|
Please see above.
|
5. Ethical Business
Conduct
|
|
|
(a) Disclose whether
or not the board has adopted a written code for the directors,
officers and employees. If the board has adopted a written code:
(i) disclose how a person or company may obtain a copy of
the code;
(ii) describe how the board monitors compliance with its
code, or if the board does not monitor compliance, explain
whether and how the board satisfies itself regarding compliance
with its code; and
(iii) provide a cross-reference to any material change
report filed since the beginning of the issuers most
recently completed financial year that pertains to any conduct
of a director or executive officer that constitutes a departure
from the code.
|
|
The board adopted, on March
24, 2005, the Code of Business Conduct and Ethics. This
Code, which was amended on July 27, 2005, is available the
Companys website at www.novelis.com and is
available in print to any shareholder who requests copies by
contacting our Corporate Secretary. The board, through its Audit
Committee, reviews, monitors and oversees the Code. Each year,
management reports to such committee on the implementation of
the Code within the organization and on any material
contravention by employees of the Company to the provisions of
the Code. No material change report has ever been filed or
required to be filed pertaining to any conduct of a director or
executive officer constituting a departure from the Code. During
2005, the Company granted no waivers from the provisions of the
Code.
|
(b) Describe any steps
the board takes to ensure directors exercise independent
judgement in considering transactions and agreements in
|
|
The Code of Business Conduct and
Ethics states that any material transaction or relationship that
could reasonably be expected to give rise to a conflict of
|
B-3
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
respect of which a director or
executive officer has a material interest.
|
|
interest should be discussed with
the person responsible for the application of the Code. In
practice, a questionnaire is sent annually to each director to
make sure that the director is in no such conflict that has not
been disclosed. Should there be a discussion or decision
relating to an organization, business or association in which a
director has an interest, the board would request such director
not to participate in any such discussion or decision.
|
(c) Describe any other
steps the board takes to encourage and promote a culture of
ethical business conduct.
|
|
The Company takes ethical business
conduct very seriously. Hence, the Board of Directors Charter
states that board members are expected to demonstrate high
ethical standards and integrity in their personal and
professional dealings; as part of the Code of Business Conduct
and Ethics, the directors, officers and employees owe a duty to
the Company to act with integrity. The Code also prescribes that
service to the Company should never be subordinated to personal
gain and advantage. Conflicts of interest should be avoided.
Additionally, a code of ethics has been adopted for the
Companys senior financial officers.
|
6. Nomination of
Directors
|
|
|
(a) Describe the
process by which the board identifies new candidates for board
nomination.
|
|
The Nominating and Corporate
Governance Committee has, as stated in its charter, the
responsibility to review candidates for nomination as directors
and recommend candidates for election to our board. When
reviewing candidates, the committee takes into consideration
factors such as judgment, independence, skill, diversity and
business experience of the individual candidates and their
expected contribution to the skill set of our board as a whole.
The committee is allowed to employ third party search firms for
identifying and evaluating nominees. Pursuant to our governing
statute, one or more shareholders holding 5% or more of our
Shares may, in certain circumstances, propose nominees for
election to our board.
|
(b) Disclose whether
or not the board has a nominating committee composed entirely of
independent directors. If the board does not have a nominating
committee composed entirely of independent directors, describe
what steps the board takes to encourage an objective nomination
process.
|
|
Our Corporate Governance
Guidelines state that the members of the Nominating and
Corporate Governance Committee shall each have no material
relationship with the Company and each member shall be otherwise
unrelated and independent under the laws, regulations and
listing requirements to which the Company is subject and in
accordance with the Guidelines on the Independence of the
Directors. As of August 31, 2006, all members of the
Nominating and Corporate Governance Committee are
independent.
|
(c) If the board has a
nominating committee, describe the responsibilities, powers and
operation of the nominating committee.
|
|
The Nominating and Corporate
Governance Committee reviews the Companys corporate
governance practices. The committee also assesses and ensures
annually the effectiveness of our board as a whole, of each
committee of the board and the
|
B-4
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
|
|
contribution of individual
directors. It reviews candidates for nominations as directors
and recommends candidates for election to our board. The
responsibilities, powers and operation of the Nominating and
Corporate Governance Committee are further described in the
charter of such committee.
|
7.
Compensation
|
|
|
(a) Describe the
process by which the board determines the compensation for the
issuers directors and officers.
|
|
The Human Resources Committee
Charter provides that the committee recommends levels of
compensation for our directors.
|
|
|
The Human Resources Committee has
the responsibility to make recommendations with respect to human
resources policy and employee relations. The Human Resources
Committee establishes our general compensation philosophy and
oversees the development and implementation of compensation
policies and programs. It also reviews and approves the level
of, and/or
changes to, the compensation of individual executive officers,
taking into consideration individual performance and competitive
compensation practices.
|
|
|
The Human Resources Committee
reviews corporate goals and objectives relevant to the President
and CEO and the COO, evaluates the President and CEOs and
the COOs performance based on those goals and objectives
and such other factors as the Human Resources Committee deems
appropriate and in the best interest of the Company, and either
alone or together with other independent directors (as directed
by the board) determines and approves CEO and COO compensation
based on this evaluation of performance and competitive
compensation in the relevant competitor group.
|
(b) Disclose whether
or not the board has a compensation committee composed entirely
of independent directors. If the board does not have a
compensation committee composed entirely of independent
directors, describe what steps the board takes to ensure an
objective process for determining such compensation.
|
|
Our Corporate Governance
Guidelines state that the members of the Human Resources
Committee shall each have no material relationship with the
Company and each member shall be otherwise unrelated and
independent under the laws, regulations and listing requirements
to which the Company is subject and in accordance with
Guidelines on the Independence of the Board of Directors. All
members of the Human Resources Committee are
independent.
|
(c) If the board has a
compensation committee, describe the responsibilities, powers
and operation of the compensation committee.
|
|
The Human Resources Committee has
the broad responsibility to review human resources policy and
employee relations matters and make recommendations with respect
to such matters to our board or our chief executive officer, as
appropriate. It reviews the effectiveness of our overall
management organization structure and succession planning and
reviews the recommendations for the appointment of executive
officers. It oversees the development and implementation of
compensation policies and approves the compensation of
individual executive
|
B-5
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
|
|
officers. It also reviews our
policy, management practices and performance in environment,
health and safety matters. The responsibilities, powers and
operation of the Human Resources Committee are further described
in the charter of such committee which is included on our
website at www.novelis.com.
|
(d) If a compensation
consultant or advisor has, at any time since the beginning of
the issuers most recently completed financial year, been
retained to assist in determining compensation for any of the
issuers directors and officers, disclose the identity of
the consultant or advisor and briefly summarize the mandate for
which they have been retained. If the consultant or advisor has
been retained to perform any other work for the issuer, state
that fact and briefly describe the nature of the work.
|
|
The Human Resources Committee
hired James F. Reda and Associates as a compensation consultant
to assist it in 2005. The primary role for the consultant was to
assist the Human Resources Committee and the board in
determining the compensation of the Companys directors and
officers.
|
8. Other Board
Committees
If the board has standing committees other than the audit,
compensation and nominating committees, identify the committees
and describe their function.
|
|
In addition to the committees
referred to above, the board has also established a Customer
Relations Committee. The Customer Relations Committee focuses on
customer relationships, competitive dynamics and market segment
analysis, among other things. For more information on the
mandate of the Customer Relations Committee, please see its
charter which is available on the Companys website at
www.novelis.com.
|
9.
Assessments
Disclose whether or not the board, its committees
and individual directors are regularly assessed with respect to
their effectiveness and contribution. If assessments are
regularly conducted, describe the process used for the
assessments. If assessments are not regularly conducted,
describe how the board satisfies itself that the board, its
committees, and its individual directors are performing
effectively.
|
|
Our Corporate Governance
Guidelines state that formal assessments of the board, its
committees and the individual directors are carried-out at least
annually in order to determine whether they are functioning
effectively and to enhance their performance. As part of the
board performance assessment, questionnaires are approved by the
Nominating and Corporate Governance Committee in order to assess
the performance of the board and its committees, the board chair
and committee chairs. Each questionnaire is sent and completed
by each director. Full reports are then made by the chair of the
Nominating and Corporate Governance Committee to the board with
suggestions to improve the effectiveness of the board, board
committees, board and committee chairs.
|
The CSA Audit Committee
Rules state that the audit committee must be composed of a
minimum of three (3) members, who must be
independent directors (as defined in those
rules).
|
|
Our Corporate Governance
Guidelines state that the members of the Audit Committee shall
each have no material relationship with the Company and each
member shall be otherwise unrelated and independent under the
laws, regulations and listing requirements to which the Company
is subject and in accordance with the Guidelines on the
Independence of the Board of Directors. In addition, all members
of the Audit Committee are independent
directors, as required under the CSA Audit Committee Rules. No
member
|
B-6
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
|
|
of the Audit Committee receives,
other than in his or her capacity as a director or member of a
board committee, directly or indirectly, any fee from the
Company or any subsidiary of the Company, nor is an affiliated
person of the Company, or any subsidiary of the Company.
|
The CSA Audit Committee
Rules state that each audit committee member must be financially
literate.
|
|
All members of the Audit Committee
are financially literate and all members of
the committee meet the criteria to be designated as
audit committee financial expert under the
rules of the United States Securities and Exchange
Commission.
In determining whether or not a director is
financially literate, the board considers if
the director has the ability to read and understand
a set of financial statements that present a breadth and level
of complexity of accounting issues that are generally comparable
to the breadth and complexity of the issues that can reasonably
be expected to be raised by the Companys financial
statements.
In determining if a director is an audit committee
financial expert, the board considers if the director is a
person who has: (a) an understanding of generally accepted
accounting principles and financial statements; (b) the
ability to assess the general application of such accounting
principles in connection with the accounting for estimates,
accruals and reserves; (c) experience preparing, auditing,
analyzing or evaluating financial statements that present a
breadth and level of complexity of accounting issues that are
generally comparable to the breadth and complexity of issues
that can reasonably be expected to be raised by the
Companys financial statements, or experience actively
supervising one or more persons engaged in such activities; (d)
an understanding of internal controls and procedures for
financial reporting; and (e) an understanding of audit
committee functions.
|
The CSA Audit Committee
Rules state that the audit committee must have a written charter
that sets out its mandate and responsibilities.
|
|
See Schedule E to this Circular.
The Audit Committee Charter is also available on the
Companys website at www.novelis.com.
|
|
|
|
The CSA Audit Committee
Rules state that the audit committee must recommend to the board
of directors: (a) the external auditor to be
nominated for the purposes of preparing or issuing an
auditors report or performing other audit, review or
attest services for the issuer; and (b) the
compensation of the external auditor.
|
|
The charter of the Audit Committee
states that the committee is responsible for recommending the
retention and, if appropriate, the termination of external
auditors, evaluating and remunerating them, and monitoring their
qualifications, performance and independence.
|
|
|
|
The CSA Audit Committee
Rules state that the audit committee must be directly
responsible for overseeing the work of the external auditor
engaged for the purpose of preparing or issuing an auditors
report or performing other audit, review
|
|
The charter of the Audit Committee
provides that the committee is responsible for overseeing the
external auditors and discussing with them the quality and not
just the acceptability of the Companys accounting
principles, including any material written
|
B-7
|
|
|
|
|
Corporate Governance Practices
|
Guidelines
|
|
at the Company
|
|
or attest services for the
issuer, including the resolution of disagreements between
management and the external auditor regarding financial
reporting.
|
|
communications between the
Company and the external auditors.
|
The CSA Audit Committee
Rules state that the audit committee must pre-approve all
non-audit services to be provided to the issuer or its
subsidiary entities by the issuers external auditor.
|
|
The charter of the Audit Committee
provides that the Audit Committee approves all audit engagement,
compensation and terms, as well as all significant non-audit
compensation and terms, subject to any requirement under
Canadian law for shareholder approval.
|
The CSA Audit Committee
Rules state that the audit committee must review the
issuers financial statements, MD&A and annual and
interim earnings press releases before the issuer publicly
discloses this information. These rules also mention that the
audit committee must be satisfied that adequate procedures are
in place for the review of the issuers public disclosure
of financial information extracted or derived from the
issuers financial statements, other than the public
disclosure referred to in the preceding sentence, and must
periodically assess the adequacy of those procedures.
|
|
The charter of the Audit Committee
provides that the Audit Committee should review and discuss with
management and the external auditors the Companys annual
audited financial statements and quarterly financial statements
prior to public disclosure thereof, including reviewing the
Companys disclosure under managements discussion and
analysis of financial condition and results of operation. It
also states that the Audit Committee should ensure that adequate
procedures are in place for the review of the Companys
public disclosure of financial information extracted or derived
from the Companys financial statements and to periodically
review the adequacy of those procedures.
|
The CSA Audit Committee
Rules state that the audit committee must establish procedures
for: (a) the receipt, retention and treatment of
complaints received by the issuer regarding accounting, internal
accounting controls, or auditing matters; and (b)
the confidential, anonymous submission by employees of the
issuer of concerns regarding questionable accounting or auditing
matters.
|
|
The charter of the Audit Committee
states that the Audit Committee is responsible for establishing
procedures for: (a) the receipt, retention and treatment
of complaints received by the Company regarding accounting,
internal accounting controls, or auditing matters; and (b)
the confidential, anonymous submission by employees of the
Company of concerns regarding questionable accounting or
auditing matters. We have adopted such procedures. Please refer
to the Companys website at www.novelis.com for more
details on these procedures.
|
The CSA Audit Committee
Rules and state that the audit committee must review and approve
the issuers hiring policies regarding partners, employees
and former partners and employees of the present and former
external auditor of the issuer.
|
|
The charter of the Audit Committee
provides that the Audit Committee should set policies on the
hiring of employees or former employees of the auditors, with a
view to preserving the auditors independence, which
policies shall include the restrictions set forth in the
applicable rules promulgated by the United States
Securities and Exchange Commission.
|
The CSA Audit Committee
Rules state that the audit committee must have the authority:
(a) to engage independent counsel and other advisors
as it determines necessary to carry out its duties; (b)
to set and pay the compensation for any advisors employed
by the audit committee; and (c) to communicate
directly with the internal and external auditors.
|
|
The charter of the Audit Committee
states that the committee is empowered to retain independent
counsel, advisors, accountants or other experts, as it deems
appropriate, without seeking approval of the board or
management. The Company provides appropriate funding to
compensate any such persons. In accordance with its charter, the
Committee must insist on maintaining free and open communication
between the Committee, the auditors, the internal auditors and
management of the Company.
|
B-8
SCHEDULE C
NOVELIS
INC. (THE CORPORATION)
As stated in the Corporations Board of Directors
Charter, a majority of the Board shall be composed of Directors
who have been determined to have no material relationship with
the Corporation and who, in the reasonable opinion of the Board,
must be unrelated and independent.
The following Guidelines have been established by the Board to
assist it in determining Director independence for this purpose:
1. A Director of the Corporation shall be considered to be
an Independent Director if he or she (i) is
free from any interest and any business or other relationship
which could, or could reasonably be perceived to, materially
interfere with the Directors ability to act without bias
and with a view to the best interests of the Corporation, and
(ii) has no relationship with the Corporation or any of its
employees that is likely to, or is likely to be perceived to,
interfere with the exercise of his or her judgement in a manner
that is independent from management.
Without affecting the general application of the foregoing:
(a) A Director will not be an Independent Director if,
within the preceding three years:
(i) the Director was employed by the Corporation;
(ii) an immediate family member of the Director was
employed by the Corporation as an officer;
(iii) the Director was employed by or affiliated with the
Corporations internal or external auditor;
(iv) an immediate family member of the Director was
employed by the Corporations internal or external auditor
as a partner, principal, manager or general employee;
(v) a senior Officer of the Corporation was on the board of
directors of a company which employed the Director, or which
employed an immediate family member of the Director as an
officer;
(vi) the Director has received, or has an immediately
family member who has received, during any twelve-month period
within such previous three years, more than $100,000 in direct
compensation from the Corporation, other than director and
committee fees and pension or other forms of deferred
compensation for prior service (provided such compensation is
not contingent in any way on continued service);
provided, that compensation received by the Director for
former service as an interim Chairman or CEO or other executive
officer need not be considered in determining independence and
compensation received by an immediately family member for
service as an employee (other than executive officer) of the
Corporation need not be considered; or
(vii) the Director is a current employee, or an immediate
family member is a current executive officer, of a company that
has made payments to, or received payments from, the Corporation
for property or services in an amount which, in any of such
previous three years, exceeds the greater of $1 million, or
2% of such other companys consolidated gross revenues
(b) The following relationships will be considered not to
be material relationships that would impair a Directors
independence:
(i) if a Director is an officer, partner or significant
shareholder in an entity that does business with the Corporation
and the annual sales or purchases, for goods or services, to or
from the Corporation are less than two percent of the
consolidated gross annual revenues of that entity;
C-1
(ii) if a Director is a limited partner, a non-managing
member or occupies a similar position in an entity that does
business with the Corporation, or has a shareholding in such
entity which is not significant, and who, in each case, has no
active role in sales to or in providing services to the
Corporation and derives no direct material personal benefit from
same; and
(iii) if a Director serves as an officer, director or
trustee of a charitable organization, and the Corporations
charitable contributions to the organization are less than two
percent of that organizations total consolidated gross
annual revenues.
2. All Members of the Audit and Human Resources Committees
of the Board and of the Nominating and Corporate Governance
Committee must be Independent Directors, who must also meet
additional criteria whereby he or she must not, directly or
indirectly, accept any consulting, advisory or other
compensatory fee from the Corporation, other than fixed amounts
of compensation under a retirement plan (including deferred
compensation) for prior service with the Corporation, and
provided that such compensation is not contingent in any way on
continued service. Indirect acceptance includes
acceptance of such a fee by a spouse, minor child or stepchild
or a child or stepchild sharing a home with the Director or by
an entity in which such member is a partner, member, an officer
such as a managing director occupying a comparable position or
senior officer, or occupies a similar position (except limited
partners, non-managing members and those occupying similar
positions who, in each case, have no active role in providing
services to the entity and derive no direct material personal
benefit from compensation paid in respect of same) and which
provides accounting, consulting, legal, investment banking or
financial advisory services to the Corporation.
In addition, the Director must not be an affiliated person of
the Corporation within the U.S. Securities and Exchange
Commissions rules relating to audit committee listing
standards.
3. In the case where the Corporation enters into a business
relationship with a corporation or entity with which a Director
is affiliated as a director, officer, partner or significant
shareholder, the following guidelines will apply:
(a) the relationship must not cause the Director to lose
his status as an Independent Director; and
(b) the relationship must not cause the Director to fail to
meet the additional criteria set out in paragraph 2 of
these Guidelines if the Director is a Member of the Audit or
Human Resources Committees or the Nominating and Corporate
Governance Committee; and
(c) either:
(i) the relationship was already in existence and fully
disclosed to the Corporation prior to the Director joining the
Board; or
(ii) the relationship was initiated at the request of the
Corporation because of the particular competence or products of
the entity in question and not by the Director; and
(d) any proposed new relationship must be brought to the
attention of the Chairman in advance and, where such
relationship is not one covered by paragraph 1 of these
Guidelines, be subject to the determination of the Corporate
Governance Committee as to its materiality and the consequent
effect on the independence of the Director; and
(e) the relationship will be disclosed in the
Corporations public disclosure documents in accordance
with applicable regulations and the Corporations policy.
C-2
4. While service by the Corporations Directors
together on the boards of other companies does not, as such,
affect their independence, no more than two Directors may serve
together on the board of another publicly-traded company.
For the purposes of these Guidelines; (i), a significant
shareholding means direct or indirect beneficial ownership
of five percent or more of the outstanding equity or voting
rights of the relevant entity; and (ii) immediate
family member includes a persons spouse, parents,
children, siblings, mothers and
fathers-in-law,
sons and
daughters-in-law,
brothers and
sisters-in-law,
and anyone (other than domestic employees) who shares such
persons home; and (iii) unless the context otherwise
requires, the Corporation includes Novelis Inc. or
any of its subsidiaries or any other member of the Novelis
consolidated group.
Any questions relating to these Guidelines or to the
interpretation of specific circumstances may be addressed to the
Chairman who will consult the Corporations Chief Legal
Officer or Corporate Secretary. The matter may, as appropriate,
be brought to the attention of the Corporate Governance
Committee for a decision.
C-3
SCHEDULE D
The Board of Directors of Novelis Inc. (the Company)
is elected by the Companys Shareholders to supervise the
management of the business and affairs of the Company. The prime
stewardship responsibility of Novelis Inc.s Board is to to
ensure the viability of the Company and to ensure that it is
managed in the interest of the Shareholders as a whole while
taking into account the interests of other stakeholders.
The Board sets policy for the Company and advises the Chief
Executive Officer and senior executives who manage the
Companys business and affairs.
|
|
II.
|
Composition
and Organization of the Board
|
The Nominating and Corporate Governance Committee of the Board
oversees the desired size of the Board, the need for recruitment
and the expected experience of the new candidates. The
Nominating and Corporate Governance Committee reviews and
recommends to the Board the candidates for nomination as
Directors. The Board approves the final choice of candidates for
nomination and election by the Shareholders.
Board members must have an appropriate mix of skills, knowledge
and experience in business and an understanding of the regions
in which the Company operates. Directors selected should be able
to commit the requisite time for all the Boards business.
A majority of the Board shall be composed of Directors who the
Board has determined to have no material relationship with the
Company and who, in the reasonable opinion of the Board, are
unrelated and independent under the laws, regulations and
listing requirements to which the Company is subject. The Board
has approved Guidelines on the Independence of Directors of
Novelis Inc. which contain specific criteria for determining
Director independence.
The Board shall appoint its Chairman and Vice-Chairman (if one
is to be appointed) from among the Companys Directors. In
the event that the Chairman is a Director who is an executive of
the Company, the Board shall also appoint a Lead Director from
among the non-executive Directors to chair the Board at all
meetings where Management is absent and to assume other
appropriate functions.
The Chairmans responsibilities include the following:
(a) presiding at meetings of Shareholders and the Board;
(b) providing leadership to enhance Board effectiveness and
focus;
(c) acting as liaison between the Board and Management;
(d) assisting in representing the Company to external
groups; and
(e) ensuring good corporate governance.
There is no mandatory retirement age for Directors.
D-1
The Directors are elected by the Shareholders at every Annual
Meeting. The term of office of each Director shall expire at the
close of the Annual Meeting of Shareholders following that at
which he or she was elected or until his or her successor shall
be elected.
|
|
III.
|
Meetings
of the Board
|
The Chairman of the Board, in consultation with the appropriate
members of Management, develops the agenda for Board Meetings.
|
|
2.
|
Board
Material Distribution
|
Information and materials that are important to the Boards
understanding of the agenda items and related topics are
distributed in advance of the meeting. The Company will deliver
information on the business, operations and finances of the
Company to the Board on a monthly basis and on an as-required
basis.
|
|
3.
|
Board
Meeting Frequency and Schedule
|
A minimum of five regularly-scheduled Board meetings shall be
held each year. Additional meetings may be held when required.
The Chairman of the Board, in consultation with the Directors
and Management, will set the frequency and length of Board
meetings. Board members may participate in meetings by means of
conference calls or similar communications equipment by means of
which all persons participating in the meeting can communicate
with each other.
|
|
4.
|
Management
at Meetings
|
Management shall participate in meetings and make presentations
to allow Directors to gain additional understanding and insight
into the Companys businesses.
Every meeting of the Board shall be followed by an in-camera
session at which management Directors and other members of
Management are not present, to ensure free and open discussion
and communication among the non-executive Directors.
|
|
IV.
|
Duties
and Responsibilities of the Board
|
In addition to its statutory responsibilities, the Board has the
following duties and responsibilities:
(a) ensuring that Novelis Inc. is operated so as to
preserve its financial integrity and in accordance with policies
approved by the Board;
(b) appointing its Chief Executive Officer, developing his
or her position description and ensuring succession preparedness
with the recommendations of the Human Resources Committee and
the Nominating and Corporate Governance Committee, which
recommendations will address the policies and principles for
selecting a successor to the Chief Executive Officer, both in an
emergency situation and in the ordinary course of business;
(c) adopting a strategic planning process and thereafter
reviewing and approving the overall business strategy for the
Company, all of which are originally developed by Management;
(d) identifying the principal risks of the Companys
businesses and ensuring the implementation of appropriate
systems to manage these risks;
(e) ensuring that appropriate structures and procedures are
in place so that the Board and its committees can function
independently of Management;
D-2
(f) providing a source of advice and counsel to Management
on critical and sensitive matters;
(g) reviewing and approving key policy statements developed
by Management on various issues such as ethics, compliance,
communications, environment and public disclosures;
(h) ensuring that its expectations of Management are
understood, that the appropriate matters come before the Board
and that the Board is kept informed of Shareholder feedback;
(i) ensuring that members of senior Management are of the
calibre required for their roles, are adequately trained and
monitored and that planning for their succession is ongoing;
(j) conducting, through the Nominating and Corporate
Governance Committee, an annual review of Board practices and
Board, Chairman and Committee performance (including
Directors individual contributions);
(k) reviewing the recommendations of the Human Resources
Committee that have been approved and recommended by the
Nominating and Corporate Governance Committee with respect to
the adequacy and form of the compensation of non-executive
Directors and ensuring their compensation adequately reflects
the responsibilities and risks involved in being an effective
Director;
(l) evaluating, through the Human Resources Committee, the
performance and reviewing the compensation of the Chief
Executive Officer and ensuring that such compensation is
competitive and measured according to benchmarks which reward
contribution to shareholder value;
(m) selecting, upon the recommendation of the Nominating
and Corporate Governance Committee, nominees for election as
Directors;
(n) selecting the Chairman of the Board;
(o) evaluating with the Nominating and Corporate Governance
Committee whether the Board as a whole, the Committees of the
Board and the Directors are capable of carrying out and do carry
out their roles effectively;
(p) ensuring that new Directors are provided with an
adequate orientation on their roles and responsibilities and the
Companys operations;
(q) encouraging all Directors to attend at least one
continuing education program for directors endorsed by
Institutional Shareholder Services (ISS) or other
internationally recognized corporate governance organization;
(r) overseeing the quality and integrity of the
Companys accounting and financial reporting systems,
disclosure controls and procedures and internal controls;
(s) approving projects requiring an investment or
disposition that is material and acquisitions where
environmental or other liabilities exist and which could result
in significant exposure to the Company are also subject to Board
approval, irrespective of amounts;
(t) reviewing alternate strategies in response to any
possible takeover bid in order to maximize value for
shareholders;
(u) discussing and developing the Companys approach
to corporate governance in general, with the involvement of the
Nominating and Corporate Governance Committee.
|
|
V.
|
Expected
Qualities of Board Members
|
Board members are expected to possess the following
characteristics and traits:
(a) demonstrate high ethical standards and integrity in
their personal and professional dealings;
(b) act honestly and in good faith with a view to the best
interest of the Company;
D-3
(c) devote sufficient time to the affairs of the Company
and exercise care, diligence and skill in fulfilling their
responsibilities both as Board members and as a Committee
members;
(d) provide independent judgment on a broad range of issues;
(e) understand and challenge the key business plans of the
Company;
(f) be willing to work in a team and be open to opinions of
others;
(g) raise appropriate and difficult questions and issues to
facilitate active and effective participation in the
deliberation of the Board and of each Committee on which he or
she serves;
(h) make all reasonable efforts to attend all Board and
Committee meetings;
(i) review the materials provided by Management in advance
of the Board and Committee meetings;
(j) inform the Chairman and Vice-Chairman (if applicable)
of the Board before accepting membership on any other board of
directors or audit committee and also inform of any change in
the Directors interests that could affect his or her
relationship to the Company.
|
|
1.
|
Number,
Structure and Jurisdiction of Committees
|
The Board delegates certain of its functions to Committees, each
of which has a written charter. There are four standing
Committees of the Board: the Human Resources, the Audit, the
Nominating and Corporate Governance and the Customer Relations
Committees. Other Committees or sub-committees may be
established from time to time by Board resolution. The roles and
responsibilities of each Committee are described in the
respective Committee charters. Task Force Committees
may be established on an ad hoc basis to deal with
specific subjects.
|
|
2.
|
Independent
Committee Members
|
Members of the Audit Committee, Human Resources Committee and
the Nominating and Corporate Governance Committee shall each
have no material relationship with the Company and each Member
shall be otherwise unrelated and independent under the laws,
regulations and listing requirements to which the Company is
subject and in accordance with the Guidelines on the
Independence of Directors of Novelis Inc. The
Nominating and Corporate Governance Committee reviews and
recommends the memberships of the various Committees to the
Board.
The Chairman of each Committee, in consultation with the
appropriate members of Management, develops the agenda for
Committee meetings.
|
|
4.
|
Committee
Report to Board
|
At the next Board meeting following each meeting of a Committee,
the Committee Chairmen will report to the Board on the
Committees activities. Minutes of Committee meetings are
provided to all Directors.
|
|
5.
|
Assignment
and Rotation of Committee Members
|
The responsibility for the assignment and rotation of Committee
Members rests with the Chairman of the Board, who acts in
consultation with and at the recommendation of the Nominating
and Corporate Governance Committee. Rotation is not required but
changes are made occasionally to accommodate the Boards
needs and individual interest and skills.
D-4
|
|
6.
|
Frequency
and Length of Committee Meetings
|
The Chairman of a Committee, in consultation with Committee
Members and Management, will set the frequency and length of
meetings of such Committee.
|
|
VII.
|
Administrative
Matters
|
|
|
1.
|
Board
Performance Assessment
|
The Board will ensure that formal assessments of the Board, its
Committees and the individual Directors are carried out at least
annually in order to determine whether they are functioning
effectively and to enhance their performance.
On a regular basis and at least every three years, the Human
Resources Committee will review Director compensation (including
components and amounts) and propose any recommendations with
respect to Directors compensation to the Nominating and
Corporate Governance Committee for its review based on market
practices and the particular demands made on Directors. The
Nominating and Corporate Governance Committee will then make
recommendations on Director compensation to the Board. Any
change to the compensation of Directors must be formally
approved by the full Board.
|
|
3.
|
Director
Share Ownership
|
In order to ensure alignment of the interests of Directors with
those of the Shareholders, at least one-half of Directors
fees are paid to non-executive Directors in Deferred Share
Units, being the economic equivalent of the Common Shares of the
Company.
Directors will maintain the absolute confidentiality of the
deliberations and decisions of the Board of Directors and
information received at meetings, except as may be specified by
the Chairman or if the information is publicly disclosed by the
Company.
|
|
5.
|
Board
Interaction with Third Parties
|
If a third party approaches a Director on a matter of interest
to the Company, the Director should bring the matter to the
attention of the Chairman who shall determine whether this
matter should be reviewed with Management or should more
appropriately be dealt with by the Board in an in camera
session.
|
|
6.
|
Communication
with the Board
|
Shareholders and other constituencies may communicate with our
Board, a committee of our Board, or an individual director by
writing to our Corporate Secretary Board
Communication at our head office. All communications will be
compiled by the Secretary and submitted to the appropriate Board
member. The Secretary will reply or take other actions in
accordance with instructions from the applicable Board contact.
The Company has a comprehensive code of business conduct and
ethics that governs all employees of Novelis Inc. as well as the
Directors.
Directors are expected to visit from time to time the
Companys plant and business locations in different parts
of the world to meet local personnel and gain insight into the
Companys business and operations.
D-5
|
|
9.
|
Orientation
and Information
|
The Company Secretary will prepare a Directors Manual
containing information on Company policies and Director
responsibilities and liabilities, which shall be updated as
necessary. Detailed current information on the Company and its
business, operations and finances are sent on a monthly basis to
the Directors. Particularly important items and information
requiring urgent attention is conveyed immediately. In addition,
new Directors are expected to spend time with members of senior
Management, including those involved in Novelis Inc.s
business operations, so that they can become familiar with the
Company, its issues, business and operations. Care is taken to
ensure that new Directors understand the roles and
responsibilities of the Board and its Committees, as well as the
commitment level that Novelis Inc. expects of its Directors.
|
|
VIII.
|
Resources
and Authority of the Board
|
The Board shall have the resources and authority appropriate to
discharge its duties and responsibilities, including the
authority to retain counsel or other experts, as it deems
appropriate, without seeking approval of Management. All
directors are invited to contact the Chief Executive Officer at
any time to discuss any aspect of the Companys business.
Directors also have complete access to other members of
management.
D-6
SCHEDULE E
The primary purpose of the Audit Committee (the
Committee) of the Board of Directors of Novelis Inc.
(the Company) is to assist the Board of Directors
(the Board) in fulfilling the Boards oversight
responsibilities for (i) the integrity of the
Companys financial statements, (ii) the
Companys compliance with legal and regulatory
requirements, (iii) the qualifications and independence of
the independent auditors (the Auditors) and
(iv) the performance of the Companys internal audit
function and the Auditors. The Committee is also responsible for
preparation of the Committees report that the Securities
and Exchange Commission (SEC) rules require be
included in the Companys annual proxy statement (the
Audit Committee Report). The Committee shall also
carry out the other functions set out in this Charter. In so
doing, the Committee shall insist on maintaining free and open
communication between the Committee, the Auditors, the internal
auditors and Management of the Company. In discharging its
oversight role, the Committee is empowered to investigate any
matter brought to its attention with full access to all books,
records, facilities, and personnel of the Company and to retain
independent counsel, advisors, accountants or other experts, as
it deems appropriate, without seeking approval of the Board or
Management.
|
|
II.
|
Composition
and Organization of the Audit Committee
|
The Committee shall consist of at least three Directors, each of
whom the Board of Directors has determined to be independent in
respect of the Company as contemplated by the laws, regulations
and listing requirements to which the Company is subject and in
accordance with the Guidelines on the Independence of the
Directors of Novelis Inc. Each Member shall be
financially literate, as such qualification is
interpreted by the Board of Directors in its business judgment,
or must become financially literate within a reasonable period
of time after his or her appointment to the Committee. At least
one Member shall be qualified as an audit committee
financial expert as defined by applicable regulations.
Members shall be appointed by the Board based on nominations
recommended by the Companys Corporate Governance Committee
or a sub-committee thereof, and shall serve for such term as the
Board may determine.
The Committee shall designate one Member of the Committee to act
as its Chair. The Secretary or an Assistant Secretary of the
Company shall act as secretary to the Committee.
If a Committee Member simultaneously serves on the audit
committee of more than three public companies (including the
Company), the Board of Directors must determine that such
simultaneous service would not impair the ability of such Member
to effectively serve on the Committee. The Company shall
disclose any such determination in its annual proxy statement.
|
|
III.
|
Meetings
of the Audit Committee
|
The Committee shall meet regularly at least four times a year,
or more frequently if circumstances so dictate. In addition, the
Members of the Committee shall meet quarterly to review the
Companys annual and quarterly releases of financial
results and Managements Discussion and Analysis of
Financial Condition and Results of Operation prior to public
disclosure.
At each regular meeting, the Committee shall meet separately
with senior Management, the Chief Internal Auditor and the
Auditors to discuss any matters that the Committee or any of
these parties believe should be discussed privately. The
Committee may request any officer or employee of the Company or
the Auditors to attend a meeting of the Committee or to meet
with any Members of the Committee. In addition, the members of
senior Management, the Chief Internal Auditor and the Auditors
shall have access to the Committee to bring forward matters
requiring urgent attention.
E-1
The Chair of the Committee shall, in consultation with the other
Members of the Committee, the Auditors and the appropriate
officers of the Company, be responsible for calling meetings of
the Committee, establishing agenda therefor and supervising the
conduct thereof. The Committee may also take any action
permitted hereunder by unanimous written consent.
The Committee shall meet in executive session, as necessary.
Subject to the laws governing the Committee, any Member may, if
all Members consent, participate at any meeting of the
Committee, by means of telephonic, electronic or other
communication facility that permits all participants to
communicate with each other during the meeting.
|
|
IV.
|
Division
of Responsibilities of the Audit Committee, the Auditors and
Management
|
The primary responsibility of the Committee is to oversee the
Companys accounting and financial reporting processes and
audits of the Companys financial statements on behalf of
the Board and report the results of the Committees
activities to the Board. The Management of the Company is
responsible for the preparation, presentation and integrity of
the Companys financial statements and for the
effectiveness of internal control over financial reporting.
Management and the internal audit department are responsible for
maintaining appropriate accounting and financial reporting
principles and policies as well as internal controls and
procedures that provide for compliance with accounting standards
and applicable laws and regulations. The Auditors are
responsible for planning and carrying out audits of the
Companys annual financial statements in accordance with
generally accepted auditing standards, reviewing the
Companys quarterly financial statements prior to the
filing of each quarterly report, annually auditing
managements assessment of the effectiveness of internal
control over financial reporting and other auditing procedures.
The Committee shall have a clear understanding with Management
and the Auditors that the Auditors are accountable to the
Committee, as the representative of the Companys
shareholders. The Committee shall recommend the appointment of
the Auditors to the Board for ultimate approval by the
shareholders. The Auditors audit engagement letter shall
be signed by the Chair of the Committee on behalf of the
Company, having been previously approved by the Committee.
|
|
V.
|
Duties
and Powers of the Audit Committee
|
To carry out its responsibilities, the Committee shall have the
following duties and powers in respect of which it shall be
entitled to full support and cooperation from Management:
|
|
1.
|
In
respect of the Auditors:
|
(i) to recommend to the Board the retention or termination
of the Auditors, having evaluated their performance;
(ii) to oversee the work of the Auditors (including the
resolution of any disagreement between Management and the
Auditors regarding financial reporting) who shall report to the
Committee;
(iii) to approve all audit engagement compensation and
terms, as well as all significant non-audit compensation and
terms, subject to any requirement under Canadian law for
Shareholder approval;
(iv) to require the Auditors to submit annually, and to
review, a formal written statement describing the Auditors
internal quality control procedures; any material issues raised
by the most recent internal quality control review, or peer
review, of the Auditors, or by any inquiry or investigation by
governmental or professional authorities, within the preceding
five years, respecting one or more independent audits carried
out by the Auditors, and any steps taken to deal with any such
issues; and all relationships between the Auditors and the
Company;
(v) to consider any reports or communications (and
Managements responses thereto) submitted to the Committee
by the Auditors as required by or referred to in applicable
auditing standards, including Independence Standards Board
Standard No. 1;
E-2
(vi) to require the Auditors to submit a report relating to
the Companys annual audited financial statements
describing all critical accounting policies and practices as
required by relevant regulations;
(vii) to discuss with the Auditors the independence of the
Auditors and any relationships or services that may impact the
quality of audit services or the objectivity and independence of
the Auditors;
(viii) to discuss with the Auditors the matters required to
be discussed by the Statement on Auditing Standards No. 61,
as well as any significant matters or difficulties encountered
in the course of the audit work, including any significant
disagreements with Management, and Managements response
thereto; the discussion should include the responsibilities,
budget and staffing of the Companys internal audit
function;
(ix) to review the annual Auditors Report;
(x) to review and pre-approve the Auditors provision
of audit and any non-audit services to the Company;
(xi) to review at each scheduled Committee meeting the
decisions of any Member(s) of the Committee to whom authority to
grant pre-approvals of audit and non-audit services is delegated;
(xii) to review and discuss with the Auditors the scope and
plan of the annual audit;
(xiii) to review and evaluate the qualifications,
performance and independence of the Auditors, including a review
and evaluation of the lead partner of the Auditors, taking into
account the opinions of Management and internal audit personnel;
(xiv) to ensure the rotation of the lead (or coordinating)
audit partner, or the audit partner responsible for reviewing
the audit, in accordance with applicable law and regulations;
(xv) to consider whether, in order to assure continuing
auditor independence, there should be regular rotation of the
Auditors;
(xvi) to set policies on the hiring of employees or former
employees of the Auditors, with a view to preserving the
Auditors independence, which policies shall include the
restrictions set forth in Section 706 of the Sarbanes-Oxley
Act of 2002 and any rules promulgated thereunder by the SEC;
(xvii) to obtain from the Auditors assurance that the audit
was conducted in a manner consistent with applicable laws and
regulations and that in the course of conducting the audit,
there were no acts detected or that otherwise came to the
attention of the Auditors that require disclosure to the
Committee under Section 10A(b) of the Securities Exchange
Act of 1934, as amended;
(xviii) to discuss with the Auditors the quality, not just
acceptability, of the Companys accounting principles,
including all critical accounting policies and practices used,
any alternative treatments of financial information that have
been discussed with Management, the ramifications of the use of
such alternative disclosures and treatments, and the treatment
preferred by the Auditors, as well as any other material written
communications between the Auditors and Management;
(xix) to remind the Auditors that they are accountable to
the Committee, as the representative of the Companys
shareholders, and that the Committee expects to be advised on
any areas that require its attention;
(xx) to present all conclusions of the Committee with
respect to the Auditors to the full Board of Directors.
|
|
2.
|
In
respect to the Internal Audit Function:
|
(i) to review and approve the appointment of the Chief
Internal Auditor;
(ii) to advise the Chief Internal Auditor that he or she is
expected to provide to the Committee summaries of the
significant issues and practices relating to accounting
principles and policies, financial reporting and internal
control over financial reporting prepared by the internal audit
department for Management and Managements responses
thereto;
E-3
(iii) to review and discuss with the Chief Internal Auditor
reports on the activities of the internal audit function;
(iv) to review the Companys internal audit plan;
(v) to review the degree of independence of the internal
audit function and the adequacy of staffing and compensation;
(vi) to review senior employee expenses and perquisites on
an annual basis.
|
|
3.
|
In
respect of Disclosure and Internal Controls:
|
(i) to advise Management, the internal audit function and
the Auditors that they are expected to provide the Committee
with a timely disclosure and analysis of transactions and other
events that would materially impact the Companys financial
statements;
(ii) to discuss guidelines and policies governing the
process by which Management assesses and manages the
Companys exposure to risk (including insurance coverage),
and to discuss the Companys major financial risk exposures
and the steps Management has taken to monitor and control such
exposures;
(iii) on a regular basis to review policies and practices
of the Company, including those related to pension governance,
funding and investments, metal and other commodity hedging
activities, insurance and foreign exchange, and to receive
updates as to current status;
(iv) to annually prepare, with the assistance of Management
and the Auditors, and issue an Audit Committee Report;
(v) to meet, review and discuss with Management and the
Auditors the Companys annual audited financial statements
and quarterly financial statements prior to public disclosure
and filing with securities authorities, including reviewing the
Companys disclosure under Managements Discussion and
Analysis of Financial Condition and Results of Operation;
(vi) to ensure that the Companys disclosure policy
and practices meet applicable regulatory requirements and the
needs of the Company;
(vii) to ensure that adequate procedures are in place for
the review of the Companys public disclosure of financial
information extracted or derived from the Companys
financial statements, other than the information referred to in
paragraph (v) above, and to periodically review the
adequacy of these procedures;
(viii) to review and discuss with Management and the
Auditors the Companys earnings press releases, as well as
financial information and earnings guidance provided to analysts
and rating agencies; these discussions may be general, covering
types of information to be disclosed and the type of
presentation to be made and need not take place in advance;
(ix) to review on an annual basis the Legal Proceedings
Report prepared by Management with a view to ensuring that all
potential material claims against the Company have been properly
evaluated, accounted for and disclosed;
(x) to discuss with the Companys Chief Legal Officer
any significant legal, compliance or regulatory matters that may
have a material effect on the financial statements or the
Companys business;
(xi) to review the Companys policies and processes
for monitoring compliance with applicable laws and regulations
and the Worldwide Code of Employee and Business Conduct
(including any annexes) and the Code of Ethics for Senior
Financial Officers;
(xii) to review the adequacy of the Companys disaster
recovery plan to ensure the ability to resume operations as
rapidly and efficiently as possible in the event of a disaster;
(xiii) to review significant tax exposures and tax planning
initiatives with a view to ensuring full compliance while
minimizing tax costs;
E-4
(xiv) to review the results of the Companys joint
ventures and investments;
(xv) to review major issues regarding accounting principles
and financial statement presentations, including any significant
changes in the Companys selection or application of
accounting standards or principles, and major issues as to the
adequacy of the Companys internal controls and any special
audit steps adopted in light of material control deficiencies;
(xvi) to review analyses prepared by Management
and/or the
Auditors setting forth significant financial reporting issues
and judgments made in connection with the preparation of the
Companys financial statements;
(xvii) to review the effect of regulatory and accounting
initiatives, as well as off-balance sheet structures, on the
Companys financial statements;
(xviii) to review Managements determination of
goodwill impairment, if any, as required by accounting standards
or principles;
(xix) to review any use of pro forma or non-generally
accepted accounting principles information by the Company in any
documents other than the financial statements;
(xx) to inquire of the Companys Chief Executive
Officer and Chief Financial Officer as to the Companys
internal controls and procedures and as to the existence of any
significant deficiencies or material weakness in the design or
operation of internal controls and any fraud that involves
Management or other employees who have a significant role in the
Companys internal controls; and review any disclosure with
respect thereto.
|
|
4.
|
In
respect of Financial Matters and Securities:
|
(i) to review any proposed material financial and capital
transactions;
(ii) to review the impact of the Companys financing
plan on capital structure and credit rating;
(iii) to review proposals from the Companys Chief
Financial Officer in respect of any issue of securities
previously approved by the Board;
(iv) to review the text of any registration or offering
document that may be required to be provided and to make
recommendations to the Board with respect to such documents;
(v) to review Managements recommendations regarding
the Companys dividend policy and make recommendations
thereon to the Board.
|
|
5.
|
In
respect of Corporate Governance:
|
(i) to prepare any report or other disclosures of the
Committee, including any recommendation of the Committee,
required by applicable laws and regulations to be included in
the Companys reports to shareholders or regulatory filings;
(ii) to review periodically the content and application of
the Code of Ethics for Senior Financial Officers of the
Company;
(iii) to deal with internal Company complaints referred to
it by the Corporate Compliance Officer or otherwise in respect
of the Worldwide Code of Employees and Business Conduct
(including any annexes) and the Code of Ethics for Senior
Financial Officers;
(iv) to deal with any reports of material violations of
securities laws or breaches of fiduciary duties brought to its
attention by Company lawyers or others;
(v) to review the activities of the Disclosure Committee of
Management assigned to review the functioning of the
Companys disclosure controls and procedures;
E-5
(vi) to establish procedures for (A) the receipt,
retention and treatment of complaints received by the Company
regarding accounting, internal accounting controls, or auditing
matters; and (B) the confidential, anonymous submission by
employees of the Company of concerns regarding questionable
accounting or auditing matters; and
(vii) to review and discuss such other matters that relate
to the accounting, auditing and financial reporting practices
and procedures of the Company as the Committee may, in its own
discretion, deem desirable in connection with the review
functions described above;
(viii) to report its activities to the Board on a regular
basis and to make such recommendations with respect to the above
and other matters as the Committee may deem necessary or
appropriate;
(ix) to prepare and review with the Board an annual
performance evaluation of the Committee and its Members; the
performance evaluation by the Committee shall be conducted in
such manner as the Committee deems appropriate;
(x) to review and recommend to the Board the appointment of
senior financial officers;
(xi) to review the adequacy and competence of the
Companys finance personnel;
(xii) to regularly review the independence, financial
literacy and financial expertise of the Committee Members;
(xiii) to review this Charter at least annually and
recommend any changes to the Board; the Committee may conduct
its review in such manner as the Committee deems appropriate.
|
|
VI.
|
Delegation
to Subcommittee
|
The Committee may, in its discretion and as appropriate,
delegate duties and responsibilities to a Member or to a
subcommittee of the Committee, subject to compliance with any
applicable legal, regulatory or listing requirements.
|
|
VII.
|
Resources,
Authority and Function of the Committee
|
The Committee shall have the resources and authority appropriate
to discharge its duties and responsibilities, including the
authority to retain independent counsel, advisors, accountants
or other experts, as it deems appropriate, without seeking
approval of the Board or Management. The Company shall provide
appropriate funding, as determined by the Committee, to
compensate any and all of such persons and to satisfy all
ordinary administrative expenses of the Committee that are
necessary or appropriate in carrying out its duties.
The function of the Committee is oversight. It is not the duty
or responsibility of the Committee or its Members (i) to
plan or conduct audits, (ii) to determine that the
Companys financial statements are complete and accurate
and are in accordance with generally accepted accounting
principles or (iii) to conduct other types of auditing or
accounting reviews or similar procedures or investigations. The
Committee, its Chair and its financial expert Member(s) are
Members of the Board, appointed to the Committee to provide
broad oversight of the accounting and financial reporting
processes and audits of the Companys financial statements,
and are specifically not accountable or responsible for the day
to day operation or performance of such activities. In
particular, the Member or Members identified as financial
experts shall not be accountable for giving professional
opinions on the internal or external audit of the Companys
financial information, but shall provide expertise in the
Committees oversight thereof.
Absent actual knowledge to the contrary (which shall be promptly
reported to the Board), each Member of the Committee shall be
entitled to rely on (i) the presumed integrity of those
persons or organizations within and outside the Company from
which it receives information, (ii) the accuracy and
completeness of the financial and other information provided to
the Committee by such persons or organizations and
(iii) representations made by Management and the Auditors
as to any non-audit services provided by the Auditors to the
Company and its subsidiaries.
E-6
SCHEDULE F
2006
INCENTIVE PLAN
ARTICLE I
ESTABLISHMENT
1.1 Purpose. The purpose of Novelis
Inc. 2006 Incentive Plan (the Plan) is to enhance
Company performance by motivating, attracting, and retaining key
employees and directors through the issuance of equity and cash
awards. This Plan is intended to supersede the Novelis
Conversion Plan of 2005 and the Novelis Inc. Stock Price
Appreciation Unit Plan and no new awards will be made under such
prior plans after the effective date of this Plan.
1.2 Effective Date. The Plan shall
be effective as of the date the stockholders of the Company
approve the Plan.
ARTICLE II
DEFINITIONS
As used in this Plan, the following terms shall be defined as
set forth below:
2.1 Award means any Short-Term
Incentive, Option, SAR, Restricted Share, Restricted Share Unit,
or Performance Award granted or payable under the Plan.
2.2 Award Agreement means an
agreement, certificate, resolution or other form of writing or
other evidence approved by the Committee which sets forth the
terms and conditions of an Award. An Award Agreement may be in
an electronic medium, may be limited to a notation on the
Companys books and records and, if approved by the
Committee, need not be signed by a representative of the Company
or a Participant.
2.3 Board means the Board of
Directors of the Company.
2.4 Cause means (a) a
Participants conviction of any crime (whether or not
involving the Company) constituting a felony in the jurisdiction
involved; (b) conduct of a Participant related to the
Participants employment for which either criminal or civil
penalties against the Participant or the Company may be sought;
(c) material violation of the Companys policies,
including, but not limited to those relating to sexual
harassment, the disclosure or misuse of confidential
information, or those set forth in Company manuals or statements
of policy; or (d) serious neglect or misconduct in the
performance of a Participants duties for the Company or
willful or repeated failure or refusal to perform such duties.
Any rights the Company may have in respect of the events giving
rise to Cause shall be in addition to the rights the Company may
have under any other agreement with a Participant or at law or
in equity. Any determination of whether a Participants
employment is (or is deemed to have been) terminated for Cause
shall be made by the Committee in its sole discretion, which
determination shall be final and binding on all parties. If,
subsequent to a Participants termination of employment
(whether voluntary or involuntary) without Cause, it is
discovered that the Participants employment could have
been terminated for Cause, such Participants employment
shall be deemed to have been terminated for Cause. A
Participants termination of employment for Cause shall be
effective as of the date of the occurrence of the event giving
rise to Cause, regardless of when the determination of Cause is
made.
2.5 Change in Control means the
first to occur of any of the following events:
(i) any person is or becomes the beneficial owner, directly
or indirectly, of securities of the Company (not including in
the securities beneficially owned by such person any securities
acquired directly from the Company or its affiliates, other than
in connection with the acquisition by the Company
F-1
or its affiliates of a business) representing 35% or more of
either the then outstanding shares of common stock of the
Company or the combined voting power of the Companys then
outstanding securities; or
(ii) the majority of the members of the Board is replaced
during any
12-month
period by directors whose appointment or election is not
endorsed by a majority of the members of the Board prior to the
date of the appointment or election; or
(iii) the consummation of a merger or consolidation of the
Company with any other entity, other than (a) a merger or
consolidation which would result in the voting securities of the
Company outstanding immediately prior to such merger or
consolidation continuing to represent (either by remaining
outstanding or by being converted into voting securities of the
surviving entity or any parent thereof), in combination with the
ownership of any trustee or other fiduciary holding securities
under an employee benefit plan of the Company, 50% or more of
the combined voting power of the voting securities of the
Company or such surviving entity or any parent thereof
outstanding immediately after such merger or consolidation, or
(b) a merger or consolidation effected to implement a
recapitalization of the Company (or similar transaction) in
which no person is or becomes the beneficial owner, directly or
indirectly, of securities of the Company (not including in the
securities beneficially owned by such person any securities
acquired directly from the Company or its affiliates, other than
in connection with the acquisition by the Company or its
affiliates of a business) representing 50% or more of either the
then outstanding shares of common stock of the Company or the
combined voting power of the Companys then outstanding
securities; or
(iv) the stockholders of the Company approve a plan of
complete liquidation or dissolution of the Company or an
agreement for the sale or disposition by the Company of all or
substantially all of the Companys assets, other than a
sale or disposition by the Company of all or substantially all
of the Companys assets to an entity, 50% or more of the
combined voting power of the voting securities of which is owned
by persons in substantially the same proportions as their
ownership of the Company immediately prior to such sale.
Notwithstanding the foregoing, no Change in Control
shall be deemed to have occurred if there is consummated any
transaction or series of integrated transactions immediately
following which the record holders of the common stock of the
Company immediately prior to such transaction or series of
transactions continue to have substantially the same
proportionate ownership in an entity which owns all or
substantially all of the assets of the Company immediately
following such transaction or series of transactions.
For purposes of this Section, beneficial ownership
shall be determined in accordance with
Rule 13d-3
under the Securities Exchange Act of 1934, as amended.
2.6 Code means the
U.S. Internal Revenue Code of 1986, as amended from time to
time.
2.7 Committee means the committee
of the Board described in Section 4.1.
2.8 Company means Novelis Inc., a
corporation organized under the laws of Canada, or any successor
corporation.
2.9 Covered Employee shall have
the meaning as set forth in Code Section 162(m).
2.10 Disability means that a
Participant is permanently and totally disabled and unable to
engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment which can
be expected to result in death or which has lasted or can be
expected to last for a continuous period of twelve months. The
existence of a Disability shall be determined by the Committee
in its sole discretion.
2.11 Employee means any person,
including an officer, employed by the Company or a Subsidiary as
an employee. The Companys employment classification of an
individual shall be binding and controlling for all purposes of
the Plan and shall apply irrespective of any contrary employment
classification of such individual by the Internal Revenue
Service, a court of competent jurisdiction or any other person
or entity.
2.12 Fair Market Value means the
fair market value of the Shares as determined by the Committee
from time to time. Unless otherwise determined by the Committee,
the fair market value shall be the closing
F-2
price for the Shares reported on the New York Stock Exchange on
the relevant date or, if there were no sales on such date, the
closing price on the nearest preceding date on which sales
occurred.
2.13 Grant Date means the date
specified by the Committee on which a grant of an Award shall
become effective, which date shall not be earlier than the date
on which the Committee takes action with respect thereto.
2.14 Incentive Stock Option means
any Option that is intended to qualify as an incentive
stock option under Code Section 422 or any successor
provision. Only Participants who are employees of the Company or
a Subsidiary may receive Incentive Stock Options.
2.15 Non-Employee Director means a
director of the Company who is not an active employee of the
Company.
2.16 Nonqualified Stock Option
means an Option that is not intended to qualify as an
Incentive Stock Option.
2.17 Option means any option to
purchase Shares granted under Article VI.
2.18 Participant means an Employee
or Non-Employee Director who is selected by the Committee to
receive benefits under this Plan.
2.19 Performance Award means an
Award of Performance Shares or Performance
Units granted pursuant to Article V that is
contingent upon the satisfaction of one or more Performance
Objectives. Each Performance Share or Performance Unit shall
have an initial value equal to the Fair Market Value of one
Share.
2.20 Performance Objectives has
the meaning set for in Article XI.
2.21 Performance Period means a
period of time established by the Committee during which the
attainment of Performance Objectives relating to an Award are to
be achieved.
2.22 Qualified Performance-Based
Award means an Award or portion of an Award that is
intended to satisfy the requirements for qualified
performance-based compensation under Code
Section 162(m). The Committee shall designate any Qualified
Performance-Based Award as such at the time of grant.
2.23 Restricted Shares means an
award of Shares granted pursuant to Article VII that are
subject to a substantial risk of forfeiture.
2.24 Restricted Share Units means
an award of a contractual right granted pursuant to
Article VII to receive a specified number of Shares or cash
at the end of a specified deferral period. Each Restricted Share
Unit shall have an initial value equal to the Fair Market Value
of one Share.
2.25 Retirement means a
Participants termination of employment on or after
(i) attaining age 65 or (ii) attaining
age 55 and completing 10 years of service with the
Company or Alcan Inc.
2.26 Shares means shares of the
Common Stock of the Company, no par value.
2.27 Short Term Incentive means an
incentive payment described in Section 8.1.
2.28 SAR means an award of a
contractual right granted pursuant to Article VI to receive
an amount equal to the appreciation in the Companys Shares
over a specified period.
2.29 Subsidiary means a
corporation or other entity in which the Company owns or
controls directly or indirectly more than 50% of the total
combined voting power represented by all classes of stock issued
by such corporation at the time of such grant.
F-3
ARTICLE III
SHARES AVAILABLE
UNDER THE PLAN
3.1 Reserved Shares. Subject to
adjustment as provided in Section 3.4, the maximum number
of Shares that may be issued or transferred pursuant to this
Plan shall not exceed 7,000,000 Shares. Such Shares may be
Shares of original issuance, Shares held in treasury, or Shares
that have been reacquired by the Company. Any shares of Common
Stock that are subject to Awards other than Options or SARs
shall be counted against such overall Plan limit as
1.75 Shares for every Share granted.
3.2 Stock Option Maximum. In no
event shall the number of Shares issued upon the exercise of
Incentive Stock Options exceed 3,000,000 Shares, subject to
adjustment as provided in Section 3.4.
3.3 Maximum Calendar Year Award. No
Employee may receive Awards representing more than
750,000 Shares or $20,000,000 in any one calendar year,
subject to adjustment as provided in Section 3.4. The
maximum number of Shares that may be granted to a Non-Employee
Director shall not exceed 7,500 Shares in any one calendar
year, subject to adjustment as provided in Section 3.4.
3.4 Adjustments. The Committee
shall make such adjustments in (a) the number of Shares
covered by outstanding Awards granted hereunder, (b) prices
per share applicable to outstanding Options and SARs, and
(c) the kind of shares covered thereby (including shares of
another issuer), as the Committee determines to be equitable in
order to prevent dilution or enlargement of the rights of
Participants that otherwise would result from any stock
dividend, stock split, combination or exchange of Shares,
reorganization, partial or complete liquidation or other
distribution of assets (other than a normal cash dividend),
recapitalization or other change in the capital structure of the
Company, or other corporate transaction or event having an
effect similar to any of the foregoing. Adjustments under this
Section 3.4 shall be made by the Committee, whose
determinations with regard thereto shall be final and binding
upon all persons.
3.5 Fractional Shares. The Company
shall not be required to issue any fractional Shares pursuant to
this Plan. The Committee may provide for the elimination of
fractions or for the settlement thereof in cash.
3.6 Unused and Forfeited
Shares. Shares related to Awards that are
forfeited, terminated, expire unexercised, tendered by a
Participant in connection with the exercise of an Award,
withheld from issuance in connection with a Participants
payment of tax withholding liability, settled in cash in lieu of
Shares, or settled in such other manner so that a portion or all
of the Shares included in an Award are not issued to a
Participant shall become automatically available for other
Awards. Notwithstanding the foregoing, any Shares used for full
or partial payment of the purchase price of the Shares with
respect to which an Option is exercised and any Shares retained
by the Company pursuant to Section 12.1 that were
originally Incentive Stock Option Shares shall be considered as
having been granted for purposes of determining whether the
Share limitation provided for in Section 3.2 has been
reached for purposes of Incentive Stock Option grants.
ARTICLE IV
PLAN
ADMINISTRATION
4.1 Board Committee
Administration. This Plan shall be administered
by the Human Resource Committee of the Board (or such other
Committee appointed by the Board from among its Non-Employee
Directors), provided that the full Board may act at any time as
the Committee. Notwithstanding the foregoing, the full Board
shall be responsible for the administration of Awards to
Non-Employee Directors.
4.2 Duties and Powers. The
Committee shall have the full power and discretion to
administer, construe, and apply the provisions of the Plan and
any Award.
4.3 Committee Delegation. The
Committee may delegate to one or more officers of the Company
the authority to grant Awards to Participants who are not
Covered Employees of the Company, provided that the Committee
shall have fixed the total number of shares of Stock subject to
such grants.
F-4
4.4 Determinations Binding. All
actions taken or determinations made by the Committee, in good
faith, with respect to the Plan, an Award or any Award Agreement
shall not be subject to review by anyone, but shall be final,
binding and conclusive upon all persons interested in the Plan
or any Award. No member of the Committee shall be liable to any
person for any such action taken or determination made in good
faith.
ARTICLE V
PERFORMANCE
AWARDS
5.1 General. The Committee may from
time to time authorize grants to Participants of Performance
Awards upon such terms and conditions as the Committee may
determine in accordance with provisions of this Article V.
Performance Awards shall be evidenced by an Award Agreement
containing such terms and provisions as the Committee may
determine consistent with this Plan.
5.2 Incentive Opportunity. Prior to
the beginning of each Performance Period, the Committee shall
specify the value of the opportunity subject to the number of
Performance Shares or Performance Units to which the Performance
Award pertains.
5.3 Performance Period. The
Performance Period with respect to each Performance Award shall
commence and end as of the dates determined by the Committee
under the terms of the applicable Award Agreement.
5.4 Performance Objectives. Each
Performance Award shall specify the Performance Objectives that
must be achieved before such Award shall become vested and
payable. The Committee may adjust such Performance Objectives
if, in the sole judgment of the Committee, events or
transactions have occurred after the grant that are unrelated to
the performance of the Company
and/or
Participant and result in distortion of the Performance
Objectives. The Committee also may specify a minimum acceptable
level of achievement below which no payment will be made and may
set forth a formula for determining the amount of any payment to
be made if performance is at or above such minimum acceptable
level but falls short of the maximum achievement of the
specified Performance Objectives.
5.5 Payment in Cash or Shares. The
amount payable upon the completion of the Performance Period and
the achievement of the Performance Objectives with respect to
any Performance Award may be paid by the Company in cash, Shares
or any combination thereof and may either grant to the
Participant or reserve to the Committee the right to elect among
those alternatives. The determination of the payment in cash or
Shares will be made at the beginning of the Performance Period,
unless otherwise specified by the Committee.
5.6 Dividend Equivalents. Prior to
the expiration of a Performance Period and payment of any Shares
or cash earned with respect to a Performance Award, no dividend
equivalents shall be paid or payable with respect to such Award.
5.7 Effect of Termination of Employment.
(i) Unless otherwise specified by the Committee, in the
event that the employment of a Participant shall terminate for
any reason other than Retirement, Cause, Disability or death
prior to the payment of any Performance Award granted to such
Participant, all Performance Awards that have not paid as of the
date of such termination shall be forfeited.
(ii) Unless otherwise specified by the Committee, in the
event that the employment of a Participant with the Company
shall terminate on account of the Retirement, death, or
Disability of the Participant prior to the payment of any
Performance Award granted to such Participant, a pro rata
portion of such Performance Award shall be payable to such
Participant following the end of the applicable Performance
Period. The amount payable pursuant to the preceding sentence
shall be determined by assuming that 100% of such Performance
Award was earned at the time of such termination of employment,
and by multiplying the earned amount by a fraction, the
numerator of which shall be the number of days that have elapsed
in the applicable Performance Period prior to the
Participants termination of employment and the denominator
of which shall be the total number of days in the Performance
Period.
F-5
(iii) In the event of the termination of a
Participants employment for Cause, all outstanding
Performance Awards granted to such Participant shall be
forfeited.
5.8 Effect of Change in
Control. Unless otherwise specified by the
Committee, a pro rata portion of a Participants
Performance Awards shall be payable to such Participant within
ten days following a Change in Control. The amount payable
pursuant to the preceding sentence shall be determined by
assuming that 100% of such Performance Awards were earned at the
time of such Change in Control, and by multiplying the earned
amount by a fraction, the numerator of which shall be the number
of days that have elapsed in the applicable Performance Period
prior to the Change in Control and the denominator of which
shall be the total number of days in the Performance Period.
ARTICLE VI
OPTIONS AND
SARS
6.1 General. The Committee may from
time to time authorize grants to Participants of Options
and/or SARs
upon such terms and conditions as the Committee may determine in
accordance with provisions of this Article VI. Options and
SARs shall be evidenced by an Award Agreement containing such
terms and provisions as the Committee may determine consistent
with this Plan.
6.2 Number of Options or SARs. Each
grant shall specify the number of Shares subject to the Option.
6.3 Exercise Price. Each grant
shall specify an exercise price per Option Share or SAR,
provided that in no event shall the exercise price be less than
the Fair Market Value per Share on the Grant Date.
6.4 Consideration for Options. The
form of consideration to be paid in satisfaction of the exercise
price of an Option and the manner of payment of such
consideration include (i) cash in the form of currency or
check or other cash equivalent acceptable to the Company,
(ii) nonforfeitable, unrestricted Shares owned by the
Participant which have a value at the time of exercise that is
equal to the option price, (iii) any other legal
consideration that the Committee may deem appropriate, on such
basis as the Committee shall determine in accordance with this
Plan, or (iv) any combination of the foregoing.
Notwithstanding the foregoing, to the extent permitted by
applicable law, any grant may provide for payment of the
exercise price of an Option from the proceeds of sale through a
bank or broker on the date of exercise of some or all of the
Shares to which the exercise relates.
6.5 Payment for SARs. Upon exercise
of a SAR, a Participant shall be entitled to receive payment
from the Company in an amount determined by multiplying
(i) the difference between the Fair Market Value of a Share
on the date of exercise over the exercise price, times
(ii) the number of Shares with respect to which the SAR is
exercised. Any grant may specify that the amount payable upon
the exercise of a SAR may be paid by the Company in cash, Shares
or any combination thereof and may either grant to the
Participant or reserve to the Committee the right to elect among
those alternatives.
6.6 Performance-Based Options and
SARs. Any grant of an Option or SAR may specify
Performance Objectives that must be achieved as a condition to
vesting
and/or
exercise of the Option or SAR.
6.7 Vesting. Each Option or SAR
grant may specify the conditions that must be satisfied before
the Options or SARs (or installments thereof) shall become
vested and exercisable.
6.8 ISO Dollar Limitation. Options
granted under this Plan may be Incentive Stock Options,
Nonqualified Stock Options or a combination of the foregoing.
Each grant shall specify whether (or the extent to which) the
Option is an Incentive Stock Option or a Nonqualified Stock
Option. Notwithstanding any such designation, to the extent that
the aggregate Fair Market Value of the Shares with respect to
which Options designated as Incentive Stock Options are
exercisable for the first time by a Participant during any
calendar year (under all plans of the Company) exceeds $100,000,
such Options shall be treated as Nonqualified Stock Options.
6.9 Exercise Period. Any grant may
specify (i) a waiting period or periods before Options or
SARs shall become exercisable and (ii) permissible dates or
periods on or during which Options or SARs shall be
F-6
exercisable. No Option or SAR granted under this Plan may be
exercised more than seven years from the Grant Date. In
addition, the exercise period for any Incentive Stock Option for
a Participant possessing more than 10% of the voting power of
all classes of stock of the Company shall not exceed five years.
The Committee may not extend the exercise period of an
outstanding Option or SAR beyond the time originally prescribed
in the Award Agreement, except to the extent permitted under
Code Section 409A and U.S. Department of Treasury
regulations or other guidance issued thereunder.
6.10 Repricing and Backdating
Prohibited. The Committee shall not reprice any
outstanding Option or SAR including the cancellation of an
existing Option or SAR and substitution of a new Option or SAR
with a lower exercise price, directly or indirectly, without the
approval of the stockholders of the Company, provided that
nothing herein shall prevent the Committee from taking any
action provided for in Section 3.4. In no event shall the
Grant Date of any Option or SAR be earlier than the date on
which the Committee takes action with respect thereto.
6.11 Notification of Disqualifying
Disposition. If any Participant shall make any
disposition of Shares issued pursuant to the exercise of an
Incentive Stock Option under the circumstances described in
Section 421(b) of the Code (relating to certain
disqualifying dispositions), such Participant shall notify the
Company of such disposition within ten (10) days thereof.
6.12 Effect of Termination of Employment.
(i) Unless otherwise provided in an applicable Award
Agreement, in the event that the employment of a Participant
shall terminate for any reason other than Retirement, Cause,
Disability or death, (a) Options and SARs granted to such
Participant, to the extent that they were exercisable at the
time of such termination, shall remain exercisable until the
expiration of 90 days after such termination, on which date
they shall expire, and (b) Options and SARs granted to such
Participant, to the extent that they were not exercisable at the
time of such termination, shall expire at the close of business
on the date of such termination; provided however, no
Option or SAR shall be exercisable after the expiration of its
term.
(ii) Unless otherwise provided in an applicable Award
Agreement, in the event that the employment of a Participant
shall terminate on account of the Retirement, death, or
Disability of the Participant, (a) Options and SARs granted
to such Participant, to the extent that they were exercisable at
the time of such termination, shall remain exercisable until the
expiration of one year after such termination, on which date
they shall expire, and (b) Options and SARs granted to such
Participant, to the extent that they were not exercisable at the
time of such termination, shall expire at the close of business
on the date of such termination; provided however, no
Option or SAR shall be exercisable after the expiration of its
term.
(iii) In the event of the termination of a
Participants employment for Cause, all outstanding Options
and SARs granted to such Participant (regardless of whether or
not exercisable at the time of such termination) shall expire at
the commencement of business on the effective date of such
termination (or deemed termination).
6.13 Effect of Change in
Control. Unless otherwise provided in an
applicable Award Agreement, all Options and SARs granted to
Participants who are employed by the Company or a Subsidiary at
the time of such Change in Control shall become fully vested and
exercisable.
ARTICLE VII
RESTRICTED
SHARES AND RESTRICTED SHARE UNITS
7.1 General. The Committee may from
time to time authorize grants to Participants of Restricted
Shares
and/or
Restricted Share Units upon such terms and conditions as the
Committee may determine in accordance with provisions of this
Article VII. Each grant of Restricted Share and Restricted
Share Units shall be evidenced by an Award Agreement containing
such terms and provisions as the Committee may determine
consistent with this Plan.
F-7
7.2 Number of Restricted Shares or
Units. Each grant shall specify the number of
Restricted Shares or Restricted Share Units to which it pertains.
7.3 Transfer of Shares. Each grant
of Restricted Shares shall constitute an immediate transfer of
the ownership of Shares to the Participant in consideration of
the performance of services, subject to the restrictions on
transfer hereinafter referred to. Each grant of Restricted Stock
Units shall constitute the agreement by the Company to issue or
transfer Shares, cash or a combination thereof to the
Participant in the future subject to the fulfillment of such
conditions as the Committee may specify.
7.4 Consideration. Each grant of
Restricted Shares or Restricted Share Units may be made without
additional consideration from the Participant or in
consideration of a payment by the Participant that is less than
the Fair Market Value per share or unit on the Grant Date.
7.5 Substantial Risk of
Forfeiture. Each grant of Restricted Shares shall
provide that the Restricted Shares covered thereby shall be
subject to a substantial risk of forfeiture within
the meaning of Code Section 83 for a period to be
determined by the Committee on the Grant Date. If any
Participant makes an election under Code Section 83(b) with
respect to any Restricted Shares granted hereunder, such
Participant shall notify the Company with ten days of such
election.
7.6 Dividends, Voting and Other Ownership
Rights. Unless otherwise provided in an
applicable Award Agreement, an Award of Restricted Shares shall
entitle the Participant to dividend, voting and other ownership
rights during the period for which such substantial risk of
forfeiture is to continue. Any Award of Restricted Shares may
require that any or all dividends or other distributions paid on
the Restricted Shares during the period of such restrictions be
automatically sequestered and reinvested on an immediate or
deferred basis in additional Shares, which may be subject to the
same restrictions as the underlying Award or such other
restrictions as the Committee may determine. To the extent set
forth in a Participants Award Agreement with respect to
Restricted Stock Units, a Participant shall be entitled to
receive dividend equivalents payable in cash or additional
Shares on a current, deferred or contingent basis.
7.7 Performance-Based Restricted Shares and
Restricted Stock Units. Any grant of Restricted
Shares or Restricted Stock Units may specify Performance
Objectives that must be achieved as a condition of vesting
and/or
payment of such Restricted Shares or Restricted Stock Units.
7.8 Effect of Termination of Employment.
(i) Unless otherwise provided in an applicable Award
Agreement, in the event that the employment of a Participant
shall terminate for any reason other than Retirement, Cause,
Disability or death prior to the vesting of Restricted Shares or
Restricted Stock Units granted to such Participant, all
Restricted Shares and Restricted Stock Units that have not
vested as of the date of such termination shall be forfeited.
(ii) Unless otherwise provided in an applicable Award
Agreement, in the event that the employment of a Participant
shall terminate on account of the Retirement, death or
Disability of the Participant prior to the vesting of Restricted
Shares or Restricted Stock Units granted to such Participant, a
proportion of such Restricted Shares and Restricted Stock Units,
to the extent not forfeited or canceled on or prior to such
termination pursuant to any provision hereof, shall vest on the
date of such termination. The proportion referred to in the
preceding sentence shall be determined by multiplying the
Participants non-vested Restricted Shares or Restricted
Stock Units by a fraction, the numerator of which shall be the
number of days that have elapsed in the applicable vesting
period prior to the Participants termination of employment
and the denominator of which shall be the total number of days
in such vesting period.
(iii) In the event a Participants employment is or is
deemed to have been terminated for Cause, all Restricted Shares
and Restricted Stock Units granted to such Participant that have
not vested as of the effective date of such termination shall be
forfeited.
7.9 Effect of Change in
Control. Unless otherwise provided in an
applicable Award Agreement, all Restricted Shares and Restricted
Stock Units granted to Participants who are employed by the
Company or a Subsidiary at the time of such Change in Control
shall become fully vested and non-forfeitable.
F-8
ARTICLE VIII
SHORT-TERM
INCENTIVES AND OTHER AWARDS
8.1 Short-Term Incentives. For each
fiscal year of the Company, the Committee may establish an
incentive pool or other incentive structure or policy with
respect to Participants who are not Non-Employee Directors. Any
such incentive pool, structure or policy shall be subject to
such terms, restrictions and conditions determined by the
Committee and consistent with the terms of this Plan. Short-Term
Incentives may be paid in the form of cash, Shares or a
combination thereof as determined by the Committee in it
discretion. Payment of such Short-Term Incentives shall be
subject to the following:
(i) Unless otherwise specified by the Committee, in the
event that the employment of a Participant shall terminate for
any reason other than Retirement, Cause, Disability or death
prior to the payment date of any Short-Term Incentive, such
incentive opportunity shall be forfeited in its entirety.
(ii) Unless otherwise specified by the Committee, in the
event that the employment of a Participant with the Company
shall terminate on account of the Retirement, death, or
Disability of the Participant prior to the payment date of any
Short-Term Incentive, a pro rata portion of such Short-Term
Incentive shall be payable to such Participant following the end
of the applicable Performance Period. The amount payable
pursuant to the preceding sentence shall be determined by
assuming that 100% of such Short-Term Incentive was earned at
the time of such termination of employment, and by multiplying
the earned amount by a fraction, the numerator of which shall be
the number of days that have elapsed in the applicable
Performance Period prior to the Participants termination
of employment and the denominator of which shall be the total
number of days in the Performance Period.
(iii) In the event of the termination of a
Participants employment for Cause, such Participants
incentive opportunity shall be forfeited in its entirety.
(iv) Unless otherwise specified by the Committee, a pro
rata portion of a Participants Short-Term Incentive shall
be payable to such Participant within ten days following a
Change in Control. The amount payable pursuant to the preceding
sentence shall be determined by assuming that 100% of such
Short-Term Incentive was earned at the time of such Change in
Control, and by multiplying the earned amount by a fraction, the
numerator of which shall be the number of days that have elapsed
in the applicable Performance Period prior to the Change in
Control and the denominator of which shall be the total number
of days in the Performance Period.
8.2 Other Stock Awards. The
Committee may, subject to limitations under applicable law,
grant to any Participant such other awards that may be
denominated or payable in, valued in whole or in part by
reference to, or otherwise based on, or related to, Shares or
factors that may influence the value of such Shares, including,
without limitation, convertible or exchangeable debt securities,
other rights convertible or exchangeable into Shares, purchase
rights for Shares, awards with value and payment contingent upon
performance of the Company or specified Subsidiaries, affiliates
or other business units thereof or any other factors designated
by the Committee, and awards valued by reference to the book
value of Shares or the value of securities of, or the
performance of specified Subsidiaries or affiliates or other
business units of the Company. The Committee shall determine the
terms and conditions of such awards. Shares delivered pursuant
to an award in the nature of a purchase right granted under this
Article VIII shall be purchased for such consideration,
paid for at such time, by such methods, and in such forms,
including, without limitation, cash, Shares, other awards, notes
or other property, as the Committee shall determine.
8.3 Payment In Lieu of Other
Obligations. The Committee may grant Shares as a
bonus, or may grant other awards in lieu of obligations of the
Company or a Subsidiary to pay cash or deliver other property
under this Plan or under other plans or compensatory
arrangements, subject to such terms as shall be determined by
the Committee.
F-9
ARTICLE IX
TRANSFERABILITY
9.1 Transfer Restrictions. No Award
granted under this Plan shall be transferable by a Participant
other than by will or the laws of descent and distribution, and
Options and SARs shall be exercisable during a
Participants lifetime only by the Participant or, in the
event of the Participants legal incapacity, by his
guardian or legal representative acting in a fiduciary capacity
on behalf of the Participant under state law. Any attempt to
transfer an Award in violation of this Plan shall render such
Award null and void.
9.2 Restrictions on Transfer. Any
Award made under this Plan may provide that all or any part of
the Shares that are (i) to be issued or transferred by the
Company upon the exercise of Options or SARs, upon the
termination of any deferral period applicable to Restricted
Share Units or upon payment of any Short-Term Incentives or
Performance Awards, or (ii) no longer subject to the
substantial risk of forfeiture and restrictions on transfer
referred to in Article VII, shall be subject to further
restrictions upon transfer.
ARTICLE X
DEFERRAL OF
AWARDS
10.1 General. The Committee may
permit Participants to elect to defer the issuance of Shares or
the settlement of Awards in cash under the Plan pursuant to such
rules, procedures or programs as it may establish for purposes
of this Plan. In the case of an Award of Restricted Shares, the
deferral may be effected by the Participants agreement to
forego or exchange his or her Award of Restricted Shares and to
receive an Award of Restricted Share Units. The Committee also
may provide that deferred settlements include the payment or
crediting of interest on the deferral amounts, or the payment or
crediting of dividend equivalents where the deferral amounts are
denominated in Shares.
10.2 Compliance with Code
Section 409A. To the extent any Award (or
portion thereof) provides for the deferral of compensation and
is subject to Code Section 409A, such deferred compensation
shall be subject to the following limitations and conditions:
(i) In no event shall any deferred compensation be
distributed earlier than separation from service, death,
disability, a time (or pursuant to a fixed schedule) specified
at the date of the deferral of such compensation, a change in
the ownership or effective control of the Company or in the
ownership of a substantial portion of the assets of the Company,
or the occurrence of an unforeseeable emergency.
(ii) In the case of a Participant who is a key employee, as
defined in Code Section 416(i), distribution due to
separation from service may not be made before the date which is
six months after the date of separation from service (or, if
earlier, the date of death of such Participant).
(iii) Except to the extent provided in U.S. Department
of Treasury regulations or other guidance, any deferred
compensation payable to a Participant may not be accelerated.
(iv) To the extent a Participant is offered an opportunity
to defer receipt of compensation for services performed during a
taxable year, such Participants deferral election must be
made not later than the close of the preceding taxable year (or
within 30 days of eligibility in the case of a newly
eligible individuals) or at such other time as provided in
U.S. Department of Treasury regulations or other guidance.
Notwithstanding the foregoing, in the case of any
performance-based compensation based on services performed over
a period of at twelve months, such election may be made no later
than six months before the end of such performance period.
(v) To the extent a Participant is offered an opportunity
to delay the payment date of any deferred compensation or to
change the form in which such deferred compensation shall be
paid, (a) the Participants new election may not take
effect for at least twelve months after the date on which the
election is made, (b) except in the case of an election
related to a payment due to disability, death or a change in
ownership or effective control of the Company, the first payment
with respect to which a new election is made must provide for a
deferral period of not less than five years from the date such
payment
F-10
would otherwise have been made, and (c) any election
relating to a specified time (or pursuant to a fixed schedule)
may not be made less than twelve months prior to the date of the
first scheduled payment.
To the extent applicable, the Plan and Award Agreements shall be
interpreted in accordance with Code Section 409A and
U.S. Department of Treasury regulations and other
interpretative guidance issued thereunder, including without
limitation any regulations or other guidance that may be issued
after the effective date of this Plan. Notwithstanding any
provision of the Plan to the contrary, in the event that
following the effective date of this Plan any Award is subject
to Code Section 409A and related U.S. Department of
Treasury guidance (including such U.S. Department of
Treasury guidance as may be issued after the effective date of
the Plan), the Committee may adopt such amendments to the Plan
and applicable Award Agreements or adopt other policies and
procedures (including amendments, policies and procedures
retroactive effect), or take any other actions, that the
Committee determines are necessary or appropriate to exempt the
Award from Code Section 409A
and/or
preserve the intended tax treatment of the benefits provided
with respect to the Award, or comply with the requirements of
Code Section 409A and related U.S. Department of
Treasury guidance.
ARTICLE XI
PERFORMANCE
OBJECTIVES
11.1 General. Performance
Objectives means the performance objectives established pursuant
to this Plan for Participants who have received Awards.
Performance Objectives may be described in terms of Company-wide
objectives or objectives that are related to the performance of
an individual Participant or the Subsidiary, division,
department or function within the Company or Subsidiary in which
the Participant is employed. Performance Objectives may be
measured on an absolute or relative basis. Relative performance
may be measured by comparison to a group of peer companies or to
a financial market index. Any Performance Objectives applicable
to a Qualified Performance-Based Award are intended to be
performance-based under Code Section 162(m) and
shall be limited to specified levels of or increases in one or
more of the following Performance Objectives: return on equity,
regional income, diluted earnings per share, net earnings, total
earnings, earnings growth, return on capital, working capital
turnover, return on assets, earnings before interest and taxes,
sales, sales growth, gross margin return on investment, increase
in the fair market value of the Shares, share price (including
but not limited to, growth measures and total stockholder
return), operating profit, cash flow (including, but not limited
to, operating cash flow and free cash flow), cash flow return on
investment (which equals net cash flow divided by total
capital), inventory turns, financial return ratios, total return
to stockholders, market share, earnings measures/ratios,
economic value added, balance sheet measurements such as
receivable turnover, internal rate of return, increase in net
present value or expense targets, productivity and satisfaction
of environment, health and safety targets.
11.2 Adjustments of Performance
Objectives. Subject to any limitation under Code
Section 162(m) with respect to Covered Employees, the
Committee shall adjust Performance Objectives and the related
minimum acceptable level of achievement if, in the sole judgment
of the Committee, events or transactions have occurred after the
Grant Date that are unrelated to the performance of the Company
and/or
Participant and result in distortion of the Performance
Objectives or the related minimum acceptable level of
achievement. Potential transactions or events giving rise to
adjustment include but are not limited to
(i) restructurings, discontinued operations, extraordinary
items or events, and other unusual or non-recurring charges;
(ii) an event either not directly related to the operations
of the Company or not within the reasonable control of the
Companys management; or (iii) a change in tax law or
accounting standards required by generally accepted accounting
principles.
ARTICLE XII
MISCELLANEOUS
12.1 Withholding Taxes. To the
extent that the Company is required to withhold federal, state,
local or foreign taxes in connection with any payment made or
benefit realized by a Participant or other person under this
Plan, the Committee may withhold any amounts necessary to
collect any withholding taxes upon any
F-11
taxable event relating to an Award. At the discretion of the
Committee, such arrangements may include relinquishment of a
portion of such benefit payable in cash or Shares.
12.2 Change in
Control. Notwithstanding any provision in this
Plan or an Award Agreement to the contrary, in the event that
the Company undergoes a Change in Control, or in the event the
Company shall become a party to any corporate merger,
consolidation, major acquisition of property for stock,
separation, reorganization or liquidation, the Committee (or the
board of directors of any corporation assuming the obligations
of the Company) shall have the sole and absolute power and
discretion to prescribe and amend the terms and conditions for
the exercise, or modification, of any outstanding Awards granted
hereunder. Such power and discretion shall include, but shall
not be limited to, the power and authority to remove
restrictions on Restricted Shares, to modify the performance
requirements for any Awards, and to provide that Options or SARs
granted hereunder must be exercised in connection with the
closing of such transaction and that if not so exercised such
Options and SARs will expire. Any such determinations by the
Committee may be made generally with respect to all
Participants, or may be made on a
case-by-case
basis with respect to particular Participants. Notwithstanding
the foregoing, any transaction undertaken for the purpose of
reincorporating the Company under the laws of another
jurisdiction, if such transaction does not materially affect the
beneficial ownership of the Companys capital, shall not
constitute a merger, consolidation, major acquisition of
property for stock, separation, reorganization, liquidation, or
Change in Control.
12.3 Certain Terminations of Employment, Hardship
and Approved Leaves of Absence. Notwithstanding
any other provision of this Plan to the contrary, in the event
of termination of employment by reason of death, Disability,
Retirement or leave of absence approved by the Company, or in
the event of hardship or other special circumstances, of a
Participant who holds an Option or SAR that is not immediately
and fully exercisable, any Restricted Shares as to which the
substantial risk of forfeiture or the prohibition or restriction
on transfer has not lapsed, any Restricted Share Units as to
which any deferral period is not complete, any Performance
Awards that have not been fully earned, or any Shares that are
subject to any transfer restriction, the Committee may in its
sole discretion take any action that it deems to be equitable
under the circumstances or in the best interests of the Company,
including, without limitation, waiving or modifying any
limitation or requirement with respect to any Award under this
Plan.
12.4 Right of Recapture. If, at any
time within one year after the date on which a Participant
exercises an Option or SAR or on which Restricted Shares or
Restricted Share Units vest or on which income is realized by a
Participant in connection with any other Award (each of which
events shall be a realization event), the Committee
determines in its discretion that the Company has been
materially harmed by the Participant, whether such harm
(a) results in the Participants termination or deemed
termination of employment for Cause or (b) results from any
activity of the Participant determined by the Committee to be in
competition with any activity of the Company, or otherwise
prejudicial, contrary or harmful to the interests of the Company
(including, but not limited to, accepting employment with or
serving as a consultant, adviser or in any other capacity to an
entity that is in competition with or acting against the
interests of the Company), then any gain realized by the
Participant from the realization event shall be paid by the
Participant to the Company upon notice from the Company. Such
gain shall be determined as of the date of the realization
event, without regard to any subsequent change in the Fair
Market Value of the Companys Shares. The Company shall
have the right to offset such gain against any amounts otherwise
owed to the Participant by the Company (whether as wages,
vacation pay, or pursuant to any benefit plan or other
compensatory arrangement).
12.5 Foreign Participants. To
facilitate the making of any Award or combination of Awards
under this Plan, the Committee may provide for such special
terms for Awards to Participants who are foreign nationals, or
who are employed by or perform services for the Company or any
Subsidiary outside of the United States of America, as the
Committee may consider necessary or appropriate to accommodate
differences in local law, tax policy or custom. Moreover, the
Committee may approve such supplements to, or amendments,
restatements or alternative versions of, this Plan as it may
consider necessary or appropriate for such purposes without
thereby affecting the terms of this Plan as in effect for any
other purpose, provided that no such supplements, amendments,
restatements or alternative versions shall include any
provisions that are inconsistent with the terms of this Plan, as
then in effect, unless this Plan could have been amended to
eliminate such inconsistency without further approval by the
stockholders of the Company.
F-12
12.6 Amendment or Termination. This
Plan may be amended or terminated at any time by action of the
Board; provided that (i) no amendment may increase any of
the limitations specified in Article III, other than to
reflect an adjustment made in accordance with Section 3.4,
without the further approval of the stockholders of the Company,
and (ii) subject to Section 12.2, no amendment or
termination may in any manner adversely affect any Awards
theretofore granted under the Plan without the consent of the
Participants holding such Awards. The Board may condition any
amendment or termination on the approval of the stockholders of
the Company if such approval is necessary or deemed advisable
with respect to the applicable listing or other requirements of
a national securities exchange or other applicable laws,
policies or regulations.
12.7 Conditional Awards. The
Committee may condition the grant of any Award or combination of
Awards under the Plan on the surrender or deferral by the
Participant of his or her right to receive a cash bonus or other
compensation otherwise payable by the Company or any Subsidiary
to the Participant.
12.8 No Employment Right. This Plan
shall not confer upon any Participant any right with respect to
continuance of employment or other service with the Company or
any Subsidiary and shall not interfere in any way with any right
that the Company or any Subsidiary would otherwise have to
terminate any Participants employment or other service at
any time.
12.9 Tax Qualification. To the
extent that any provision of this Plan would prevent any Option
that was intended to qualify under particular provisions of the
Code from so qualifying, such provision of this Plan shall be
null and void with respect to such Option, provided that such
provision shall remain in effect with respect to other Options,
and there shall be no further effect on any provision of this
Plan.
12.10 Duration of the Plan. Unless
sooner terminated in accordance with Section 12.6, this
Plan shall automatically terminate on the fifth anniversary of
the date upon which it is approved by the stockholders of the
Company, and no Award shall be granted after such fifth
anniversary.
12.11 Limitations Period. Any
person who believes he or she is being denied any benefit or
right under the Plan may file a written claim with the
Committee. Any claim must be delivered to the Committee within
forty-five (45) days of the specific event giving rise to
the claim. Untimely claims will not be processed and shall be
deemed denied. The Committee, or its designated agent, will
notify the Participant of its decision in writing as soon as
administratively practicable. Claims not responded to by the
Committee in writing within ninety (90) days of the date
the written claim is delivered to the Committee shall be deemed
denied. The Committees decision shall be final and
conclusive and binding on all persons. No lawsuit relating to
the Plan may be filed before a written claim is filed with the
Committee and is denied or deemed denied and any lawsuit must be
filed within one year of such denial or deemed denial or be
forever barred.
12.12 Governing Law. The validity,
construction and effect of this Plan and any Award hereunder
will be determined in accordance the laws of state of Georgia.
12.13 Investment
Representations. As a condition to the exercise
or granting of an Award, the Committee may require the person
exercising or receiving such Award to represent and warrant that
the Shares are being purchased only for investment and without
any present intention to sell or distribute such Shares if, in
the opinion of counsel for the Company, such a representation is
required.
12.14 Uncertificated Shares. To the
extent that the Plan provides for issuance of certificates to
reflect the transfer of Shares, the transfer of such Shares may
be effected on a non-certificated basis, to the extent not
prohibited by applicable law or the rules of any stock exchange.
12.15 Unfunded Plan. Participants
shall have no right, title, or interest whatsoever in or to any
investments that the Company may make to aid it in meeting its
obligations under the Plan. Nothing contained in the Plan, and
no action taken pursuant to its provisions, shall create or be
construed to create a trust of any kind, or a fiduciary
relationship between the Company and any Participant,
beneficiary, legal representative or any other person. To the
extent that any person acquires a right to receive payments from
the Company under the Plan, such right shall be no greater than
the right of an unsecured general creditor of the Company. All
payments to be made hereunder shall be paid from the general
funds of the Company and no special or
F-13
separate fund shall be established and no segregation of assets
shall be made to assure payment of such amounts except as
expressly set forth in the Plan.
12.16 Beneficiary Designation. Each
Participant under the Plan may, from time to time, name any
beneficiary or beneficiaries (who may be named contingently or
successively) to whom any benefit under the Plan is to be paid
in case of his or her death before he or she receives any or all
of such benefit. Each such designation shall revoke all prior
designations by the same Participant, shall be in a form
prescribed by the Committee, and will be effective only when
filed by the Participant in writing with the Committee during
the Participants lifetime. In the absence of any such
designation, benefits remaining unpaid at the Participants
death shall be paid to the Participants estate.
F-14
|
|
|
Proxy
|
|
|
This Proxy is solicited by the Board of Directors and
Management for the Annual Meeting of Shareholders (the
Meeting) on October 26, 2006 at The Westin
Buckhead Atlanta, 3391 Peachtree Road, Atlanta, GA 30326.
The undersigned holder of common shares of Novelis Inc.
(Shares), Inc. hereby appoints William T. Monahan,
or failing him, Nichole A. Robinson, or instead of the
foregoing,
,
as the proxy of the undersigned, with full power of
substitution, to attend, vote and otherwise act for and on
behalf of the undersigned in respect of all matters that may
come before the Meeting or any postponement or adjournment
thereof to the same extent and with the same power as if the
undersigned were personally present, and hereby revokes any
proxy previously given.
Without limiting the general authorization and powers hereby
given, the proxyholder is specifically directed to vote as
follows:
|
|
|
|
|
1. Election of Directors
|
|
2. Appointment of
PricewaterhouseCoopers LLP as independent registered public
accounting firm and authorize directors to fix remuneration
|
|
|
|
o FOR
all nominees listed below
(except as marked)
|
|
o FOR o WITHHOLD
|
|
|
|
o WITHHOLD
vote for all nominees listed
below
|
|
3. Approval of the
Novelis Inc. 2006 Incentive Plan
|
|
|
|
|
|
01. William T. Monahan
02. Edward A. Blechschmidt
03. Jacques Bougie, O.C.
04. Charles G. Cavell
05. Clarence J. Chandran
06. C. Roberto Cordaro
07. Helmut Eschwey
|
|
08. David J. Fitzpatrick
09. Suzanne Labarge
10. Rudolf Rupprecht
11. Kevin M. Twomey
12. John D. Watson
13. Edward V. Yang
|
|
o FOR o AGAINST o WITHHOLD
4. To vote at the discretion of the proxyholder on any amendments or variations to the foregoing and on any other matters which may properly come before the meeting or any postponement or adjournment thereof.
|
|
(Instructions: To withhold
authority for any
individual nominee, strike through the nominees name in
the list above)
|
|
|
|
|
|
|
|
|
|
Signature
of Shareholder
|
|
|
|
|
|
|
|
|
|
Signature
of Co-owner
|
|
|
|
|
|
|
|
|
|
Dated this
_
_
day of
_
_
2006
|
See notes on reverse side
NOTES:
|
|
1.
|
If the Shares are registered in the name of more than one owner
(for example, joint ownership, trustees, executors, etc.), then
all those registered should sign this Proxy. When signing as
attorney, executor, administrator, trustee, guardian or
corporate officer, please give your full title after your name.
|
|
2.
|
If this Proxy is not dated, it will be deemed to bear the date
on which it is mailed by Novelis.
|
|
3.
|
If you appoint the persons whose names are printed above to act
as your proxyholders, the Shares represented by this Proxy will
be voted as directed. If no direction is given on any matter,
the Shares will be voted FOR Proposals 1, 2 and 3 and at
the discretion of the proxyholder on any amendments or
variations to the foregoing and on any other matters which may
properly come before the meeting or any postponement or
adjournment thereof.
|
|
4.
|
You have the right to appoint person(s), other than those
whose names are printed above, as your proxyholder(s), to attend
and act on your behalf at the Meeting. You may use the space
provided above (or another appropriate form of proxy) for that
purpose. You are advised that it is in your own interest to
specify a choice for voting in respect of each of the matters to
be acted upon at the Meeting.
|
Voting Options and Instructions:
Options available to convey your voting instructions are further
described in the Information Circular.
Registered shareholders may vote:
1. By mail;
2. On the Internet; or
3. By telephone.
1. To vote by mail:
|
|
|
|
n
|
Complete, sign and date the Proxy;
|
|
n
|
Return the Proxy by mail in the prepaid envelope provided or
return it to Novelis Inc., c/o CIBC Mellon Trust Company,
PO BOX 66297 STN BRM B TORONTO, ON M7Y 4K1 on or before
October 25th, 2006 by 5:00 pm (EDT) otherwise it
shall be invalid.
|
2. To vote on the Internet:
|
|
|
|
n
|
Use the Internet to transmit your voting instructions up until
noon (EDT) on October 25, 2006;
|
|
n
|
Have the Proxy in hand;
|
|
n
|
Go to the following website:
http://www.eproxyvoting.com/novelis; and
|
|
n
|
Enter your Control Number located on the front of your proxy
at the bottom right hand side and follow the instructions.
|
3. To vote by telephone:
|
|
|
|
n
|
Use any touch-tone phone to transmit your voting instructions up
until noon (EDT) on October 25, 2006;
|
|
|
|
|
n
|
Have the Proxy in hand;
|
|
|
|
|
n
|
Call 1-866-271-1207 in Canada and the U.S. only and;
|
|
n
|
Enter your Control Number located on the front of your proxy
at the bottom right hand side and follow the instructions.
|
Unregistered shareholders should contact their broker or other
nominee for further instructions on how to vote.